Investigating the effects of Cinnamomum-cassia nanoparticle conjugate on the Histomorphology of the kidney in type 2 diabetic rats. by Kouame, Koffi.
i 
 
Investigating the effects of Cinnamomum-cassia nanoparticle 
conjugate on the Histomorphology of the kidney in type 2 
diabetic rats. 
 
 
By 
 
KOFFI KOUAME  
207503022 
 
 
 
 
 
A Thesis submitted to 
Discipline of Clinical 
Anatomy 
School of Laboratory Medicine and Medical 
Sciences College of Health Sciences 
University of 
KwaZulu-Natal 
Durban, South Africa 
 
In fulfilment of the Requirement for the Degree 
of Doctor of Philosophy in Clinical Anatomy 
 
Supervisor: Prof Onyemaechi Okpara Azu 
Co-Supervisors: Dr Coleridge Stephen Naidu  
                             Dr Aniekan Imo Peter   
ii 
 
Investigating the effects of Cinnamomum-cassia nanoparticle 
conjugate on the Histomorphology of the kidney in type 2 
diabetic rats. 
 
 
   By 
 
KOFFI KOUAME  
207503022 
 
 
 
 
 
A Thesis submitted to 
Discipline of Clinical 
Anatomy 
School of Laboratory Medicine and Medical 
Sciences College of Health Sciences 
University of 
KwaZulu-Natal 
Durban, South Africa 
          
In fulfilment of the Requirement for the Degree 
of Doctor of Philosophy in Clinical Anatomy 
Supervisor: Prof Onyemaechi Okpara Azu 
Co-Supervisor: Dr Coleridge Stephen Naidu  
                            Dr Aniekan Imo Peter   
                                               January 2019
ii 
 
 
 
Preface 
 
The study described in this thesis was carried out in the Discipline of Clinical Anatomy, 
School of Laboratory Medicine and Medical Sciences, College of Health Sciences, 
University of KwaZulu-Natal, Durban, South Africa from February 2016 to April 2019, 
under the supervision    of Prof. O.O. Azu, Dr. E.C. S Naidu and Dr A. I. Peter for the award 
of Doctor of Philosophy Degree in Clinical Anatomy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
 
Declaration 
 
I, Mr. KOFFI KOUAME, declare as follows: 
That the work described in this thesis, to my knowledge, has not been submitted to UKZN or any 
other tertiary institution for the purpose of obtaining an academic qualification, whether by myself or 
any other party. 
That my contributions to the project were as follows: 
I was involved in the design and submission of the proposal for ethics approval by the University 
Animal Research Ethics Committee. 
I was wholly responsible for carrying out the experiments and data and sample collection. 
I performed all sample analyses, collate and did all the data analyses. 
I was responsible for the writing of all the manuscripts and the thesis. 
This thesis does not contain other person’s written, data, pictures or other information unless 
specifically acknowledged as being sourced from other persons or researchers. Where other written 
sources have been quoted then: 
Their words have been re-written but the general information attributed to them has been referenced 
Where their exact word has been used, then it has been properly referenced in the reference section. 
 
 
  .                                                   25-04-2019 
Signed                                                                                                                                  Date 
 
 
 
 
iv 
 
 
 
Dedication 
 
To   GOD, the owner and source of knowledge and understanding as well as to My family. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
Acknowledgements 
 
I deeply acknowledge THE LORD, my creator, my pillar and source of inspiration for His grace, 
wisdom, knowledge, and understanding he has bestowed upon me all through the period of this study. 
On your wings only have I soared, I am thankful Lord! 
I would like to express my sincere gratitude to my Supervisor Prof O.O Azu, my Co-supervisors Dr 
E. C. S. Naidu and Dr A. I. Peter for their continuous support, patience and mentorship to pursue a 
Doctor of Philosophy Degree. I could not have imagined having better advisors and mentors for my 
Ph.D. study. I am really grateful. 
I appreciate the support and contributions of all the people I worked with in the Morphology and 
Andrology group at various stages/time during my study. Prof. Onyemaechi Azu, DR. Edwin Naidu, 
DR. Aniekan Peter, DR. Edidiong Akang, DR. Ifeoluwa Okewumi, DR onanuga ismail, DR. Tosin 
Ogedengbe, Ugochukwu Offor, DR. Misturah Adana, Thato Mogologolo, Slindile Mdlalose, DR. 
Aung khaing Zaw and Tebatso manyaka. 
I acknowledge the College of Health Sciences, UKZN for their financial support to my study. This 
work is partly supported by the National Research Foundation of South Africa to the grant awarded 
to Prof OO Azu (Unique Grant no: U 99053) 
 and Dr Roshila Moodley (Unique Grant no. 94041). We also thank the School of Chemistry and 
Physics, UKZN (Westville Campus) especially the support of Judie Magura and Bongisiwe 
Shelembe.  
 I also acknowledge the UKZN Nanotechnology Platform. 
My thanks to the Staff of Biomedical Resource Unit, for their enormous assistance.  
I also acknowledge and appreciate the support I received from Professor Moses Chimbari (Former 
Dean of Research, College of Health Sciences, UKZN) during my study.  
I appreciate very immensely the assistance of Ms MaryAnn Marilyn Francis: Public Relations 
Manager- College of Health Sciences. 
THANK YOU GOD THE FATHER, THANK YOU GOD THE SON, THANK YOU GOD THE 
HOLY SPIRIT 
 
vi 
 
 
Table of contents                                                                                                                           Page 
Title page………………………………………………………………………..……………………i 
Preface…………………………………..…………………………………………….……………...ii 
Declaration………………..…………………………………………………………………………iii 
Dedication………………………………………………………..……………….……………...…. iv 
Acknowledgements………………………………………………….……………………….………v 
Table of contents…….………….……………………………….…………………………………...vi 
List of figures………...…………………………………………………………………….…………x 
List of tables………..………………………………….…………………………………….……….xi 
Abbreviations…………………………………………….…..………………..……………..……..xii 
Abstract…………………..……………………………………..……………………….…..……...xiv 
Isifingqo (Isizulu Abstract) ………………………...…………………..……………. ….…….…. xvi 
CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW…………………...……1 
1.0 Background……………………………….………………………………………….…….…….1 
1.1 Prevalence of diabetes mellitus………………..……..…………………………….….………...3 
1.2 Diabetes Mellitus in Africa………...…...…..…………………………………………...………5 
1.3 Classification of diabetes……...…....…………………………………….…………….……….8 
1.3.1 Type 1 Diabetes Mellitus (T1DM)….…...………………………..……………….…..……9 
1.3.2 Type 2 Diabetes Mellitus (T2DM)………………..………………..…..……….....10 
1.4 Diabetes nephropathy ………………...…..…………………………………………...…11 
1.5 Diagnosis of diabetic nephropathy ………………………...………………………...........……16 
1.6 Insulin…...…………....………………………………………………….…….…………..……17 
1.6.1 Insulin secretion.…………………………………………………………..…….…21 
1.6.2 Insulin degradation………………….…………………………….………..……....22 
1.6.3 Insulin receptor ………………..….……………………………………….……….22 
1.6.4 Effects of insulin on its targets…..………………………………………….……...24 
1.6.5 Action of insulin on glucose transporters (GLUT)……….…….…………..……...…24 
1.6.6 Action of insulin on the liver……...…………………………………………….….………24 
1.6.7 Effect of insulin on muscle…...………………………………………..…………..……….25 
1.6.8 Effect of insulin on adipose tissue..…………...……………………………………....……25 
1.7 Current antidiabetic drugs…………………………………………….…………….…….....….26 
vii 
 
1.7.1 Metformin………………………………………..……………….………………………..….26 
1.7.2 Glibenclamide…………..…….…………………………………………………………….…29 
1.8   Overview of current animal models of T2D…………………………...………………………30 
1.8.1 Diet induced models of T2D ………………………………………………..…………….…...30 
1.8.1.1 Fat fed Model…...………………………………………………..…………………….…....30 
1.8.2 Chemically induced rodent models of T2D …...……………………………………….……. 30 
1.8.2.1 Alloxan …………………………………………..……………………………….…….…..30 
1.8.2.2 Streptozotozin ………………………………………………..…………………….…….…31 
1.9 Models of Streptozotozin-nicotinamide ……………………..………………………………….33 
1.10 Overview of Anatomy of kidney…………………………….……………………………..….34  
1.10.1 Anatomy of the rat kidneys……………….…………………………………………………34 
1.11 Anatomy of Human kidneys…………………...…………………………………………….....37 
1.11.1 Nephrons as the functional unit of the kidney……………….………………………………40 
1.11.2 Histology of the kidney……………………………………………………………………...41 
1.11.3 Renal Circulation……………….……………………………………………………………44 
1.11.4 Urine Formation……………………………………………………….…………….………46 
1.11.5 Glomerular Filtration……………………………………………………………..…………46 
1.11.5.1 Glomerular filtrate rate (GFR)……………………………………………..……….……..47 
1.11.6 Tubular Reabsorption………………………………………………..………………………48 
1.11.7 Selective Reabsorption………………………………………………………………………48 
1.11.8 Tubular Secretion…………………………....………………………………………………48 
1.12 Nanoparticles and Herbal Formulations…………………………….……………....…………49 
1.13 Diabetes and Nanotechnology……………..…………………….………………………….…52 
1.14 Diabetes and Silver nanoparticles ……………………………………………………………..54 
1.15 Diabetes and herbal remedies …………………………………………………………………56 
1.16 Cinnamomum cassia…………………...……………………………………….……….………………57 
1.17  Statement of problem……………………………………………………………….…………62 
1.18 Justification…………………………………………………………….……………..63 
1.19 Aims…………………………………………………………………………….…….64 
1.20 Specific objectives……...………………………………………………………..…….………64 
1.21 Research questions………………………………...………………………………….……….65 
1.22 Contribution to knowledge……………………………………………………………..………65 
viii 
 
1.23 Animal management/ Experimental design…………………………………….…….65 
1.24 Non diabetic group……………………………………………………………………….…….67 
1.25 Diabetic group…………………………………………………..…………………….….…….67 
1.26 Induction of type 2 diabetes……………………………………………………………………69 
1.27 Body and Kidney Weight …………………………………………………………………..….69 
1.28 Urinalysis ….………………………………………………………………………….……….69 
1.29 Collection of Blood Samples ……………………………………………………….…………71 
1.30 Histopathological Examination of Kidneys……………………...………………...…………71 
1.31 Histochemical Evaluation of the Kidneys………………………...…………….………….….73 
1.32 Stereological Analyses of Kidneys……………………...…………….……….…….………...73 
1.33 Transmission electron microscope ……………………….…………...…………..…….…….74 
1.34 Measurement of kidney tissue Malondialdehyde (MDA) level ……………..…………..……74 
1.35 Measurement of kidney tissue Glutathione Concentration (GSH)………...……...……..……76 
1.36 Renal function analyses………………..……………...………….…….…………..…….……76 
1.37 Statistical analysis ……………………………………………………………….…………….76 
References………………………...……………………………………………….………………..78 
BRIDGING text–between chapter one and two……………………………………………………..93 
CHAPTER two-Manuscript…one.………………..…….. .. …………………….....……....………94 
 
BRIDGING between chapter two and three ………………...……………….………….….…..…102 
CHAPTER three-Manuscript two…………………………………………….…………...………103 
BRIDGING text between chapters three and four ……………………………………….………  134 
BRIDGING between chapters four and five ……………………………………………..….........135 
BRIDGING between chapters  five and Six……………………………………………………….136 
CHAPTER SEVEN, SYNTHESIS, CONCLUSION AND RECOMMENDATION………...…...137 
7.0 Synthesis ………………………………………………………………………………...…….137 
7.1 Conclusions ………………………………………………..…………….……………………157 
7.2   Recommendations………………………………………………………….……...………....157 
     References ………………………………………..……………………..…………...….…..…159 
Appendix  ……………………………………………………………………………............................................…..…166 
ix 
 
List of figures 
       
Page 
Figure 1.1: The Diabetes Epidemic: Global Projections.…………….…………………..……..........4 
Figure 1.2: Pancreas…………………………….…………….……………………………………..17 
Figure 1.3: Structure of human proinsulin...………...……………………………… ……………...19 
Figure 1.4 Model of the control of insulin release from the pancreatic ß-cells by glucose…..…….20 
Figure 1.5 Schematic diagram of the probable structure of the insulin receptor tetramer in the activated 
state...……………………………………………………………………………………………..…22 
Figure 1.6: Mechanism of action metformin………...…..………………………………………….27 
Figure 1.7: Chemical Structure of Streptozotozin ……………….……...………………….……....30 
Figure 1.8: Schematic drawing showing location of kidneys…………..…..……………..………..35 
Figure 1.9: Sagittal section of rat kidney……………….......…………………………………….....37 
Figure 1.10: Schematic diagram showing sagittal section of human kidneys….………….………..38 
Figure 1.11: Schematic diagram showing structure of the nephron…...………………..………......40 
Figure 1.12: Microscopic anatomy of the kidney……...………………………………………..…..43 
Figure 1.13: Renal Circulation……………………………………..………………………...……..44 
Figure 1.14: Chemical struture of Cinnamomum cassia…………..………………………..………60 
Figure 1.15: Sprague –Dawley rats housed in the the Plastic cages…..………………………...….65 
Figure 1.16: Experimental design……………..………………………………………...………….67 
Figure 1.17: Sprague – Dawley rats housed in a metabolic cagse..……………..………….………69 
Figure 1.18 Dissected Sprague-Dawley rat on autopsy table…...…………………………….…….71 
 
 
 
 
 
 
x 
 
 
 
 
 
 
 
List of tables 
Page 
                                     
Table 1.1: Classification of diabetes Mellitus………………………….............................................9 
Table 1.2: Analysis of the plant Cinnamomum cassia ……..……………….……………..……….59 
Table 1.3: List of manuscript from project…………………….……………………………….…...75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
 
Abbreviations 
 
ADH       Antidiuretic hormone 
ADP-ribose      Adenosine diphosphate ribose 
Ag+      Silver ion 
AgNPs      Silver nanoparticles 
AgNO3       Silver trioxonitrate (Abou-Seif and Youssef) 
ALT       Alanine aminotransferase 
AMPK,      Adenosine monophosphate-activated protein 
kinase 
ATP      Adenosine triphosphate 
ARV      Antiretroviral 
AST       Aspartate transaminase 
AV      Absolute volume 
Cc       Cinnamomum Cassia 
CcAgNPs      Cinnamomum cassia silver nanoparticles 
CoA      Acetyl Co-Enzyme A 
CPP      Cell penetrating peptides 
DCT      Distal convoluted tubules 
DMLB       Distributed Multi-criteria load balancing 
DM       Diabetes Mellitus 
ECMs      Extracellular Matrix 
ESKD                                                                    End Stage Kidney disease 
FBG       Fasting blood glucose 
FFA       Free fatty acids 
FTIR       Fourier transform infrared spectroscopic 
xii 
 
GBM      Glomerular basement membrane 
GFAT       Glutamine fructose-6-phosphate aminotransferase 
GFR       Glomerular filtration rate 
GLUT-2      Glucose transporter 2 
GSH       Glutathione 
HAART      Highly active antiretroviral therapy 
HDL      High density lipoprotein 
H&E       Hematoxylin and Eosin 
IgA      Immunoglobulin 
IRS       Insulin-receptor substrates 
KW       Kidney weight 
LDL       Low density lipoproteins 
MDA       Malondialdehyde 
MDRD      Modification of diet in renal disease 
MT       Masson’s trichrome 
NAD       Nicotinamide adenine dinucleotide 
NDDS       Novel drug delivery system 
NPs       Nanoparticles 
OGT       Oral glucose tolerance 
OsO4       Osmium tetraoxide 
PAS       Periodic acid Schiff 
PBMC       Peripheral blood mononuclear cell 
PCT       Proximal convoluted tubules 
PPAR-γ     Peroxisome proliferator-activated receptor 
ROS      Reactive oxidant species 
SDS       Sodium dodecyl sulfate 
STEM       Scanning transmission electron microscopy 
STZ       Streptozotozin 
T1D       Type 1 diabetes 
xiii 
 
T2D       Type 2 diabetes 
TBA       Thiobarbituric acid 
TB       Tuberculosis 
TEM       Transmission Electron Microscopy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
Abstract 
 
Introduction 
 
Diabetic nephropathy remains one of the biggest complications of diabetes. The incidence is 
increasing and more patients are experiencing progressive kidney failure due to lack of hyperefficient 
treatment. This study investigated the antidiabetic activity of Cinnamomum cassia silver 
nanoparticles (AgNPs) [(CcAgNPs)] and its effects on the kidneys of Sprague-Dawley rats induced 
with type 2 diabetes following administration of Streptozotozin. 
 
Materials and methods 
 
Adult healthy, pathogen-free male Sprague-Dawley rats, of a total number of 65 (N=65), weighing 
250.0 ± 20 g were divided into 10 groups. Groups A-E (positive controls) consists of 30 rats, with 6 
rats per group and the experimental groups F-J, consists of 35 rats, with 7 animals per group. Diabetes 
was induced in animals using Streptozotocin 60 mg/kg administered intraperitoneally. The animals 
were subjected to various treatments with Cc (100 mg/kg and 200 mg/kg) and CcAgNPs (5 mg/kg 
and 10 mg/kg). The treatments were administered orally using orogastric gavage and administration 
was carried out daily following treatment protocol for 56 days. The selected protocol for the 
experiment was officially approved by the Animal Ethics Committee (protocol reference number: 
AREC/74/016D).   
 
Cinnamomum cassia Silver Nanoparticles (CcAgNPs) was synthesized using the green option and 
characterized using UV (ultraviolet)–TEM (Transmission electron microscopy)-FTIR (Fourier-
transform infrared spectroscopy) –XRD (X-ray powder diffraction), prior to administration. The 
animals were sacrificed on day 56. Blood and urine samples were collected for biochemical analysis. 
The kidneys were examined for histopathological changes using Hematoxylin and Eosin (H&E), 
xv 
 
periodic acid Schiff and Masson’s trichrome staining. Transmission Electron Microscope (TEM) and 
Stereological studies were carried out as well.  
 
Results 
 
Urinalysis showed extensive protein and albumin deposits in the urine. Ketones and nitrites levels 
which are markers of renal function were significantly lower (p< 0.05) in groups treated with 
CcAgNPs compared to negative controls.  Urea and creatinine were also significantly (p < 0.05) 
reduced in treated groups compared to negative controls. The levels of reduced glutathione (GSH) 
was significantly different across all groups (p < 0.05).   Serum Malondialdehyde (MDA) 
concentrations were significantly (p < 0.05) lower in CcAgNPs compared to controls. 
 
Liver enzymes (alanine aminotransferase) ALT was reduced significantly in groups treated with a 
low dose of CcAgNPs compared to negative controls. In the group treated with high dose (10 mg/kg) 
of CcAgNPs, (Aspartate transaminase) AST levels were significantly lower (p < 0.05), compared to 
the group treated with Cc (Cinnamomum cassia) and to the negative control.  
Stereological studies showed significantly decreased (p < 0.05) number of glomeruli and tubules in 
groups treated with Cc and CcAgNPs, compared to the negative control. 
Transmission Electron Microscope (TEM) revealed the thickness of glomerular basement membrane, 
in experimental groups, compared to positive controls. 
Histopathology of renal tissue showed severe glomerular distortion, tubular lesions with H & E and 
thickening of the basement membrane; pyknotic nuclei and vacuolization with PAS and MT, in the 
untreated negative control group.  Positive controls showed regular glomeruli with normal Bowman’s 
capsular space, normal basement membrane and regular capillary network compared to negative 
controls. The degree of histopathological changes in the glomeruli and tubules appear to be dose-
dependent. 
xvi 
 
Conclusion 
 
Diabetes negatively alters the cytoarchitecture and biochemistry of the kidneys of Sprague-Dawley 
rats while Cinnamomum cassia Silver Nanoparticles have the potential to ameliorate these changes. 
The possible pathway involved CcAgNPs may provoke the release of insulin-like, as well as the 
thioredoxin (Trx), which is one of the central antioxidants that can alleviate renal injuries in diabetic 
nephropathy.    
Keywords: Cinnamomum cassia; silver nanoparticles; diabetes; histomorphology 
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Isifingqo (Isizulu Abstract) 
 
Singeniso 
 
 
Enye yezinkinga ezinkulu zesifo sikashukela i-nephropathy yesifo sikashukela. Lesi sigameko sanda 
futhi iziguli eziningi zibhekene nokuhluleka kokuqeda izinso ngenxa yokuntula ukwelashwa 
okuphumelelayo. Lolu cwaningo luphenye umsebenzi we-antidiabetic we-Cinnamomum cassia- we-
nanoparticles wesiliva (i-AgNPs) [(CcAgNPs)] kanye nemiphumela yayo ezinsweni zama-Sprague-
Dawley amagundane abanjwe ngohlobo lwesifo sikashukela ngemuva kokuphathwa kwe-
Streptozotozin. 
 
 
Izimpahla nezindlela 
 
 
Amantombazane angamahhala, ama-pathogen angamahhala ama-sprague-Dawley amagundane, 
angama-65 (N = 65), anesisindo esingama-250.0 ± 20 g ahlukaniswe ngamaqembu angu-10. 
Amaqembu A-E (ukulawula okuhle) aqukethe amagundane angu-30, namaqembu angu-6 ngeqembu 
kanye namaqembu okuhlola (isifo sikashukela) F-J, aqukethe amagundane angu-35, anezilwane 
ezingu-7 ngeqembu ngalinye. Isifo sikashukela sathinteka ezilwaneni ezisetshenziswa nge-
intraperitoneally Streptozotozin 60 mg / kg. Izilwane zazitholwa ngezindlela ezihlukahlukene 
zokwelashwa nge-Cc (100 mg / kg no 200 mg / kg) kanye ne-CcAgNPs (5 mg / kg no-10 mg / kg). 
Lezo zelashwa zenziwa ngomlomo ngokusebenzisa i-oro-gastric gavage kanye nokuphathwa 
okwenziwa nsuku zonke emva kokulandela ukwelashwa kwezinsuku ezingu-56. Ikomidi leNyuvesi 
yaseKwaZulu-Natali yokuziphatha kwezilwane (AREC), lavuma ukucwaninga ngenombolo 
yereferensi yokuziphatha: AREC / 074/016 D. 
 
 
 I-Cinnamomum cassia yesiliva i-nanoparticles (CcAgNPs) yenziwe ngokwenziwa kohlobo oluhlaza 
futhi luchazwe nge-UV (ultraviolet) - I-TEM (i-Transmission electros microscopy) -FTIR (i-Frarier-
transform spectroscopy infrared) -XRD (i-X ray ray diffraction), ngaphambi kokuphatha. Izilwane 
xviii 
 
zahlatshwa ngosuku lwama-56. Amasampuli egazi ne-urine aqoqwe ukuhlaziywa kwezinto 
eziphilayo. Izinso zahlolwa ngezinguquko zakhe ezingasetshenziswa kusetshenziswa i-Hematoxylin 
ne-eosin (i-H & E), i-periodic acid Schiff  ne-Masson's trichrome . I-Transmission Electron 
Microscope (TEM) kanye nezifundo zesayensi zenziwa ukugcina nokukala izici ze-ultrastructural 
izinso. 
 
 
 
Imiphumela 
 
Ukuhlolwa kwe-urinalysis kubonise amaprotheni amaningi futhi i-albin ibeka imali emcinini. 
Amazinga kaKetoni nama-nitrites ayimisebenzi yokweqa (p <0.05) ngamaqembu aphathwa nge-
CcAgNPs uma kuqhathaniswa nokulawulwa okungalungile. I-Urea ne-creatinine nayo yaba kakhulu 
(p <0.05) inciphise ekuphatheni uma kuqhathaniswa nokulawulwa okungalungile. Amazinga we-
glutathione encishisiwe (i-GSH) awafani neze kakhulu kuwo wonke amaqembu (p < 0.05). I-Serum 
Malondialdehyde (MDA) yayigxile kakhulu (p <0.05) ephansi ku-CcAgNPs uma kuqhathaniswa 
nezilawuli. 
 
Ama-enzyme enesibindi (i-alanine aminotransferase) i-ALT yancishiswa ngamaqembu aphathwa 
nge-dose ephansi ye-CcAgNP uma kuqhathaniswa nokulawulwa okungalungile. Eqembu lalashwa 
ngezinga eliphezulu (10 mg / kg) lama-CcAgNPs, ama-AST ama-AST amazinga ayephansi kakhulu 
(p <0.05), uma kuqhathaniswa neqembu eliphathwa ngeCc (Cinnamomum cassia) nokulawulwa 
okubi. 
Ucwaningo lwezinkanyezi lubonakele kakhulu (p <0.05) inombolo ye-glomeruli nama-tubules 
ngamaqembu aphathwe nge-Cc ne-CcAgNPs, uma kuqhathaniswa nokulawulwa okungalungile. - 
I-Transmission Electron Microscope (TEM) yembula ukuqina kwekhanda eliphansi le-glomerular, 
emaqenjini okuhlola, uma kuqhathaniswa nokulawula okuhle. 
 
 
Ukuphefumula kwakhe kwamathambo e-renal kubonakele ukuphazamiseka okukhulu kwe-
glomerular, izilonda ze-tubular nge-H & E kanye nokuqina kwesimbatho esincane, i-pyknotic nuclei 
kanye nokuphumula ngaphandle kwe-PAS no-MT, eqenjini lokulawula elingalungile. Izilawuli 
xix 
 
ezinengqondo zibonisa i-glomeruli evamile nekhala elijwayelekile le-Bowman's capsular, insimu 
evamile yesigqebhezana nesisetshenziswa senethiwekhi ejwayelekile ngokuqhathaniswa 
nokulawulwa okungalungile. Izinga lokuguquka kwezinto ezithinta izinto ezinhlobonhlobo ku-
glomeruli kanye namashubhu kubonakala sengathi kuncike ekutheni. 
 
 
 
Isiphetho 
 
Isifo sikashukela sishintsha kabi i-cyto-architecture kanye ne-biochemistry yezinso zama-sprague-
Dawley amagundane ngenkathi i-Cinnamomum cassia yesiliva ye-nanoparticles ingakwazi 
ukuthuthukisa lezi zinguquko. Indlela engabandakanyeka, i-CcAgNPs ingabangela ukukhululwa 
kwe-insulini efana, kanye ne-thioredoxin (i-Trx), engenye ye-antioxidant ephakathi, ukunciphisa 
ukulimala kwe-renal ku-nephropathy yesifo sikashukela. Amagama angukhiye: Cinnamomum cassia; 
nanoparticles zesiliva; isifo sikashukela; i-histomorphology 
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CHAPTER ONE 
 
 
INTRODUCTION AND LITERATURE REVIEW 
 
 
 
 
1.0 Background 
 
 
 
Diabetes is a group of common serious metabolic disarrangement featured by hyperglycemia, 
resulting mainly from a deficiency in insulin production in the body. Diabetes is known as a complex, 
heterogeneous metabolic disorder, caused as a result of the redundant environment as well as genetic 
factors (Cnop et al., 2005). Type 2 diabetes (originally named non-insulin-dependent or adult onset 
diabetes) results from the body’s inefficient use of insulin (WHO, 2016). Diabetes is on the rise and 
is no longer a disease of mostly rich nations. The frequency of diabetes is steadily increasing 
everywhere, most markedly in the world’s middle-income countries (WHO, 2016). Diabetes is 
categorized as one of the most challenging diseases confronting society and health care professionals 
today (Subramoniam, 2016). Diabetes and its complications are known to be one of the leading causes 
of high mortality and morbidity rate and a universal problem (WHO, 2016). The prevention of 
diabetes and its complications is not only a major issue for the future but essential if health for all is 
to be achieved (WHO, 1999). 
 
 
 
Diabetes is a chronic disease that happens when the insulin secreted by the pancreas is not enough or 
when the body cannot efficiently use the insulin it produces. Blood sugar is controlled by Insulin.   
The common side effect of unregulated diabetes is hyperglycemia or raised blood sugar which over 
time leads to severe damage to many of the body's systems, especially the nerves and blood vessels 
(Roessner et al., 2012). Diabetes and its complications are the foremost cause of mortality and 
morbidity (Inzucchi et al., 2012). Some genetic factors are also causing diabetes, using the oxidative 
stress pathways; this is common to type 1 and type 2 diabetes mellitus. 
2  
 
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that leads to the destruction of the 
pancreatic beta cells, which produces the insulin within the islets of Langerhans. T1DM is most 
commonly diagnosed in children and young adults, and by the time of diagnosis, patients have very 
little endogenous insulin secretion. Daily subcutaneous injections replace the Insulin. Unfortunately, 
in many settings, the absence of efficient policies to create a supportive environment for healthy 
lifestyles are not being encouraged (WHO, 2016). When diabetes is not regulated, it generates negative 
consequences for health and well-being. In addition, diabetes and its associated complications 
(nephropathy, neuropathy, skin conditions, and retinopathy) generate a heavy financial burden on 
individuals and their families and the economy of nations. People suffering with diabetes are 
financially harmed by high list prices of insulin as well as high out-of-pocket costs (WHO, 2016). 
 
 
 
The serious long-term microvascular complications of diabetes occur in nearly 40% of diabetic 
patients, diabetic nephropathy is one of the main causes of end-stage kidney disease (ESKD) 
throughout the world. Diabetic nephropathy has got a risk factor as microalbuminuria (Tuttle et al., 
2014). Progressively increasing albumin in the urine is a sign of early diabetic nephropathy (Perkins 
et al., 2003). The medicines that lower blood pressure is mainly used to treat diabetic nephropathy as 
they protect the kidneys. These medicines possess the property to reverse kidney damage and are 
started as soon as any amount of protein is detected in the urine. Generally, two or more medicines 
may be needed to lower blood pressure, in order to protect the kidneys, when patients experience high 
blood pressure (Beck et al., 2018). 
 
 
 
The International Obesity personnel estimated that there are approximately 300 million individuals 
suffering from obesity and out of this number, 150 million persons suffer from type 2 diabetes (Reuter, 
2007; Shirwaikar et al., 2006) (figure 1.1). In South Africa,80.000 persons were reported to have 
diabetes and the international community expected this statistical result to climb to over 1.2 million 
in 2030. (WHO, 2016) (figure 1.1).  
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Because the symptoms Type 2 diabetes can be mild and may develop gradually. it takes about seven 
years for a person to be diagnosed with the disease. As a result, about 30% of people with Type 2 
diabetes will be experiencing serious complications by the time they are diagnosed (Chen et al., 2012). 
Heart disease, stroke, blindness, amputations, and kidney failure are listed among the complications 
of diabetes. Early diagnosis and proper treatment may avoid these complications. Type 2 diabetes is 
brought a heavy burden on the South African healthcare system. Effective management of diabetes 
requires efficient daily treatment, regular monitoring, a healthy diet associated with lifestyle and 
ongoing education. The costs associated with diabetes are alarming. The hospital and medication 
costs constitute the direct cost of diabetes and disability grants as well as indirect costs, such as work 
absenteeism, time spent caring for sick relatives and less productivity (Seuring et al., 2015). 
 
 
 
The percentage of diabetes-related deaths in South Africa in people younger than 60 years is about 
76% and this represent the most economically active age group of the population. Health expenditure 
for adults diabetics in South Africa is projected to increase by 50% between 2010 and 2030 (Peer et 
al., 2014). 
 
 
 
1.1 Prevalence of diabetes mellitus 
 
 
 
Diabetes mellitus is a heterogeneous disorder with varying prevalence among different ethnic groups. 
It affects a large number of people around the world. In 2011, it was estimated that 366 million people 
had DM and this number is expected to reach 552 million by 2030 as shown below in figure 1.1 
(Whiting et al., 2011). In the same year (2011), IDF reported that China, India, and the USA had 90.0, 
61.3 and 23.7 million peoples living with diabetes may be increased up to 129.7, 101.2, and 29.3 
million people respectively, by 2030 (Hu et al., 2013). Further, IDF reported that in 2010, the number 
of people with T2DM will be increasing from 285 million to 438 million by 2030, with more than 70% 
of cases from developing countries (Shaw et al., 2010) (figure 1.1). 
 
Home et al. (2013) reported that WHO revealed that the highest increases in diabetes prevalence
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have occurred in low- and middle-income countries of Africa, Asia, and South America. It was once 
believed that DM is unusual in the developing world but has now arisen as a major public health issue 
in Africa. In Sub-Saharan Africa, about 90% of type 2 Diabetes Mellitus cases were recorded (Levitt 
et al., 2011). The expected increase for sub- Saharan Africa is 98%, from 12.1 million in 2010 to 23.9 
million in 2030 (Sicree et al., 2010) (figure 1.1). Similarly, the frequency of DM in Ethiopia was 2.5 
% in the year 2000 and it is estimated to rise to 3.5 % by 2030 (Atlas, 2006). According to Atlas 
(2006), 4.6 million deaths were directly linked to diabetes, constituting 6.8% of the total global 
mortality in each year (Home et al., 2013). It was projected that diabetes-related deaths will be 
increasing by 50% in the next 10 years if no urgent action is taken (WHO, 2016) (figure 1.1). The 
number of deaths in Ethiopia attributed to diabetes reached over 21,000 in 2007. Nigatu et al. (2013) 
also reported that this estimation was increased to about 25,000 in 2011. 
 
 
 
 
 
Figure 1.1: The Diabetes Epidemic: Global Projections, 2010-2030 (Kumar et al., 2018). 
5  
 
1.2 Diabetes Mellitus in Africa 
 
 
 
Most countries are facing demographic transition in Africa and African societies from the urban area 
are increasingly rising within the sphere of the influence of Western market economies. The lifestyle 
of city dwellers tends to be linked to material, with the adoption of cosmopolitan behavior and 
consumption of resources. These changes in lifestyle have evolved against a background of increasing 
diabetes mellitus prevalence as well as diabetic complications in Africa (Zimmet, 1999). However, 
the African societies in rural zone, have seen an increase in DM due to environmental factors, which 
appear to be associated with drought, poverty, war, and socio-economic deprivation. 
 
 
In South Africa, a number of studies were conducted, and it was revealed that there were at least 6.5 
million diagnosed diabetics cases and possibly up to an equal number who are currently undiagnosed 
(Guariguata et al., 2014). In South Africa, the incidence of diabetes was high and was estimated to be 
14% in the Colored community, 13% in the Indian community, 6% in the African community and 
6% in the European community (Puoane et al., 2002). 
 
 
Epidemiological data had boosted the current knowledge of diabetes in sub-Saharan Africa, taken 
during sporadic, predominantly convenience-based community testing initiatives and hospital data 
from patients who experienced diabetes complications (Pastakia et al., 2017). There were few 
comprehensive surveys which showed huge variations in prevalence that makes it difficult to have an 
accurate estimate of the impact of diabetes in the region (Hall et al., 2011). Type 2 diabetes is revealed 
to be the predominant form of diabetes in sub-Saharan Africa with estimated 85%–95% cases (Sobngwi 
et al., 2001). It is common knowledge that 62.5% of diabetics cases are undiagnosed in the World and 
the majority of those patients are in the sub-Saharan Africa region (Guariguata et al., 2014). Lack of 
access to health care facilities, poorly trained health care providers, ignorance and lack of screening 
is contributing to the increasing percentage of under-diagnosed cases. 
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The rapid urbanization of sub-Saharan African populations has further anticipated to increase the 
number of cases and subsequently the incidence of diabetes (Pastakia et al., 2017). This had increased 
the number of population who are exposed to the more diabetogenic sedentary lifestyle with a diet 
rich in calorie, living in urban area (Mbanya et al., 2010). The cultural attitude of some population 
among Sub-Saharan African cultures that perceive being overweight or obese as a symbol of wealth 
and prosperity, has also increased the incidence of diabetes. Type 2 diabetes prevalence was 1.5 – 4 
times higher in urban settings compared with rural settings, because of the shift of lifestyle in urban 
zone (Jamison, 2006). The rapid urbanization taking place in sub-Saharan African populations has 
further complicated the situation. In 2013, the study revealed that about 37% of the population lived 
in urban areas compared with only 10%–15% in 1950 (Muthuri et al., 2016). Sub-Saharan Africa will 
be the fastest growing diabetic population living in urban area in the world in 2030, with an increase 
of 50% of the number of cases (Muthuri et al., 2016). 
 
 
 
 
Moreover, increase in diabetes prevalence depends on changes in lifestyle adding to nutrition, being 
common in sub-Saharan African populations. Life expectancy in sub-Saharan Africa increasing along 
with the probability of developing diabetes. Additional gains in life expectancy in Africa, associated 
to improvement of health care infrastructures and living conditions, will continue to increase the 
prevalence of diabetes as the population ages (Mbanya et al., 2010). 
 
 
 
 
The vantage point from both economic and health care is that diabetes is particularly devastating in 
sub-Saharan Africa. The highest rate of morbidity and mortality in the world is unfortunately linked 
to diabetes in sub-Saharan Africa, particularly in the population who are able to work (Guariguata et 
al., 2014). 76.4% of deaths recorded were basically caused by diabetes among people aged <60 years 
in sub-Saharan Africa in 2014, (Guariguata et al., 2014). The late diagnosis and poor care that patients 
receive throughout the course of the disease are the sources of the primary reasons for these high rates 
of morbidity and mortality. 
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In sub-Saharan Africa, associated infections (HIV, TB, and Pneumonia) to diabetes generates a 
twofold burden. There are needs to have greater focus on addressing mental health conditions, like 
depression in order to manage these more commonly diabetes-related complications, that often 
aggravate care for patients with diabetes. Diabetes specialist clinic in Kenya revealed that 21% of its 
patients from a rural zone were experiencing depressive symptoms, that were associated with 
worsened glycaemic control compared with screen negative patients (Shirey et al., 2015). 
 
 
 
 
Cost is a major barrier to access medicines for patients with diabetes. Medicines consume large 
portions of household incomes in diabetes populations. Health care expenditure is mostly out-of- 
pocket, further promoting the vicious cycle of poverty. The care for a person suffering from diabetes 
in Mali necessitated nearly 70% of a family’s income (Azevedo and Alla, 2008). While in Nigeria it 
was recorded that a monthly mean cost of 1 NGN for a diabetic person equaled 29% of the total 
monthly income of an individual on minimum wage (Ogbera and Kuku, 2012). 
 
 
 
 
Sub-Saharan African Populations of origin are mostly considered at high risk of developing diabetes 
(Choukem et al., 2014). In Africa, it has been reported that the degree of urbanization of the 
geographical location and time spent in that particular environment has got an impact on the incidence 
of T2D (Choukem et al., 2014). Africans living in Africa to Afro-Caribbean, African Americans and 
African immigrants living in other developed countries showed an increase of prevalence of T2D, 
compared to other population. Mbanya et al. (2010) reported T2D incidence of 0.8% and 2% among 
Cameroon population living in rural and urban area respectively as well as of 8.5% in Jamaica and 
14.6% among blacks living in Manchester, UK. It was reported that Black South African patients 
showed rapid progression to type 2 diabetes, compared to white South African patients with impaired 
glucose tolerance (Mbanya et al., 2010). In sub-Saharan African, the causes for the rapid deterioration 
of beta-cell function and most importantly the rapid progression of diabetes patients are not 
conclusive. With regards to the cosmopolitan diabetic population, there is need to formulate new  
                   approaches for the management of diabetes mellitus (Cubero and Rojas, 2017). 
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1.3 Classification of Diabetes Mellitus 
 
 
 
A suitable classification is needed for the management of diabetes mellitus using orderly 
epidemiologic and clinical research. Furthermore, the process to comprehend the etiology of disease 
and studying its natural history engages the potential to identify and differentiate between its various 
forms and placing them into a rational etiopathologic framework (Alberti et al., 2004). In 1979, the 
National Diabetes Data Group elaborated the current classification of diabetes and other categories 
of glucose intolerance, based on research on this heterogeneous syndrome. Two important forms of 
diabetes are recognized in the countries located in the Western zone; insulin dependent diabetes 
mellitus (IDDM, type I diabetes) and non-insulin dependent diabetes (NIDDM, type II diabetes) 
(Table 1.1). 
 
 
 
 
Apart from these important types of diabetes mellitus, other recognized types of diabetes comprises 
Maturity Onset Diabetes of the Young (MODY), an autosomal dominant genetic defect of β-cell 
function, whereby patient developed hyperglycemia at early onset by the age of 25 years due to an 
impairment of insulin production with minimal or no loss of insulin action (Asmat et al., 2016; 
Bissinger et al., 2018). Others include gestational diabetes mellitus; a condition defined by the 
presence of impaired glucose tolerance in pregnancy and has been linked to increased prevalence of 
complications in pregnancy including intra-uterine fetal death (IUFD), stillbirths and macrosomic 
babies (Bissinger et al., 2018). Recently, type 3 diabetes mellitus (T3DM) was described, and can be 
characterized by brain tissue resistance to insulin action. The features are similar to those of 
Alzheimer’s disease which shows positive responses to insulin sensitizers (Suzanne, 2012). Table 1.1 
shows the classification of diabetes mellitus. 
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Table 1.1: Classification of Diabetes Mellitus 
 
Class of Diabetes Mellitus Mechanism of Diabetes Development 
Type 1 Diabetes Mellitus Pancreatic beta-islet cell destruction; Absolute 
insulin deficiency 
Type 2 Diabetes Mellitus Insulin resistance, relative insulin deficiency 
Gestational Diabetes Insulin resistance 
Others Genetic defects in B-cell dysfunction 
Genetic defects in Insulin action 
Disease of exocrine pancreas 
Endocrinopathies 
Drugs or chemical Induced 
Infection 
Immune mediated defects 
Genetic syndromes associated with DM 
Source: Adapted from www.care.diabetesjournals.org. 
 
 
 
 
1.3.1 Type 1 Diabetes Mellitus (T1DM) 
 
 
 
 
Type I diabetes is generally characterized by the sudden onset of severe symptoms, dependence on 
exogenous insulin to assist life and disposition to ketosis even in the basal state, all of which is caused 
by absolute insulin deficiency. In developing countries, among children and young adults, T1DM 
formally termed juvenile diabetes is the most prevalent type of diabetes (Alberti et al., 2004). It is a 
catabolic disorder characterized by an increase of glucagon within the plasma, in which circulating 
insulin is virtually lacking and the pancreatic B cells fail to respond to all insulinogenic stimuli 
(Olubomehin, 2014). 
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People whose immune systems are genetically predisposed to develop a vigorous autoimmune 
response against pancreatic B cell antigens will be developing T1DM subsequent to an infectious or 
toxic environmental contingency. Sensitized immunocytes extrinsic factors viruses such as the 
mumps virus and coxsackievirus B4, chemical agents or destructive cytotoxins and antibodies 
released from that might affect B cell functioning including damage. 
 
 
 
 
Development of B cell failure after viral infections may be linked to an underlying genetic defect 
relating to pancreatic B cell replication of the patient or function. In addition, exact HLA genes may 
increase sensitivity to a diabetogenic virus or may be associated with certain immune response genes 
that prompt patients to a destructive autoimmune response against their own islet cells (auto- 
aggression). When immunosuppressive drugs such as cyclosporine or azathioprine are given at the 
initial manifestation of T1DM, pancreatic B cell damage appears to be lessened, supports the 
importance of auto-aggression by the immune system as a serious factor in the pathogenesis of this 
type of diabetes (Olubomehin, 2014). 
 
 
1.3.2 Type 2 Diabetes Mellitus (T2DM) 
 
 
 
 
Type 2 diabetes mellitus greatly outnumbers all other forms of diabetes. Exogenous insulin for 
prevention of ketonuria is not needed for patients with T2DM and those patients are not prone to 
ketosis. However, they may require insulin for the correction of fasting hyperglycemia if this cannot 
be achieved with the use of diet or oral agents, severe stress precipitated by infections or trauma may 
lead to ketosis (Alberti et al., 2004). 
 
 
Because the body does not utilize insulin efficiently, it causes T2DM, although the pancreas produces 
insulin. Insulin-receptors or other intermediates in the insulin signaling pathways within body cells 
are insensitive to insulin due to peripheral tissue insulin resistance and consequently, glucose does 
not readily enter the tissue leading to hyperglycemia or elevated blood glucose concentrations (Porte 
11  
 
et al., 2005). There are many evidences that demonstrate that diabetic complications are mainly 
associated with oxidative stress caused by generation of free radicals (Pitkänen et al., 1992). Type-2 
diabetes mellitus (T2DM) constitutes a multifunctional disease which is associated with 
hyperglycaemia and lipoprotein disorders (Ugochukwu and Babady, 2002). Damage to the cell, in turn 
results in the increase of reactive oxygen species (ROS) production. Abnormally high level of ROS 
are thought to play an important role in promoting the development and pathogenesis of T2DM. Free 
radicals are readily formed during the diabetic state and these play an important role in the genesis of 
diabetic complications (Ahmed et al. 2014a). Antioxidant enzymes such as superoxide dismutase 
(SOD), catalase (CAT), glutathione peroxidase (GPx) and reduced glutathione (GSH) play an 
important role in scavenging these free radicals by breaking them down. Researchers have pointed out 
a defect in the normal ROS scavenging machinery in T2DM patients when compared to normal 
controls (Ahmed et al. 2013). Disorders in the lipid profile are so profound that diabetes has been 
called more “a disease of lipid than carbohydrate metabolism” (Rawi et al., 1998).  
 
Obesity, which generally results in impaired insulin action, is a common risk factor for this type of 
diabetes, and most patients with T2DM are obese (Olubomehin, 2014) and multiple anti- diabetic 
agents are required to keep adequate glycaemic control (Kendall et al., 2009). 
 
 
 
1.4 Diabetic Nephropathy 
 
 
 
Diseases of the kidney are a common finding in people with diabetes, with up to half demonstrating signs 
of kidney damage in their lifetime (Weir et al., 2004). The common cause of end-stage renal failure is 
diabetic nephropathy which is a significant complication of DM. The pathogenesis of DN involves mainly 
oxidative stress as common events and antioxidants may play a beneficial role in its prevention. 
Oxidative stress persuaded by generation of free radicals is linked to diabetic complications (Ahmed et 
al., 2015). Hyperglycaemia and lipoprotein abnormalities are mainly associated with Type-2 diabetes 
mellitus (T2DM), which is a multifunctional disease (Ahmed et al., 2015). Enhancement of reactive 
oxygen species (ROS) production is caused by damage to the cell. The development and pathogenesis of 
T2DM are generated from an abnormally high level of ROS. The genesis of diabetic complications is 
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associated with the formation of free radicals during the diabetic state (Matough et al., 2012). Diabetes 
has been also named “more a disease of lipid than carbohydrate metabolism because of the high 
disturbances in the lipid profile. 
 
 
 
Major complications of diabetes are coronary artery disease, nephropathy, retinopathy, and 
neuropathy. The development of most of these complications is mainly provoked by oxidative stress 
(Giacco and Brownlee, 2010). When antioxidant mechanisms are not working efficiently, oxidative 
stress may happen, especially in dietary deficiencies of vitamin E, vitamin C or the essential elements 
like selenium, zinc, and manganese among others. The antioxidant enzymes glutathione peroxidase, 
superoxide dismutase, and catalase are formed by the later elements. Excessive endogenous 
production of free radicals by diseases progression as in diabetes mellitus and cancer constitutes one 
of the causes of oxidative stress (Irshad and Chaudhuri, 2002). 
 
 The major ROS sources in the diabetic nephropathy were: autoxidation of glucose, the activation of 
polyol pathways, mitochondrial respiratory chain deficiencies, xanthine oxidase activity, NAD(P)H 
oxidase, advanced glycation end products (AGEs) and nitric oxide synthase (Adiga et al., 2016). 
Injuries of the glomeruli, tubular interstitial tissue and vasculature are caused by the increased 
oxidative stress levels. It will result in the mesangial expansion of extracellular matrix and caused an 
increased glomerular filtration rate, urine protein excretion, the progression of glomerular sclerosis 
and tubular interstitial fibrosis (Nath, 1992). 
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Chronic hyperglycaemia causes increased insulin secretion in an attempt to lower blood glucose 
levels, causing hyperinsulinemia. Another interesting feature of diabetes type 2, the hyperglycaemia, 
resulting from three main effects, namely: increased generation of hepatic glucose, decrease of insulin 
secretion and finally reduction in glucose intake (insulin resistance) (Stumvoll et al., 2005). As insulin 
resistance arises from dysfunction of the main event in insulin functioning in the liver, liver-related 
biochemical mechanisms including gluconeogenesis, glycogenolysis, glycogen synthesis, and 
glycolysis become dysfunctional. Insulin hepatic resistance in the liver leads to an inability to 
suppress the hepatic generation of glucose. Fasting hyperglycaemia (described earlier as blood 
glucose levels exceeding 140 mg/dl) in type 2 diabetes patients has been attributed mainly to increased 
hepatic glucose production (Day, 2005). 
 
 
 
Moreover, insulin considered against diabetic medication has demonstrated a few symptoms, for 
example; hypoglycaemia and weight variations from the norm, and deficient to control related 
complexities. (Antopolsky et al., 2012) along these lines revealed that the infection may provoke 
certain difficulties, for example; renal parenchymal illness or renal dead tissue, and additionally renal 
sore in which there is extension of the renal case from oedema or hematoma provoked, following 
flank pain. That ceaseless ailment will additionally cause an increment in the connective tissue of 
kidneys and accordingly cause tubular cell devastation, corruption and in addition renal abscess. 
Furthermore, the internal structure, for example, glomerular filtration rate will relentlessly decrease 
because of the effect of diabetes on the kidneys and fundamental circulatory strain will be expanded 
too (Ahmad, 2015). Glomerular basement membrane (GBMs) will be thickened, which, alongside 
mesangial extension, will prompt diminished patency of hair like lumens and 
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diminished ultrafiltration surface territory which SAKAI and Kriz (1987); called membranous 
proliferative glomerulonephritis. 
 
 
 
Although, in the case of type II diabetes mellitus, there is elevated GFR during their early 
manifestation. The increased GFR is usually not as pronounced as are observed with insulin- 
dependent diabetes mellitus. In addition, at the time of detection of diabetes, there is a greater 
incidence of hypertension and microalbuminuria present, with as many as 10% to 25% of patients 
presenting with these abnormalities. Type II cases may have unrecognized diabetes, living with the 
disease for many years because they are not ketosis-prone and may live with other associated 
conditions predisposing to renal abnormalities (Skorecki et al., 2015). 
 
 
 
Currently the disease is treated and managed by nine (9) major types of drugs of diabetes namely 
insulin, sulfonylureas such as glibenclamide (commonly called glyburide), biguanides such as 
metformin (also known as Glucophage), the dipeptidyl peptidase iv inhibitors eg sitagliptin, the 
Glucagon-like peptide 1 agonists, alpha-glucosidase inhibitors such as acarbose, thiazolidinediones 
such as pioglitazone and less commonly phenylalanine derivatives and meglitinides. 
 
 
 
The severe, chronic complication of diabetes mellitus is diabetic nephropathy, which is the leading 
cause of end-stage renal failure in diabetic patients. The disease results from the combined effects of 
various genetic and environmental factors. Elevated glucose and cholesterol levels, increased 
production of inflammatory cytokines are the predisposing factors which lead to the progression of 
renal damage in diabetic nephropathy. Generating reactive oxygen species (ROS) and attenuating 
antioxidative machinery via glycation of the antioxidant enzymes are caused by elevated glucose 
levels, recognized as a pathogenic factor of chronic diabetic complications by (Goodwill and Frisbee, 
2012). 
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The major cause of end-stage kidney disease (ESKD) throughout the world, occurring in nearly 40% 
of diabetic patients is basically, a devastating complication of diabetes, and its prevalence has more 
than doubled in the past decade, largely due to the increasing proportion of obesity as well as type II 
diabetes mellitus (Himmelfarb and Sayegh, 2010). 
 
 
 
Clinically, the sequence of stages starting with initial glomerular hyperfiltration, glomerular 
hypertrophy, and microalbuminuria are the features of diabetic nephropathy. Elevated mean arterial 
pressure (MAP), is usually seen in patients with diabetic nephropathy (Manigrasso and Maric-Bilkan, 
2013). It is further characterized by progressive glomerular basement membrane thickening, and 
mesangial matrix expansion, which lead to the development of glomerular sclerosis. The subsequent 
renal biopsy shows diffuse or nodular (Kimmelsteil-Wilson) glomerulosclerosis (Skorecki et al., 
2015). Although the Kimmelsteil-Wilson lesion is a classified pathognomonic for advanced diabetic 
nephropathy. Only approximately 25% of patients manifest this lesion. In light-chain nephropathy, a 
nodular pattern of glomerulopathy imitating Kimmelsteil-Wilson lesions may also be seen. Nodular 
glomerular lesions may be observed as cases showing amyloidosis and membranoproliferative 
glomerulonephritis type II (Skorecki et al., 2015). 
 
 
 
An additional pathognomonic finding revealed that both afferent and efferent arteriolar hyalinosis, 
characterized diabetic nephropathy unlike the arteriolar lesion of essential hypertension, which is 
restricted to the afferent arteriole (Skorecki et al., 2015). In overt diabetic nephropathy, the decline in 
renal function in a number of progressive renal diseases causes also progressive tubulointerstitial 
fibrosis, including diabetic nephropathy. GFR will subsequently commence declining from the 
normal range, although, serum creatinine may remain in the normal range (Skorecki et al., 2015). 
 
 
 
Hyperfiltration is the earliest stage of diabetic nephropathy, where the glomerular filtration rate (GFR) 
is significantly increased than normal. Identification of hyperfiltration is not clinically useful, as it 
appears difficult to determine using the regular testing technique (Lemley et al., 2000).  
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The earliest clinical sign of diabetic nephropathy is chronic albuminuria. Initially, a small amount of 
albumin is leaked, below the detection via urine dipstick. This stage is qualified as 
“microalbuminuria” (McFarlane et al., 2013). This can progress negatively so that the urinary albumin 
excretion is sufficiently increased to be detectable by a urine dipstick, a stage known as “overt 
nephropathy.” The normal rate of progression from normoalbuminuria to microalbuminuria then to 
overt nephropathy is basically slow, typically for a period of 5 years or longer to progress through 
each stage (Jacobsen et al., 1999). 
 
 
 
There is a persistent decline in renal function to end-stage disease where a nephrotic range of 
proteinuria is at a value of >3.5 g/24 hours, seen in advanced diabetic nephropathy and also associated 
with systemic hypertension, without manifestation of inflammatory glomerular (red blood cell casts) 
or tubulointerstitial white blood cells casts lesions. The kidneys may be therefore inappropriately 
oversized for the observed degree of renal insufficiency (Skorecki et al., 2015). 
 
 
The socio-economic consequences of diabetes are highly significant and a major world power such 
as China lost over USD 558 billion from national income, due to diabetes and its complications 
(Tomino et al., 2012). 
 
 
 
1.5 Diagnosis of Diabetic Nephropathy 
 
 
 
Monitoring renal function parameters appear to be a good indicator for early diagnosis of diabetic 
nephropathy. Testing regularly all diabetic patients by means of a dipstick test (a diagnostic tool used 
to determine pathological changes in urine) to detect the onset of microalbuminuria, every year for 
type 1 diabetes mellitus, from the 5th year of diabetes, and every year since its discovery in type 2 
diabetes mellitus (Gross et al., 2005). Two positive tests performed over a period of 3 to 6 months, 
may easily confirm the diagnosis. It must also have eliminated some other causes, especially urinary 
tract infection or another renal disease. Below 20 mg/d of albumin in the urine, indicates that excretion 
is normal. It is usually not detected by dipstick testing. Just as a debutante urine dipsticks is reactive, 
i t  does not yet detect microalbuminuria, between 30 and 200 mg/day (Gross et al., 2005). 
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Proteinuria may be confirmed by an assay of a sample of urine or urine collection issued for 24 hours. 
In 10% of the cases, renal biopsy is performed for rapid progression of nephropathy and for suspicion 
of another kidney disease. However, in most cases, these conditions are diagnosed without biopsy, 
especially in type 1 diabetes mellitus and association of microalbuminuria in the urine which is a 
major indication of diabetic nephropathy. 
 
 
 
1.6 Insulin 
 
 
 
 
The pancreas is a long, slender organ, most of its structure is located posterior to the bottom half of 
the body of the stomach (Figure 1.2). Although the pancreas is primarily an exocrine gland, which is 
secreting a variety of digestive enzymes, the organ has also an endocrine function. The pancreatic 
islets are clusters of cells generally known as the islets of Langerhans are mainly designed to secrete 
glucagon, insulin, somatostatin, and pancreatic polypeptide (PP) hormones (Longnecker, 2014). 
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Figure 1.2: Pancreas. www.pharmatips.net. January 2019. 
 
 
 
 
 
 
 
The pancreatic islets contain four major varieties of cells (Longnecker, 2014): 
 
 
(i) The alpha cell produces the hormone called glucagon and constitutes approximately 20 
percent of each islet. Glucagon plays an important role in the regulation of blood glucose. 
When the blood glucose levels decrease, it stimulates the release of the hormone (Figure 1.2). 
(ii) The beta cell secretes the insulin hormone, which constitutes approximately 75 percent 
of each islet. The increase in blood glucose levels stimulates the release of insulin hormone 
(Figure 1.2). 
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(iii) The delta cell constitutes about 4% of the islet cells and secretes mainly the peptide 
hormone somatostatin, which is an inhibiting hormone, designed to inhibit the release of both 
glucagon and insulin (Figure 1.2). 
 
 
The PP cell accounts for about 1% of islet cells, responsible for the secretion of the pancreatic 
polypeptide hormone. It is known to play an important role in appetite, as well as in the regulation of 
pancreatic exocrine and endocrine secretions (Figure 1.2). 
 
 
 
 
The beta-cells of the pancreatic islets synthesize insulin from preproinsulin which is a single chain 
precursor of 110 amino acids. After translocation through the membrane of the rough endoplasmic 
reticulum, proinsulin will then be formed from the 24-amino-acid N-terminal signal peptide of 
preproinsulin. Here, the molecule folds and the disulphide bonds are formed (Figure 1.3). In the Golgi- 
complex, human proinsulin will go through a process of conversion to insulin, subsequently, four 
basic amino acids and the remaining connector or C peptide are removed by proteolysis. This process 
will result in the formation of two-peptide chains (A and B) (Figure 1.3) of the insulin molecule, 
which contains one intra-subunit and two inter-subunit disulfide bonds. The A chain usually is 
composed of 21 amino acids and the B chain 30. The two major chains compose insulin and form a 
highly ordered structure with several helical regions in both the A and B chains. 
 
 
Two ions of Zn2+ are coordinated in a proinsulin hexamer and pancreatic ß cells stored in the granules 
in the form of insulin. It is believed that Zn2+ has a functional role in the formation of crystals and that 
crystallization facilitates remarkably the conversion of proinsulin to insulin, as well as the storage 
hormone (Jones and Persaud, 2017). 
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Figure 1.3: Structure of human proinsulin. Insulin is shown as the shaded peptide chains, A and B 
(Cubero and Rojas, 2017). 
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1.6.1 Insulin secretion 
 
 
 
 
Insulin is mainly released from pancreatic ß-cells at a low basal rate and at a much higher rate 
subsequent to response to a variety of stimuli, such as blood glucose levels. Hyperglycaemia results 
in increased intracellular ATP (adenosine triphosphate) levels, which will lead to close the ATP- 
dependent potassium channels. Decreased outward potassium levels through this channel result in 
depolarization of the ß-cell and the opening of voltage-gated calcium channels. Thence the increased 
intracellular of calcium triggers the secretion of the hormone (Figure 1.4). 
 
 
Figure 1.4: Model of the control of insulin release from the pancreatic ß-cells by glucose 
(Olubomehin, 2014). 
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1.6.2 Insulin degradation 
 
 
 
Insulin hormone is removed from the circulation by the two main organs, Liver and kidney, 
presumably by hydrolysis of the disulfide connection between the two chains A and B through the 
action of glutathione insulin transhydrogenase (insulinase). After this reductive cleavage, further 
degradation by proteolysis will happen. Kidneys are removing 35 – 40% of the endogenous hormone, 
while the liver normally clears the blood of approximately 60% of the insulin released from the 
pancreas by virtue of its location as the terminal site of the portal vein blood flow. However, in 
diabetics patients, insulin-treated, receiving subcutaneous insulin injections, this ratio is reversed such 
that 60% of exogenous insulin hormone is being cleared by the kidney and the liver is removing no 
more than 30-40%. The half-life of circulating insulin is 3-5 minutes (Olubomehin, 2014). 
 
 
                   1.6.3. Structures of Insulin receptor 
 
 
 
Once insulin has entered the circulation, specialized receptors that are located on the membranes of 
most cells, bound the hormone. However, the biological responses promoted by this insulin–receptor 
complexes have only been identified in some target tissues, e.g. muscle, liver, and adipose tissue. 
Those biological receptors, with high specificity and affinity, bind insulin hormone, in the picomolar 
range. The full insulin receptor consists of two heterodimers, each heterodimer is containing an alpha 
subunit, which is entirely extracellular and constitutes the recognition site, and a beta subunit that 
spans the membrane (Figure 1.5). The ß- subunit possesses a tyrosine kinase. When insulin binds to 
the alpha subunit on the outer surface of the cell, tyrosine kinase activity is subsequently stimulated 
in the beta portion. Although the ß dimeric form is capable of binding insulin hormone, it does so 
with a much lower affinity than the tetrameric ß form. Self-phosphorylation of the ß portion of the 
receptor causes an increased aggregation of ß heterodimers and leads to the stabilization of the 
activated state of the receptor tyrosine kinase. 
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In clinical situations, elevated levels of circulating insulin in obesity or insulinoma, causes the 
concentration of insulin receptors to be reduced. This downregulation of insulin receptors seems to 
provide an intrinsic mechanism whereby the target cells may act to limit their response to excessive 
hormone concentrations (Olubomehin, 2014). 
 
 
 
 
 
Figure 1.5: Schematic diagram of the probable structure of the insulin receptor tetramer in the 
activated state (Olubomehin, 2014). 
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1.6.4 Effects of insulin on its targets 
 
 
 
Insulin promotes the storage of fat as well as glucose, using specialized target cells which influences 
cell growth as well as metabolic functions of a wide variety of tissues. 
 
 
 
1.6.5 Action of insulin on glucose transporters  
 
 
 
 
Insulin has demonstrated the important effect on several transport molecules to facilitate glucose 
movement across cell membranes. These transporters may play a major role in the etiology of diabetes 
as well as the manifestation. The glucose transporter, GLUT 4, represent quantitatively, the most 
important in terms of lowering blood glucose, is inserted into the membranes of muscle and adipose 
cells from intracellular storage vesicles. Defects in the glucose transporter (GLUT 2), mediated 
transport of glucose into pancreatic ß-cells may contribute to the development of reduced insulin 
secretion which characterizes type II diabetes. 
 
 
 
1.6.6 Action of insulin on the liver 
 
 
 
 
The function of the liver is to increase storage of glucose (glycogen) and to reset the liver to the fed 
state by reversing catabolic mechanisms, such as glycogenolysis, ketogenesis, and gluconeogenesis, 
which are associated with the post-absorptive state. Liver remains, the first major organ reached by 
endogenous insulin via the portal circulation. These effects are caused by activating pyruvate kinase, 
phosphofructokinase, and glucokinase, while reprieving gluconeogenic enzymes, including pyruvate 
carboxylase, phosphoenolpyruvate carboxykinase, fructose bisphosphatase, and glucose 6- 
phosphatase which are activated by insulin-induced phosphorylations. The indirect effects of Insulin 
in decreasing hepatic gluconeogenesis and ketogenesis are reducing the fatty acid flux to the liver 
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through its antilipolytic action on adipocytes. In addition, insulin decreases urea production, protein 
catabolism, cAMP (cyclic adenosine monophosphate) in the liver, contributes to the promotion of 
triglyceride synthesis and increases potassium and phosphate uptake by the liver. 
 
 
 
 
1.6.7 Effect of insulin on muscle 
 
 
 
Protein synthesis is promoted by insulin hormone, by increasing the amino acid transport and by 
stimulating ribosomal activity. It also promotes glycogen synthesis to replace the glycogen stores 
expended by series of activities executed by muscle. This is accomplished by increasing the 
transportation of glucose into the cells of the muscles and by inducing glycogen synthase and 
contributing to inhibit glycogen phosphorylase. 
 
 
 
 
1.6.8 Effect of insulin on adipose tissue 
 
 
 
Circulating free fatty acids may be reduced by the insulin hormone. Additionally insulin will be 
promoting the triglyceride storage in adipocytes by three mechanisms: 
1) induction of lipoprotein lipase, which actively hydrolyzes the triglycerides contained in 
the circulating lipoproteins; 
2) transportation of glucose into cells which will lead to the generation of glycerophosphate 
as a metabolic product permitting esterification of fatty acids supplied by lipoprotein 
hydrolysis; 
3) direct inhibition of intracellular lipase, subsequent to the reduction of intracellular 
lipolysis of stored triglyceride (Olubomehin, 2014). 
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1.7 Current Anti-Diabetic Drugs 
 
 
 
 
Nine (9) major types of drugs are currently used in the treatment and management of diabetes namely 
insulin, sulfonylureas such as glibenclamide (commonly called glyburide), biguanides such as 
metformin (also known as Glucophage), the dipeptidyl peptidase iv inhibitors eg sitagliptin, the 
Glucagon-like peptide 1 agonists, alpha-glucosidase inhibitors such as acarbose, thiazolidinediones 
such as pioglitazone and less commonly phenylalanine derivatives and meglitinides (Setter et al., 
2003). While, Metformin, is official, a biguanide, and primarily derived from its parent compound, 
guanidine, originally found in the plant Galega officinalis (Bailey and Day, 1989). 
 
 
 
 
 
1.7.1 Metformin 
 
 
 
Metformin remains the most widely used and prescribed anti-diabetic drug in the world (Grisouard 
et al. (2010) and has been a well-known drug for over half a century for the treatment of type 2 
diabetes (Howlett and Bailey, 1999). Metformin may be used in monotherapy or in well-designed 
combination with other drugs such as the insulin or sulfonylureas (Krentz and Bailey, 2005). Unlike 
sulfonylureas (e.g. glibenclamide), metformin does not possess the capacity to increase insulin 
secretion, (Howlett and Bailey, 1999) but rather improves hepatic sensitivity to insulin thereby causing 
an apparent decrease of both fasting and postprandial blood glucose (Dunn and Peters, 1995). 
 
 
Metformin is associated with an increased expression of glucose transporters and glycolytic enzymes 
(Figure 1.6). This serves to widely increase glucose utilization, and thus decrease considerably blood 
glucose levels (Grisouard et al., 2010). In experimental animal, metformin may elevate the tyrosine 
kinase activity, which is involved in insulin signaling (DeFronzo et al., 1991). An increase of tyrosine 
kinase will cause improvement both skeletal glucose usage and glycogen synthesis and causing the 
reduction of blood glucose levels (Prato et al., 1995). Metformin has also been found to hugely offer 
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some beneficial results for lipid profiles. It has been shown to successfully reduce total cholesterol, 
triglycerides and LDL cholesterol. It has, however, shown no significant increases to high-density 
lipoprotein (HDL) cholesterol levels (Trischitta et al., 1992). 
 
 
 
 
The detailed pathway by which metformin acts are still poorly understood (Leverve et al., 2003). One 
of those mechanisms involves the capability of metformin to trigger AMP-activated protein kinase 
(AMPK) (Figure 1.6) which appears to be the regulatory enzyme in energy homeostasis within the 
body (Zhou et al., 2012). Researchers revealed that metformin plays an important role in the reduction 
of both cellular respiratory and mitochondrial functions through the inhibition of the enzymatic 
activity of chemical complex I in the respiratory channels both in skeletal muscle and hepatocytes 
(Detaille et al., 2002). Grisouard et al. (2010) demonstrated that AMPK might be concurrently 
activated in response to the hindrance of complex I. 
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Figure 1. 6: Mechanism of action of metformin. Adapted from Bailey and Day (2010). 
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1.7.2 Glibenclamide 
 
 
 
Glibenclamide, also called glyburide (Langer et al., 2000) is part of the second-generation 
sulphonylurea antidiabetic drug that is used currently to treat type 2 diabetes. This drug causes 
increase in plasma concentrations of insulin, while reducing plasma concentrations of both glucose 
and non-esterified fatty acids. It works by increasing insulin secretion by the pancreatic β-cells. It 
cannot be effective if the pancreatic β-cells are destroyed (Musbah and Furman, 1980). Glibenclamide 
have been shown to increase insulin sensitivity in the liver and subsequently reducing gluconeogenic 
activity. 
 
 
The vivo studies by McGuinnes and Cherrington (1990) revealed the capability of glibenclamide to 
elevate insulin’s opposing effect on the gluconeogenic hormone called glucagon. These researchers 
also noted that in the absence of insulin in the case of diabetes type 1, glibenclamide could not perform 
negatively on the action of glucagon. However, glibenclamide may play an indirect role as an inhibitor 
of glucagon while improving the action of insulin. 
 
 
It may reach its hypoglycaemic effects by several mechanisms such as: increasing glycogen synthesis 
by improving production of glycogen synthase, obstructing glycogenolysis by reducing 
phosphorylase α activity and thereafter stopping gluconeogenesis, increasing metabolic mechanism 
flux to glycolysis by decreasing A- kinase – activity (Caro, 1990). It also triggers other major 
biochemical mechanisms such as the glycolytic pathway by increasing the action of the main rate- 
limiting enzyme of this pathway (glucosidase), which phosphorylates glucose to glucose-6- 
phosphate. This would cause glucose to be metabolized by the liver and to generate energy in excess 
amounts that would be stored as glycogen in muscle or fat in adipose tissue. 
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1.8 Overview of current animal models of T2D 
 
1.8.1 Diet induced models of T2D 
 
 
1.8.1.1 Fat fed models 
 
 
The most commonly used fat fed mouse model is the Diet Induced Obese (DIO) model using male 
C57BL/6J mice. The development of obesity is subjective to the amount of fat added to the diet, with 
high-fat diets used to induce obesity, whilst low-fat diets are unable to induce obesity. An important 
consideration when using fat fed rodents to induce insulin resistance is the initiation of fat feeding in 
diets at a young age between 6-8 weeks, as this has been shown to be most effective to develop obesity 
(Reuter, 2007). Mice are basically fed from a diet that contains 40-60% of calories from fat. These are 
high fat fed male C57BL/6J, approximately 8 times higher fat content compared with control mice for 
8-16 weeks, although experimental mice became diabetic after just 4 weeks. The longer duration of 
fat-feeding contributes to the development of insulin resistance, impaired glucose tolerance revealing 
elevated serum insulin and glucose, abnormal lipid profiling and hyperglycaemia in a mild to 
moderate state; the degree to which is mainly dependent on the duration of the experiment and the 
type of fat (Reuter, 2007). Pancreatic islet dysfunction is also noted in this model, which is essential 
pathogenesis for T2D. The DIO rat model most popularly uses outbred Sprague-Dawley rats as it has 
a major sensitivity to high-fat diets to inducing insulin resistance and diabetes contrary to other rat 
strains. 
 
 
1.8.2 Chemically induced rodent models of T2D 
 
 
1.8.2.1 Alloxan 
 
 
 
Alloxan was the first chemical inducer of T2D used in 1943 (Goldner and Gomori, 1943). Alloxan is 
a uric acid derivative that destroys only pancreatic β-cells through the mechanisms of oxidative stress 
(RERUP, 1970). On the other hand, Streptozotocin (STZ), is a natural antibiotic generated by the 
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bacterial species Streptomyces achromogenes (Islam and Wilson, 2012). It remains structural the 
analog of N-acetyl glucosamine that acts as a potent alkylating agent which results in the disruption 
of glucose transport, glucokinase activity as well as the induction of multiple DNA strand breaks 
(Goyal et al., 2016). 
 
 
1.8.2.2 Streptozotozin 
 
 
 
The natural antibiotic, Streptozotocin (STZ) (Figure 1.7) is produced by the microorganisms 
Streptomyces, (Fröde and Medeiros, 2008). It is a derivative from nitroso group and urea and 
structural analog of N-Acetyl-D-glucosamine (GlcNAc) Konrad et al. (2001) that acts as a potent 
alkylating agent which will cause disarrangement of glucose transport, glucokinase activity as well 
as induction of multiple DNA strand break (Bolzán and Bianchi, 2002). 
 
 
 
 
Figure 1.7: Chemical Structure of STZ adopted from Konrad et al. (2001) 
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STZ is able to penetrate the pancreatic β-cells through Glucose transporter 2 (GLUT-2) receptors 
resulting in DNA damage through alkyl group from one molecule to another, as well as causing the 
production of toxic superoxide and hydroxyl radicals. These radicals result in the destruction of the 
pancreatic β-cells by necrotic mechanisms (Szkudelski, 2001). Due to this reason, the use of STZ in 
diabetic research is widely used and it has been a non-surgical method to safely induce diabetic 
hyperglycaemia as well as progressive pancreatic β-cell destruction (Amirshahrokhi et al., 2008). 
Inducing diabetes with STZ has been vital as it selectively targets pancreatic β-cells through the 
alkylation of their DNA. It has been of major help in both types of diabetics for research (Zhang et 
al., 2015). 
 
 
 
The residual pancreatic β-cell mass that will remain after the administration of STZ is estimated at 
20%, which will progressively increase to 50% due to regeneration mechanisms of the pancreatic β- 
cell (Masiello, 2006). A mere single high dose of STZ administration (Figure 1.7), results in massive 
pancreatic β-cell damage, and is more characteristic of type 1 diabetes, whereas the injection of a low 
dose of STZ causes only partial disorder to insulin secretory mechanisms seen in type 2 diabetes 
(Srinivasan and Ramarao, 2007). 
 
 
 
Several combinations over the decades were safely used to develop models for type 2 diabetes for 
selected research, including single high dose STZ injection, multiple low dose STZ injections or in 
combination with nicotinamide. It is, however, known that a single high dose of STZ administration, 
higher than 60 mg/kg body weight (BW) causes wide pancreatic β-cell destruction. This is more than 
the characteristic of type 1 diabetes, whereas low dose STZ injections between 40-55 mg/kg BW can 
cause only partial dysfunction to insulin production mechanisms as observed in type 2 diabetes 
(Srinivasan and Ramarao, 2007). But the dosages lower than 35 mg/kg BW in rats fed with ad libitum, 
with commercial diet fails to bring forth any hyperglycaemic effects in the experimental rats 
(Srinivasan and Ramarao, 2007). These composed drugs can be administered either via intravenously 
(I.V) or via intraperitoneally (I.P) at the following concentrations, 35-65 mg/kg body weight in rats, 
100-200 mg/kg body weight of STZ in mice (Islam and Wilson, 2012). 
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1.9 Models of Streptozotozin-nicotinamide 
 
 
 
Nicotinamide is the amide derivative of nicotinic acid and is commonly used as an agent in diabetic 
research. It is a potent scavenger of free radicals and provides a valuable portion of the coenzyme 
nicotinamide adenine dinucleotide (NAD). High dose of nicotinamide has been revealed to have a 
protective role in pancreatic β-cell survival against both exogenous toxic agents as well as from 
immune responses (Knip et al., 2000). This can reduce the toxic effects caused by STZ on pancreatic 
β-cells (Masiello, 2006). STZ causes damage of DNA in pancreatic β-cells and activates the enzyme 
poly (ADP-ribose) synthesize. 
 
 
Nicotinamide inhibits the activity of the enzyme, thereby causing reduction of the apoptotic levels 
within the damaged pancreatic β-cells, and promoting pancreatic β-cell survival (Masiello, 2006). 
The STZ-nicotinamide model was originally brought forward by (Masiello et al., 1998) and later, 
(Nakamura et al., 2006) adapted similarly to a non-obese non-genetic model of type 2 diabetic in mice. 
The STZ-nicotinamide models may, therefore, guarantee many similarities to type 2 diabetics that are 
non-obese. This model is mainly characterized by normal weight gain and insulin secretion despite a 
moderate disruptive ability to produce insulin from pancreatic β- cells. Furthermore, it shows minimal 
disruptive fasting blood glucose levels and only mild glucose intolerance (Nakamura et al., 2006). 
This model possesses some positive effects in comparison to another non-genetic type 2 diabetics 
models as it can quickly change in a 5 weeks’ time period, thus, helping to reduce experimental costs.  
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1.10 Overview of Anatomy of kidney 
 
1.10. 1 Anatomy of the rat kidneys 
 
 
 
The kidney of the rat is smooth and their borders are convex and concave. Each of the kidneys has got 
surfaces located dorsally and ventrally and medial and lateral borders. Each kidney has got indented 
hilus and an upper and lower pole. This is in agreement with Al-Samawy (2012), who also revealed 
that the kidneys of Wistar rat were bean shape and smooth. The hilus and sides of the kidney of the 
rat are surrounded by adipose tissue. 
 
 
Anatomically the rat kidneys are located alongside the vertebral column in the abdominal cavity 
(Figure 1.8) and above their poles are situated at the suprarenal glands. The right kidney is situated more 
cranially than the left. The right kidney is situated more cranial than the left kidney and related to the 
liver while the left is related to the stomach, pancreas, descending colon, spleen and small intestine. 
This result is supported by that of Al-Samawy (2012) who registered that the paired kidneys of the 
two investigated rodents were bean shaped and dark red bodies located in the dorsal wall of the 
abdominal cavity. The mean weight of the right kidney is about 1.1 gm while the left one is about 
0.96 gm. The mean length, width, and thickness of the right kidney are 1.28 cm, 0.88 and 0.81 cm 
respectively while those of the left are 1.23 cm, 0.85 and 0.79 cm. 
 
 
 
 
The color of rat kidneys is reddish-brown and are covered by a thin connective tissue capsule that is 
adherent to subcapsular connective tissue, in agreement with (Mohamed, 2014). Each kidney is made 
of connective tissue which may contain a distinct layer of smooth muscle in its deepest portion and is 
enclosed by a fibroconnective tissue capsule. With reference to the histology, the kidney of rat is 
formed by two regions, the outer cortex, and the inner medulla. The cortex and medulla are arranged 
into more pyramidal shape called renal pyramids. The apex of each pyramid is named renal papilla 
(Figure 1.9). The nephron forms the basic and functional unit of the rat kidney. 
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Each nephron may be safely subdivided into a number of distinct parts into the cortex and medulla. 
The nephron composed of a renal corpuscle and the first part of nephron consists of glomerulus and 
Bowman’s capsule, the proximal convoluted tubules, a loop of Henle which arranged into ascending 
and descending limb and then the distal convoluted tubules. In the cortex, we may observe renal 
corpuscles, proximal convoluted tubules and distal convoluted tubules (Mohamed, 2014). The renal 
corpuscle is a rounded or irregular structure which forms the glomeruli that are enveloped by 
Bowman’s capsule. The Bowman’s capsule is formed by two thin cellular layers, the outer parietal layer 
and an inner visceral layer. The parietal layer consists of a flat single layer of squamous epithelium 
enclosing a narrow space, or the urinary space is continuous with the lumen of the proximal 
convoluted tubule. The visceral layer is surrounding the glomerular capillaries. The visceral space of 
renal corpuscle communicates with arteries of glomeruli (Mohamed, 2014). The renal corpuscle is a 
spherical structure formed by glomerulus which is enclosed by Bowman’s capsule. 
 
 
 
 
The initial and terminal parts of the nephron are composed by the proximal convoluted tubule and 
distal convoluted. The proximal convoluted tubule arises from the arterial epithelium of Bowman’s 
capsule of the urinary space of the renal corpuscle. The proximal tubule exits as a small, uneven 
lumen and a single layer of cuboidal cells with eosinophilic, granular cytoplasm. The proximal tubules 
and the distal convoluted tubules are different, in that the cells lining are of the cuboidal type with 
rounded and large nuclei, possess no brush border. The distal convoluted tubules appear shorter than 
the proximal convoluted tubules and are fewer in number in the regional cortex (Mohamed, 2014). 
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Figure 1.8: Schematic drawing showing location of the kidneys in the abdomen of a rat. 
www.biologydiscussion.com (February 2019). 
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1.11 Anatomy of Human kidneys 
 
 
 
The kidneys are two bean-shaped organs that lie on either side of the spine in the retroperitoneal space 
between the parietal peritoneum and the posterior abdominal wall. They are roughly the size of 11 
cm long and the male kidney is typically a bit larger than the female kidney. About 25 percent of the 
cardiac output at rest is released to the kidneys, the reason why kidneys are well vascularized. One of 
the major excretory organs of the body is the kidney (Al-Samawy, 2012). Each kidney weighs about 
120 to 150gms and a thin, tough fibrous capsule protect the kidney as a protective layer. 
 
 
 
The hilum of the kidney is concave, located medially, receives the renal artery that enters to deliver 
oxygenated blood and renal vein exits with deoxygenated blood. In addition, the ureter leaves the 
kidney at the same point. The components of the kidney are arranged in three layers. A frontal section 
through the kidney reveals an outer region called the renal cortex and an inner region called the 
medulla (Al-Samawy, 2012). The cortex has a brownish red and granular appearance. It contains the 
corpuscles of the kidneys and convoluted tubules (Figure 1.10). At intervals, cortical tissue penetrates 
the medulla in the form of columns, called columns of Bertini. Tubular structures and the nephrons 
are found in the medulla which has a striated appearance, radially. Medulla mass is divided into 8 to 
18 medullary or Malpighian pyramids (Figure 1.10). The basal portion of each pyramid is in contact 
with the cortex and the apex projects into a minor calyx (Al-Samawy, 2012). 
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Figure 1.9: Sagittal section of rat kidney. www.sharelike.me, Febrauary, 2019 
. 
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Figure 1.10: Schematic diagram showing sagittal section of human kidney (Adapted from Rolfe, 
2017). 
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                    1.11.1 Nephrons as the functional unit of the kidney 
 
 
 
The “functional units” of the kidney are nephrons. They cleanse the blood and balance the constituents 
of the circulation. The afferent arterioles form a tuft of high-pressure capillaries is about 200 µm in 
diameter. The rest of the nephron consists of a continuous sophisticated tubule whose proximal end 
surrounds the glomerulus in an intimate embrace (Suchy-Dicey et al., 2016). This is the Bowman’s 
capsule. The renal corpuscle is composed of glomerulus and Bowman’s capsule. Some nephrons have 
a short loop of Henle that does not expand beyond the cortex, and they are called cortical nephrons. 
About 15 percent of nephrons have long loops of Henle that are found deep into the medulla named 
juxtamedullary nephrons (Suchy-Dicey et al., 2016). The nephrons possess various portions that are 
functioning differently in their capacity to reabsorb water and specific solutes (Figure 1.11). While 
much of the reabsorption and secretion occur passively based on the polarity, the regulation of the 
amount of water that is sponged up or lost is strictly performed. This water management is mainly 
performed by ADH and aldosterone, and indirectly by renin. Most water is recovered in the PCT, 
loop of Henle, and DCT. About 10 percent (about 18 L) reaches the collecting ducts. ADH helps to 
recover almost all of the water passing through the collecting ducts, in cases of dehydration, or almost 
none of the water, in cases of over-hydration (Suchy-Dicey et al., 2016). 
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Figure 1.11: Schematic diagram showing structure of the nephron. Adapted from Feig et al. (2008). 
 
 
 
 
1.11. 2 Histology of the kidney 
 
 
 
 
The internal or visceral layer surrounding the glomerular capillaries possesses modified epithelial 
cells named podocyte. The podocytes are constituted by long processes, called foot processes and 
foot projections, or pedicels, which serve as the origins of the name podocyte (Al-Samawy, 2012). 
The glomerulus ("little ball") is essentially a small knot of capillaries and supporting structures 
suspended within Bowman's capsule. The glomerulus will initially filtrate the plasma that is 
eventually processed into the urine. Because of this function, the glomerulus appears as the most 
significant component of the nephron. Mesangial cell nuclei may sometimes be recognized as small, 
irregularly shaped, and rather heterochromatic nuclei within the glomerulus. Lacis cells or cells of 
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Goormaghtigh are extra-glomerular mesangial cells, which occupy the space between the glomerulus 
and the macula densa of the distal tubule. The mesangial cells are covered by the mesangial matrix 
that is extracellular material which apart from offering some mechanical support to the glomerular 
capillaries, the function of the mesangial matrix is unknown. 
 
 
 
 
Proximal convoluted tubules possess internally lining cuboidal epithelial cells which relaxing on the 
basement membrane and are thin structures distinguishable by the widest lumen (Figure 1.12). The 
descending of the proximal tubules is much related in the structure to the proximal convoluted tubules 
while the straight (ascending) segments of the distal tubules are like the distal convoluted tubules. 
These cells are characterized by ground eosinophilic cytoplasm, large nuclei located in the center and 
possess apical surface that is mainly covered by microvilli (brush border) (Al-Samawy, 2012). Simple 
cuboidal epithelium constitutes the lining structure of the proximal convoluted tubule whose cells 
have several characteristic features. The brush border plainly visible in routine histological 
preparations, but proximal tubule cells tend to have indistinct apical ends (in contrast to the more 
definite apical border of cells comprising distal tubules and collecting ducts). Cells have a high 
proportion of mitochondria in their cytoplasm, to provide the energy in order to pump ions and 
molecules against their concentration (Al-Samawy, 2012). The apical end of each cell has a brush 
border of microvilli. Microvilli provide an increased surface area to accommodate the membrane 
channels that are responsible for absorbing into the cell small molecules from the filtrate in the tubular 
lumen. 
 
 
 
 
Tubules descending segments of the proximal tubules, ascending segments of the distal tubules and 
the collecting tubules constitute the medullary rays (Al-Samawy, 2012). While the epithelial lining 
of distal convoluted tubules shows extensive lumen and the cuboidal cells can be identified by the 
cytoplasm, clearly less eosinophilic than that of the proximal tubules and the apical surface of the 
distal convoluted tubule (Figure 1.12). Straight parts of the tubules and the loop of Henle are found 
in the medulla only. The loop of Henle is the structure which consists of two segments, thick and thin 
descending and ascending. 
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The loop of Henle is a major feature of the renal tubule, associated with the remarkable function of 
the renal medulla in water conservation. Basically, the loop of Henle helps to establish a hypertonic 
saline environment within the medulla, which in turn allows subsequent recovery of water from 
collecting ducts and associated concentration of urine within the collecting ducts. Descending limb, 
having an initial short thick segment followed by a long thin segment, and an ascending limb, with a 
thin segment followed by a thick segment form the loop of Henle. The descending thick segment is 
lined by simple cuboidal epithelium that is structurally similar to the proximal convoluted tubule. 
This segment is essentially a continuation of the proximal tubule (sometimes called pars recta in 
contrast to pars convolute). Simple squamous epithelium lining in the descending thin segment as 
well the ascending thin segment (Murayama and Sakai, 1975). 
 
 
 
 
But simple cuboidal epithelium lining in the ascending thick segment that is structurally similar to 
the distal convoluted tubule (as for the proximal tubule, this segment is sometimes called pars recta 
of the distal tubule in contrast to pars convolute). 
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               Figure 1.12: Image of Microscopic anatomy of Kidney, February, 2019. www.auanet.org.  
               Magnification × 400. 
 
 
 
1.11.3 Renal Circulation 
 
 
From the left interior side of the abdominal aorta arise the renal arteries, immediately below the 
superior mesenteric artery, and supply the kidneys with blood. Each is directed across the crus of the 
diaphragm, so as to form nearly a right angle (Figure 1.13). The renal arteries carry a large amount 
of total blood flow to the kidneys. Up to 25% of total cardiac output may pass the renal arteries to be 
filtered by the kidneys (Fattah et al., 2019). Paired renal arteries are formed by the Aorta, each of 
which enters the kidney at the hilum and will be dividing into an anterior and posterior branch, which 
later, breaks into about five segmental arteries. The interlobar arteries are formed by segmental 
arteries, which penetrate the medulla between the pyramids to reach the border zone between the 
medulla and cortex. Henceforth, they, in turn through a horizontal course join with adjacent arteries 
to form the arcuate arteries (arterial arches). Several straight arteries are produced from these arches 
and run radially outward through the cortex. They are then named interlobular arteries. Numerous 
afferent arterioles are the division of each interlobular artery, which subdivides into 4 to 5 large 
capillary loops, which unite to the efferent arterioles to form the renal portal system. 
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         Figure 1.13: Renal circulation, February, 2019. www.pt.slideshare.net.
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1.11.4 Urine Formation 
 
 
 
Kidneys excrete the rejected substances, including metabolic end products, and those substances, 
which are present in excessive quantities in the body, via urine. Normally, the body generates about 
1-1.5 liters of urine per day. The mechanism of urine formation passes through various processes. It 
commences with a portion of blood that enters the glomerular capillaries. The plasma is filtered into 
the Bowman’s capsule. When this filtrated blood passes through the tubular portion of the nephron, 
it undergoes several changes with regard to its quality and quantity (Suchy-Dicey et al., 2016). Many 
desirable substances like glucose, amino acids, water and electrolytes are picked up from the tubules. 
This is tubular reabsorption. Some undesirable substances are ejected into the tubule through the 
blood vessels of the peritubular area. This process is called tubular secretion or excretion. 
 
The production of the urine follows three steps: 
(i) Glomerular filtration; 
(ii) Reabsorption through the tubules, and; 
(iii) Secretion via the tubules. 
 
 
 
1.11.5 Glomerular Filtration 
 
 
 
The circulation of the blood through the glomerular capillaries enables the plasma to be filtered into 
the Bowman’s capsule. Plasma proteins are the only substances which are not filtered among others. 
The filtered fluid is the glomerular filtrate (Suchy-Dicey et al., 2016). During the filtration process, 
substances pass through three layers of filtrating membrane namely: 
1. The endothelium of capillary membrane 
2. Basement membrane and 
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3. Endothelium of visceral layers of bowmen’s capsule 
The glomerular filtration is named ultra-filtration due to minute particles that are filtered. The plasma 
proteins are not filtered because of their larger molecular size than size of the slit pores. The 
composition of glomerular filtrate is similar to that of plasma except in the absence of plasma proteins. 
 
 
 
                     1.11.5.1 Glomerular filtrate rate (GFR) 
 
 
 
The total quantity of filtrate generated in all the nephrons of both kidneys during a period of time 
depends on the glomerular filtration rate. Normal glomerular filtration rate is 125 ml per minute or 
about 180 litre/day. The glomerular filtration rate constitutes the volume of filtrate formed by both 
kidneys per minute (GFR). About, 5 L of blood are ejected per min under resting conditions by the 
heart (Levey et al., 1999).  
  
The amount of blood generated equates to a volume of about 180 L/day in male and 150 L/day in 
female. Meanwhile, 75% of this filtered blood is pushed back into the circulation by reabsorption so 
that only about 1–2 litres of urine are generated per day (Levey et al., 1999). Although up to 180 litres 
per day passes through the nephrons, obviously, major portion of that fluid and its contents will be 
reabsorbed. Proximal convoluted tubule (PCT), loop of Henle, distal convoluted tubule (DCT), and 
the collecting ducts are the recovery sites. 
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1.11.6 Tubular Reabsorption 
 
 
 
When the glomerular filtrate crosses (passes through) the tubular portion of nephron, quantitative and 
qualitative changes rapidly occur. The tubular epithelial cells possess the power to reabsorb huge 
amount of water, electrolytes and other substances. The substances, which are reabsorbed, are injected 
into the interstitial fluid of the renal medulla, and thence the substances are moved into the blood in 
the peritubular capillaries. Because the substances are ejected back into the blood, the entire process 
is named tubular reabsorption. 
 
 
 
1.11.7 Selective Reabsorption 
 
 
 
  
The kidney selectively reabsorbs the substances found in the glomerular filtrate via the tubular cells, 
based on the needs of the body. This is the selective tubular reabsorption. Active reabsorption and 
Passive reabsorption are forming the process of reabsorption.  In active reabsorption, molecules are 
moved against the electrochemical gradient and subsequently demands utilization of energy and the 
energy is derived from ATP while in passive reabsorption, molecules will be passing more along the 
electrochemical gradient which does not require energy. 
 
 
 
1.11.8 Tubular Secretion 
 
 
This refers to a process whereby some materials are secreted into the lumen from the peritubular 
capillaries through the tubular epithelial cells. During this process some substances, such as hydrogen 
ions, creatinine, and drugs will be subjected to be cleaned from the blood through the peritubular 
capillary mechanism within the collecting duct. The urine will subsequently form as end product, 
which is a collection of substances, that are basically not reabsorbed during glomerular filtration or 
tubular reabsorption (Suchy-Dicey et al., 2016). 
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Water that has not been reabsorbed forms mainly the urine, which is the way in which the body lowers 
blood volume, by increasing the amount of water that becomes urine instead of becoming reabsorbed. 
Many salts and other waste components compose the urine. Urine does not contain red blood cells 
and sugar under normal condition, whence found, it may indicate glomerulus injury and diabetes 
mellitus respectively. Tubular secretion of solutes is more efficient than glomerular filtration and it 
is strong mechanism for elimination of drug, subsequently may cause important clinical consequences 
of secretion disorder. Investigating tubular secretion as an independent marker of kidney function 
may provide a light into the etiology of kidney disease and improve prediction of adverse outcomes. 
One may estimate the secretion function by recording secreted solute. 
 
 
 
1.12 Nanoparticles and Herbal Formulations 
 
 
 
 
Despite the introduction of various antidiabetic and hypoglycemic agents, diabetes and its associated 
complications continue to pose a major problem in the world population (Subramoniam, 2016). 
Various types of currently used anti-diabetic drugs cannot manage blood glucose levels and develop 
side effects and/or insufficient response after prolonged use of these drugs. The necessity to look for 
new medicines and interventions that can be used to manage this metabolic disorder has been noted 
by various researchers and practitioners in this field (Subramoniam, 2016). This is supported by 
(Martone et al., 2010), who stressed that alternative therapy is required; and there is currently a need 
to shift towards African indigenous plant and herbal formulations. Biomedical applications using 
nanoparticles (NPs) have become a very active research area in recent years (Mieszawska et al., 
2013). 
 
 
 
 
Compared with conventional formulations, nanotechnology-based drug carriers have more medical 
benefits (Zhou et al., 2012). Novel drug delivery systems (NDDS) not only reduce the repeated 
administration to overcome non-compliance, but also help to increase the therapeutic value by 
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reducing toxicity and increasing the bioavailability. Nanotechnology is the novel approach. Nano- 
sized drug delivery systems of herbal drugs have potentials for enhancing the activity and contribute 
to overcome problems linked to plant medicines (Subramoniam, 2016). Hence, integration of the 
nanocarriers as a NDDS in the traditional medicine system is essential to combat and control 
efficiently chronic diseases like asthma, and cancer, in addition to diabetes (Subramoniam, 2016). 
 
 
 
 
Incorporation of the herbal extracts into novel formulation systems have certain added advantages, 
such as overcoming bulk dosing and lower absorption, which are the major problems being faced, 
and thus drawing the attention of major pharmaceutical corporations (Subramoniam, 2016). Plants 
have long demonstrated the capacity to assimilate and aggregate inorganic metallic particles (Shah et 
al., 2015). The use of Cinnamomum cassia in nanoparticles synthesis, appears eco-accommodating, 
compared to the naturally based system like parasites, which have different focal points, maintains a 
strategic distance and have a tendency to be costly (Shah et al., 2015). 
 
 
 
On the other hand, biosynthesis of silver nanoparticles from plants or plant-based concentrates as 
Cinnamomum cassia has all the earmarks of being sheltered, have generally short generation times, 
and have a lower development cost in contrast with other natural frameworks. Moreover, plant-based 
biosynthesis has a straight forward technique that can be effortlessly scaled up for substantial scale 
generation of nanoparticles. 
 
 
It has been revealed that not every natural substance can securely be combined with nanoparticles 
because of their chemical exercises and characteristic metabolic action (Shah et al., 2015). 
Consequently, it is essential to precisely determine fitting organic substance important to make 
nanoparticles with very much characterized properties, for example, size and morphology (Shah et 
al., 2015). Cinnamomum cassia is endorsed as a powder that is typically utilized and blended with 
different meds (Ghasemi Pirbalouti et al., 2014). Researchers have revealed that Cinnamon has insulin 
potentiating movement and in this way it might assume a part in glucose digestion (Magistrelli, 2010).
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In spite of wide utilization of Cinnamon, for many remedies, the world does not have adequate 
understanding on organ toxicity or safety of Cinnamomum cassia especially after long term treatment. 
 
 
 
 
Nanoparticles have many advantages for herbal drugs, including enhancement of solubility and 
bioavailability, protection from toxicity, enhancement of pharmacological activity, enhancement of 
stability, improving tissue macrophage distribution, sustained delivery, protection from physical and 
chemical degradation (Subramoniam, 2016). Nanoparticles have made major contributions to clinical 
medicine in the areas of drug/gene delivery. Nanocarriers have the ability to: 
i. protect the associated peptide from degradation in the gastrointestinal fluids; 
 
ii. facilitate the intestinal absorption of the associated peptide, 
 
iii. have a large (functional) surface which is able to bind, adsorb and carry other compounds such as 
drugs, and proteins. 
 
 
 
 
NPs have a surface that might be chemically more reactive compared to their analogues (Borm et al., 
2004). The biocompatible nanoparticles with physical, chemical and biological properties can be 
applied to optimize and overcome the limitations of conventional administration by improving drug 
solubility, increasing the rate of drug release and developing the penetration and distribution of drugs. 
Therefore, drug delivery systems provide the routes for drug delivery, which dramatically promote 
therapeutic effect of drugs (Karimi et al., 2016). The study done by Murthy (2007), about the 
toxicological effects of nanoparticles associated with medical applications such as iron oxide and 
nanoparticles revealed no toxicity. Nanoparticles have been found to be “nontoxic” according to many 
anecdotal reports (Connor et al., 2005). 
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1.13 Diabetes and Nanotechnology (Nanomedicine) 
 
 
 
Nanotechnology is a branch of science and technology operating at the nanoscale, which is about 1 
to 100 nanometers. Nanomedicine is defined as integration of nanotechnology in medicine to improve 
human health care. Nanoscience and nanotechnology possess a wide range of applications in various 
fields, such as green chemistry, herbal drug research (Riehemann et al., 2009). New opportunities for 
advancing biomedical science and disease treatment in human health care are opened up through new 
field of nanomedicine (Table 1.3). Rapid advances in health care, creates Nanomedicine scale 
limitations excludes at the lower end atoms (0.1 nm) and at the upper-end biological entities such as 
bacteria (1000–10000 nm) and body cells. Human body has configured many of its bio components 
as nanostructures, such as proteins, mitochondria, ion channels, membranes, secretory granules, 
lysosomes and many others, but new nanomaterials and structures are now being manufactured that 
might be of use in medicine, such as nanoparticles, capsules, films and tubes, and complex molecules 
(Riehemann et al., 2009). 
 
 
 
 
 
Nanomedicine can be classified into measurement (or ‘nanometrology’), which deals with either 
measurement of very small amounts of analyses (e.g. microphysiometer) or using very small sized 
devices for measuring (e.g. Quantum dots) (Carneiro and Programme, 2002). Therapy, as all of the 
manipulations and constructions of materials at the nano-level used for therapies (e.g. Artificial Nano 
pancreas). The major problems faced by conventional finger-prick capillary blood glucose, self-
monitoring are widely accepted. It is painful (leading to non-compliance) and cannot be performed 
when the patient is sleeping or driving a motor vehicle (times when the patient is especially vulnerable 
to hypoglycemia) and, because it is intermittent, it can miss dangerous fluctuations in blood glucose 
concentrations between tests. Currently in the market several implanted needle-type enzyme 
electrodes or micro dialysis probes are available for continuous glucose monitoring but those are 
limited impaired by responses and unpredictable signal drift in vivo, and also need calibration against 
capillary glucose tests and contributes to sensor inaccuracies (Garg and Hirsch, 2018). 
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The successive repeated insertion of the sensor probe is also semi-invasive. Nanomedicine is needed 
to overcome the fact that drug (herbal medicine) needs more time to show anti-diabetic activity 
because herbal drugs are basically more insoluble in nature. Herbal mediated silver nanoparticles 
(HMSNP’s) are using less particle size, more surface area, more solubility which results in the 
optimum dose of drug that can reach to systemic circulation and onsite of action is very quick. 
 
 
 
 
 
To efficiently solve the problem of intracellular reservoirs, Nanoparticulate systems using 
encapsulated payload can be internalized either by non-specific endocytosis or receptor-mediated 
endocytosis (Amiji et al., 2009). With regard to receptor-mediated endocytosis, the surface of 
nanoparticulate carrier needs to be adapted with a specific ligand that will recognize its receptor on 
the cell of interest. Nanoparticles bearing specific superficial layer with arginine-rich cell penetrating 
peptides (CPP) has been shown to enhance intracellular delivery (Amiji et al., 2009). As an example, 
some authors positively utilized encapsulated saquinavir in biodegradable hydrophobic polymeric 
designed with nanoparticles and made with poly (ethylene oxide)-modified poly(epsilon- 
caprolactone) (PEO-PCL) (Shah and Amiji, 2006). 
 
 
 
The management of diabetes has new research area in nanotechnology which is perceived to be 
effective (Awan et al., 2016). One of the important applications of nanotechnology in the medical 
field is the use of it in drug delivery to target tissues for therapy of disease such as diabetes (Table 
1.3). In addition, one of the limitations in the use of traditional medicine systems is that there is lack 
of target specificity, which reduces the effects of compounds due to drug metabolism in the body and 
the cellular toxicity of some drugs (Lee, 1995). In another study, animals with Streptozotocin-induced 
diabetes showed marked reductions in blood glucose levels after 4 weeks of continuous 
administration of aqueous extract of Cassia fistula and Cassia fistula gold nanoparticles (Daisy and 
Saipriya, 2012). 
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Decreased serum urea, creatinine, and uric acid are observed more effectively upon oral 
administration of nanoparticles to diabetics rats, than crude extracts of Cinnamomum cassia, and this 
is explained by the regenerative ability over the renal tubules (Tedong et al., 2006). Various chronic 
diseases such as diabetes, cancer, AIDS, nephritis, metabolic and neurodegenerative disorders may 
be manageable through the scavenging power of enzymatic and non-enzymatic antioxidants of 
nanoparticles (Kuppusamy et al., 2016). The free radicals formation are controlled by the antioxidant 
agents, including enzymatic and non-enzymatic substances. Cellular damage including brain damage, 
atherosclerosis and cancer are caused by free radicals. Reactive oxygen species (ROS) such as 
superoxide dismutase, hydrogen peroxides and hydrogen radicals contributing to the production of 
free radicals. Biomolecules such as proteins, glycoprotein, lipids, fatty acids, phenolic, flavonoids 
and sugars controlled free radical formation (Kuppusamy et al., 2016). 
 
 
 
1.14 Diabetes and Silver nanoparticles 
 
 
 
Insulin therapy has several negative effects like insulin resistance and may contribute to several other 
complications, under diabetic state. There is, thus, major need for an efficient and economic 
therapeutic molecule that is capable of positively and safely controlling diabetic mellitus and its 
complications while also preventing oxidative stress pathways associated with diabetes mellitus. 
Discovery of new safer molecules, capable of manipulating those available structures, naturally into 
Nano size could be advantageous for their greater potential to greatly improve health care (Sahoo et 
al., 2007). 
 
 
 
Wide range of biological applications characterized the gold nanoparticles, because of their unique 
physical and chemical properties. Gold nanoparticles have been, recently, positively, demonstrated 
into various biomedical fields, (biosensors, immunoassays, genomics, photo thermolysis of cancer 
cells, microorganism’s detection and control, targeted drug delivery, optical imaging, monitoring of 
biological cells and tissues by exploiting resonance scattering, or in vivo photoacoustic techniques 
(Kumar et al., 2011). Great attention has been given to gold compounds, as anti-inflammatory agents 
through their ability to inhibit expression of NF-kappa B and subsequent inflammatory reactions 
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(BarathManiKanth et al., 2010). Swarna Bhasma which possess immunomodulatory, antioxidative 
and restorative activity, used in cerebral ischaemic rats, has revealed their perceptive application in 
the treatment of ischaemia and cerebral damages (BarathManiKanth et al., 2010). 
 
 
 
There is a serious lack of information concerning the impact of nanoparticles on human health and 
the environment, despite the positive and wide application of nanoparticles. Several bioactivities were 
performed using metal nanoparticles, especially silver and gold (Pandiarajan et al., 2016). 
 
 
 
Silver nanoparticles has opened doors to their wide-spread use, because of their strong antimicrobial 
property, in bedding, water purification, toothpaste, shampoo, rinse, infant nipples nursing bottles, 
fabrics, deodorants, filters, kitchen utensils, toys and humidifiers. Metallic silver has been subjected 
to engineered nanotechnology causing some extraordinary novel morphologies and characteristics. 
Silver nanoparticles (AgNPs) are groups of silver atoms ranging in size from 1 to 100 nm, in at least 
one dimension (typically spherical diameter) (Table 1.3). Silver nanoparticles (AgNPs), an emerging 
Nanomedicine is renowned for its promising therapeutic possibilities (Table 1.3), in health care, due 
to its significant properties such as biocompatibility, high surface reactivity and strong resistance to 
oxidation (Morones et al., 2005). 
 
 
 
Silver nanoparticles possess inhibitory activity against VPF/VEGF165, that lead to proliferation of 
endothelial cells, and provide clear evidence over their therapeutic potential in the treatment of 
diseases like chronic inflammation, pathological neovascularization, rheumatoid arthritis, and 
neoplastic disorders (Shen et al., 2017). While the small size of nanoparticles makes them so useful 
in the domain of medicine and industries, it may also present a potential hazard to human health and 
the environment. Because, silver nanoparticles have demonstrated promising potential medicinal 
activity to manage inflammatory and autoimmune diseases, their medicinal activity has triggered 
enormous interest that lead to the investigation of their anti-oxidative and anti-hyperglycemic activity 
in diabetes (BarathManiKanth et al., 2010). 
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1.15 Diabetes and herbal remedies 
 
 
 
 
 
For the treatment and management of type II diabetes, numerous medicinal plants are used by local 
communities of South Africa. Plants extracts such as crude botanical, are also commonly used in the 
treatment and control of diabetes (Boaduo et al., 2014). Acarbose has shown a major role in the 
treatment of non-insulin-dependent diabetes mellitus. The use of herbal remedies for diabetes 
management is considered an important treatment modality available in South Africa (Boaduo et al., 
2014). Medicinal plants, Cinnamomum cassia is known to basically contain an insulin-like peptide. 
They have been widely studied to some extent as antidiabetic agents under either in vitro or ex vivo 
conditions. It is used in Africa as an astringent, germicide for chronic bronchitis and many other 
ailments. Several clinical trials using Cinnamomum cassia has proven its efficacy and its effectiveness 
in lowering plasma glucose levels in diabetic patients (Borzoei et al., 2018). 
 
 
 
Herbal remedies have attracted huge interest, due to its local availability, lack of side effects 
associated with the oral hypoglycemic agents; and their lower cost compared to conventional 
therapeutic agents (Nookabkaew et al., 2006). Medicinal Plants are known to be excellent sources of 
antidiabetic medicines (Marles and Farnsworth, 1995). Some of the new bioactive drugs isolated from 
plants continue efficiently to develop antidiabetic activity, during the past few years, compared with 
the oral hypoglycemic agents used in clinical therapy (Malviya et al., 2010). In the management and 
treatment of diabetes, many studies have confirmed the benefits of medicinal plants with 
hypoglycemic effects (Marles and Farnsworth, 1995; Malviya et al., 2010). Complications of diabetes 
may be delayed by the effects of these plants and correct metabolic abnormalities (Malviya et al., 
2010). 
 
 
 
Recently, complementary and alternative medicines have triggered attention in their major role for 
the treatment of various acute and chronic diseases, Aruoma et al. (2006), and previous studies Azu 
et al. (2010) support the use of plant-based adjuvants for disease management like diabetes, cancers, 
etc. An estimated 80% of Africans are said to rely on complementary and alternative medicines for 
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the management of diverse physio-pathological conditions (Milan et al., 2008). For the majority of 
this group of individuals, consultation with traditional health practitioners (THP) is the first call for 
health services (Owen-Smith et al., 2007). The high burden of diabetic nephropathy has drawn the 
attention of several studies designed to accommodate a holistic management viewpoint, involving the 
use of traditional medicines. 
 
 
 
Of the various classes of plants, interest has been focused on medicinal plants with various kinds of 
pharmacological properties such as anti-inflammatory, antibacterial and antidiabetic properties etc. 
The Cinnamomum cassia, plant has been recognized to possess antidiabetic properties (Marles and 
Farnsworth, 1995). Coumarin (2H-chrome-2-one) (Figure 1.14), Ravindran et al. (2003), the least 
complex portion from this class (Table 1.2), as an unadulterated compound or as a constituent of 
Tonka beans had been utilized as a flavouring specialist in nourishment, mixed drinks and tobacco 
(Egan et al., 1990).  
 
 
 
1.16 Cinnamomum Cassia 
 
 
 
 
Cinnamomum cassia, also known as Chinese cassia or Chinese cinnamon, is an evergreen tree 
originating from southern China and widely cultivated in southern and eastern Asia (India, Indonesia, 
Laos, Malaysia, Taiwan, Thailand, and Vietnam). In South Africa, mostly in KwaZulu Natal region, 
it is used as a spice and for medicinal remedy in various illnesses, such as diabetes. Nowadays, the 
plant is also found in the Southern Africa countries like Zimbabwe, Namibia, Mozambique, etc. 
Cinnamomum cassia may grow under a wide range of climatic conditions, such as warm and humid 
climate with a well distributed annual rainfall of around 2000-2500 mm, and average temperatures of 
about 27°C (Anitha and Hore, 2018). Tropical evergreen rainforests offer better climate conditions to 
wild cinnamon trees. It grows positively at low altitudes and is usually grown without shade, but 
being basically a forest tree, light shade is tolerated. It grows very well on various soils in the tropics, 
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but soil type has a pronounced impact on bark quality. In some countries, fine sandy and lateritic 
gravelly soils rather than rocky and stony substrates may be best.  
 
 
 
 
These ecological characteristics of both cinnamon and cassia are more or less the same. The species 
occurs up to 2000 m altitude, on well-drained hillside soils of low fertility and pH 4-6 (Ravindran et 
al., 2003). All the plants part is aromatic, but only its leaves and bark are exploited commercially. 
The essential constituent of leaves and bark oil are Cinnamaldehyde. The leaves are opposite, 
glabrous above, minutely hairy below, three ribbed from about 5 mm above the base and are 
triplinerved. The trees are coppiced periodically keeping the height to 3 -4 m, the bark produced from 
higher altitudes has got better quality, with reference to their oil. The immature fruits are often dried 
and sold in the market as cassia buds. 
 
 
 
 
Cinnamomum cassia is ready for harvesting after two to three years when the plants reach a height of 
1.5 to 2 m with three to four shots, and the bark turn in brown in colour. Harvesting can be done twice 
yearly depending on the season. Two to three crops are taken every year depending on the rainfall. 
Cinnamomum cassia extracts has been shown to have antidiabetic effects in vitro ((Marles and 
Farnsworth, 1995). It has also, been reported that Cinnamomum cassia lowers blood glucose, blood 
pressure, and serum cholesterol levels and have anti-oxidant and free-radical scavenging properties 
as well as being hepato-protective (Ranasinghe et al., 2017). 
 
 
 
 
In addition, Ranasinghe et al. (2017) pointed out the following beneficial health effects of 
Cinnamomum cassia: (1) lowering of blood glucose, blood pressure and serum cholesterol, (2) 
antioxidant and free-radical scavenging properties, (3) inhibition of tau aggregation and filament 
formation (hallmarks of Alzheimer’s disease), (4) anti-secretagogue and anti-gastric ulcers (hepato- 
protective). Moreover, Hoehn and Stockert (2012) also, demonstrated similar beneficial health effects 
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of Cinnamomum cassia: 1) lowering of blood glucose, blood pressure, and serum cholesterol, 2) 
antioxidant and free-radical scavenging properties, 3) inhibition of tau aggregation and filament 
formation (hallmarks of Alzheimer’s disease), 4) anti-secretagogue and anti-gastric ulcer, 5) hepato- 
protective. Cinnamaldehyde (extracted from Cinnamomum cassia) has been shown to have 
antidiabetic effects in vitro (Lee, 2002). 
 
 
 
 
A meta-analysis by Ranasinghe et al. (2017) and a systematic review by Bandara et al. (2012)) on the 
effects of Cinnamomum cassia extracts on diabetes showed numerous advantageous effects both in- 
vitro and in-vivo. In-vitro, Cinnamomum cassia has demonstrated a potential for diabetes 
management (Knip et al., 2000). Reducing post-prandial intestinal glucose absorption by (1) 
contributing in the inhibition of the activity of enzymes involved in carbohydrate metabolism 
(pancreatic α–amylase and α–glycosidase), (2) Contributing to trigger cellular glucose uptake by 
membrane translocation of GLUT-4, (3) Activating glucose metabolism and glycogen synthesis, (4) 
Inhibiting gluconeogenesis by effects on key regulatory enzymes and stimulating insulin release and 
increase insulin receptor activity. However, this research did not either point out the beneficial impact 
of Cinnamomum cassia extracts on the morphology of diabetic kidneys 
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Table 1.2: Analysis of the plant Cinnamomum Cassia 
 
Contents Results Required 
Water 11.6%  
Total ash 18.01%  
Acid insoluble ash 4.2% Max 12.0 
Volatile oil 0.3% Max 7.0 
Cumarin 2.04% MAX 2.0 
Microbiology 1.743 MG/kg Min 1.0 
Mculds 60000 CFU/G Max 100.000 
E-Coli <10 CFU/G 10.00 
Staphylococcus aureus <10 CFU/G Max 100 
Bacillus cereus 1.700 CFU/G MAX 10.000 
Sulphite reducing clostridia 150 CFU/G MAX 10.00 
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Figure 1.14: Chemical Structure of Cinnamomum cassia, powder, adapted from US National Library 
National center for biotechnology information, 2018. 
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                      1.21 Statement of problem 
 
 
 
 
Diabetes affects the size of kidneys as well as the corticomedullary architecture due to medullary 
fibrosis (Raparia et al., 2013); called nephrosclerosis. Antopolsky et al. (2012) revealed that diabetes 
causes chronic kidney disease which ultimately leads to renal dysfunction. Diabetes will further cause 
kidney tissue hyperplasia and hypercellularity, consequently leading to tubular cell destruction, 
necrosis as well as renal hemorrhage. 
 
 
Glomerular filtration rate will steadily decline due to the impact of diabetes on the kidneys and 
systemic blood pressure will be increased as well. Glomerular basement membranes (GBMs) will be 
thickened, which along with mesangial expansion will lead to capillary wall occlusion and decreased 
glomerular surface area (Raparia et al., 2013). This in addition to extracellular matrix accumulation, 
cytoplasmic lipid droplets and presence of hyaline substances further disrupts the endothelial 
homeostasis and eventually lead to tissue lesion. This lesion is characterized by an imbalance between 
the oxidant-antioxidant pathways in the endothelial cells giving rise to deposition of free radicals in 
the renal intracellular milieu. The presence of free radicals and the simultaneous decline of antioxidant 
defense potentialities observed in diabetic patients, advance the development of diabetic 
complications (Godin et al., 1988). 
 
 
 
 
The renal tubules in diabetic patients will show changes that are usually associated with glomerular 
alterations and tubular atrophy. The dilatations of proximal and distal convoluted tubules with an 
accumulation of lipid droplets in the epithelial cells are the effects of diabetic nephropathy (Raparia 
et al., 2013). It is a fact that various types of currently used antidiabetic drugs cannot fully control 
glucose level and often cause side effects and or insufficient response after prolonged use of these 
drugs. In addition, insulin considered as a major anti-diabetic drug has shown several side effects 
such as hypoglycaemia and weight abnormalities. 
 
63  
 
 
1.18 Justification 
 
 
 
The problems associated with diabetes continues to attract the attention of researchers both in 
experiments and clinical trials due to its heterogeneous nature that is majorly characterized by insulin 
resistance and pancreatic ß-cell dysfunction. With its global prevalence particularly the type 2 
diabetes, intensive studies have been carried out into the pharmacodynamics of insulin-mimetic drugs 
with majority of these work being performed on animal models (Islam and Wilson, 2012). 
 
 
 
 
Investigation of animal models in the pharmacokinetics or pharmacodynamics of diabetic drugs may 
represent a similar pattern in humans. Therefore, using animal models for diabetic research offers 
significant insight into the biochemical pathways that may be similar to humans in clinical research. 
In this study, the rat serves as a suitable model for investigating the kidney based on its similarity in 
structure and physiologic functions, while being considered as easy to handle and less expensive. 
More, so while it may not be feasible to carry out the experimental protocol on humans, yet. The 
associated microvascular complications (diabetic nephropathy) of diabetes necessitate the need for a 
complementary medicinal plant that can revert or ameliorate the deleterious consequences posed by 
diabetes. 
 
 
 
 
The search for medicinal plants has continued to grow due to its easy accessibility, relatively low 
cost, and perceived effectiveness. It is estimated that 80% of the general population in sub-Saharan 
Africa rely on African traditional medicines to treat various diseases (Hostettmann et al., 2000). 
Cinnamomum Cassia falls into this category and has been widely used for the treatment of various 
ailments within the region and studies have attributed this to the pharmacological properties it 
possesses (Albrecht et al., 1995). 
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1.19 Aims 
 
 
The aims of this study are: 
 
1. To develop a novel approach in synthesizing silver nanoparticles using Cinnamomum 
cassia extracts for the management of type 2 diabetes in the kidney of experimental 
rats. 
 
2. To investigate the histomorphological and biochemical effects of Cinnamomum 
cassia extracts nanoparticles on the kidneys of type 2 diabetic rats. 
 
 
 
1.20 Specific objectives 
 
i. To evaluate the impact of Cinnamomum cassia extracts (nanoparticle conjugate) on the renal 
histomorphology of STZ induced type 2 diabetic rats. 
ii. To evaluate and report the biochemical and histopathological effects of Cinnamomum cassia 
and Cinnamomum cassia silver nanoparticles on the kidneys. 
iii. To assess any possible renal toxicity of the effects of Cinnamomum cassia extracts 
(nanoparticle conjugate) in STZ-induced type 2 diabetic rats. 
iv. To investigate the ultrastructural changes on renal tissue and mesangial cells of the kidneys 
of STZ- induced type diabetic rats, treated with Cinnamomum cassia extracts (nanoparticle 
conjugate). 
v. To determine the antioxidant effects of Cinnamomum cassia extracts (nanoparticle 
conjugate) on STZ- induced oxidative stress. To measure the biomarkers of damaged kidneys 
using the urine and the blood of the experimental rats. 
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1.21 Research questions 
 
 
1. Does Cinnamomum cassia possess antioxidant properties? 
 
2. Does Cinnamomum cassia silver nanoparticles possess antioxidant properties 
3. Can the known chronic hyperglycaemia effect of STZ be corrected by Cc and or CcAgNPs? 
4. Can the persistent hyperglycaemia on the experimental animals be mitigated by Cc and or 
CcAgNPs? 
5. Can the histopathological and biochemical effects of long-term hyperglycaemia on the kidneys 
be revered by Cc or CcAgNPs? 
6. Does CcAgNPs mitigate renal clinically impairment in diabetic nephropathy? 
 
 
 
1.22 Contribution to knowledge 
 
 
 
This study is the first to report on the use of Cinnamomum cassia capped into silver nanoparticles in 
an experimental model for diabetic nephropathy. The study hopes to use qualitative and quantitative 
techniques that would offer additional interpretive values in renal pathology and morphology. 
 
 
 
1.23 Animal management/ Experimental design 
 
 
 
 
Sixty-five (65) healthy adult male Sprague Dawley weighing between 250 g to 270 g were used for 
this study. Animals were allowed to acclimatize for 7 days before commencement of the experiment. 
The animals were fed ad libitum and maintained at the Animal House of the Biomedical Resources 
Unit, University of KwaZulu-Natal (Council, 2010). The selected protocol for the experiment was 
officially approved by the Animal Ethics Committee (protocol reference number: AREC/74/016D). 
The experimental rats had unrestricted access to consume food (standard rat pellets) as well as water. 
Rats were all housed in plastic cages (3 rats/cage) with the dimensions of 30 cm long, 20 cm wide 
and 13 cm high. Their beds, used in the cages, were made with soft wood shavings, utilized as bedding 
66  
 
in the cages. Experimental Rats were maintained and conditioned under the standardized animal 
house (temperature: 28~31 ºC; light: approximately 12 hr. natural light per day; humidity: 50~55%). 
The animals were later randomly distributed into five (Carneiro and Programme, 2002) non-diabetic 
groups (A-E) of six (6) rats per group, and diabetic group (F-J) of five (7) rats per group (Figure 1.15). 
 
 
 
 
 
 
 
Figure 1.15: Sprague - Dawley rats housed in the plastics cages 
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1.24 Non diabetic group 
 
 
 
Group A received 1ml normal saline (Negative control) (Figure 1.16) 
Group B received Cinnamomum cassia extracts (100 mg/kg). 
Group C received Cinnamomum cassia extracts (200mg/kg). 
Group D received Cinnamon cassia silver nanoparticles (5 mg/kg). 
Group E received Cinnamon cassia silver nanoparticles (10 mg/kg). 
 
 
1.25 Diabetic group 
 
 
 
 
Group F received 1 ml of normal saline (Positive control) (Figure 1.16) 
Group G received Cinnamon cassia extracts (100mg/kg). 
Group H received Cinnamon cassia extracts (200mg/kg). 
Group I received Cinnamon cassia (5 mg/kg). 
Group J received Cinnamon cassia (10 mg/kg). 
Cinnamon cassia silver nanoparticles and Cinnamon cassia were dissolved in normal saline. All 
treatments were administered orally and daily for 56 days using a rat gavage needle (Turner et al., 
2012). 
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Figure 1.16: Experimental design 
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1.26 Induction of type 2 diabetes. 
 
 
 
Diabetes was induced by firstly intraperitoneal injection of 100 mg/kg of nicotinamide (Sigma 
Aldrich, South Africa) which was dissolved into normal saline; 15 minutes before administration of 
Streptozotocin at a dose of 60 mg/kg i.p. Meanwhile, STZ was dissolved into citrate buffer at PH 
(4.50) immediately before use. The animals were then kept under observation. After 72 Hours the 
blood glucose of the animals was tested using; Accu-chek Active 50, blood glucose strips (Dis-Chem 
SA), with blood, collected from the tail vein of the rats. The animals with a fasting blood glucose 
level > to 9 mmol/l were considered diabetics. In addition, urinary measurements were monitored for 
urinalysis. 
 
 
 
1.27 Body and Kidney Weight 
 
 
The body weights (BW) of experimental rats were carefully recorded on the first day before treatment 
(initial) and thereafter on a weekly basis for 56 days, day of sacrifice, which gave the final weight. 
kidney weight (KW) was measured using an electronic balance (Mettler Toledo; Microsep (Pty) Ltd, 
Greifensee, Switzerland). Kidneys of each rat were measured individually, and the average value 
obtained for each of the two measurements was regarded as one observation. The values were 
expressed in grams (g) for KW. 
 
 
1.28 Urinalysis 
 
Animals were relocated in different metabolic cages weekly for collection of urine (Figure 1.17). 
Urinalysis was then performed to detect and measure the level of various substances in the urine, 
including protein, glucose (sugar), ketones, blood, and other substances. For these tests, we used a 
thin strip of plastic (dipstick) impregnated with chemicals that react with substances in the urine and 
quickly change color. They are urine test strip or dipstick test (a basic diagnostic tool used to 
determine early kidney disease in our experiments rats. 
70  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17: Sprague – Dawley rats housed in a metabolic cage. 
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1.29 Collection of Blood Samples 
 
 
 
At the end of the experimental period, all animals were sacrificed (Figure 1.18) by an expert, after 
inhalation of excess halothane in a gas anaesthetic chamber. Blood samples were then carefully 
collected by utilizing cardiac puncture into pre-cooled tubes filled with heparin and serum bottles; 
deposited on ice for 3 hours and thereafter centrifuged in a desktop centrifuge model 90-1 (Jiangsu 
Zhangji Instruments Co., China) for 15 minutes at 3000 revolutions per minute. Serum was gradually 
poured into Eppendorf tubes and stored at -80 0C for further analysis. 
 
 
 
1.30 Histopathological Examination of Kidneys 
 
 
 
Kidneys were carefully removed and weighed following a laparotomy (Figure 1.18). They were 
examined for gross pathology and immediately fixed in 10% Neutral buffered saline. After 2 days of 
fixation, the kidneys were processed for histology. Following standard histology procedure, kidneys 
tissues were exposed to consecutive section at 4 µm intervals using a microtome 
(Microm HM 315, Germany) and stained with hematoxylin and eosin (H&E). The closed evaluation 
was performed by histopathologist blinded to the study protocol. 
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Figure 1.18: Dissected Sprague-Dawley rat on Autopsy table, Adapted from (McLachlan and Patten, 
2006). 
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1.31 Histochemical Evaluation of the Kidneys 
 
 
 
 
In order to perform histochemical analysis, kidneys tissues were carefully stained with Periodic acid 
Schiff, a technique to assess glycogen and neutral polysaccharides. Examination of the stained tissue 
sections was done by a histopathologist blinded to the study protocol. 
For histochemical analysis, kidney tissue was also stained with Masson's trichrome. This is a three- 
color staining protocol used in histology for kidney pathologies (e.g. glomerular fibrosis). It is suited 
for distinguishing cells from surrounding connective tissue staining red keratin and muscle fibers, 
blue or green collagen and bone, light red or pink cytoplasm, and dark brown to black cell nuclei. It 
also differentiates between collagen and smooth muscle in tumors, and the increase of collagen in 
diseases such as cirrhosis. It is a routine stain for kidney biopsies. 
 
 
 
 
1.32 Stereological Analyses of Kidneys 
 
 
 
 
The method was performed using the point-counting strategy in order to calculate the volumes of the 
glomeruli and tubules.  This was done in accordance with the idea formerly described by (Weibel, 
1979).   We selected four different sections, whereby between two points, we kept a distance of 5 
mm within a particular kidney and six fields per section were randomly chosen for analysis.  
Under the microscope, fields of view were sampled from the sections before final measurements 
are sampled from the fields of view. Then random sampling was introduced at each step of the 
selection process, in the positioning and in the orientation of slices. Whatever quantity is being 
estimated, slice position was randomized, spread the sample as evenly as possible throughout the 
whole specimen. Fields of view from tissue sections was sampled using the x- and y-axes of 
microscope stage micrometers.  
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 Fields were sampled from images captured using Leica SCN 400 (Leica Microsystems GmbH, 
Wetzlar, Germany) and measured at X 100 magnification using image analyzer Leica (DMLB) and 
Leica microsystem software. The Volume densities of the structures of the kidneys was determined by 
randomly superimposing a transparent grid comprising 160 test points per image arranged in a quadratic 
array (Freitas et al., 2011). 
 
 
 
1.33 Transmission electron microscope (TEM) 
 
 
 
 
Transmission electron microscope (TEM) was used to further provide a more detailed morphologic 
and compositional information on samples (most especially on glomeruli and tubules). This was done 
after the tissues were fixed overnight at 4 0C in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer 
(pH 7.4) and transferred to 0.1 M phosphate buffer (pH 7.2). The cells were post-fixed in 1% osmium 
tetraoxide in S-collidine, dehydrated in graded ethanol, transferred to propylene oxide, and embedded 
in Epon 812. Semi-thin sections (25nm) were stained with 1% methylene blue. The samples were 
further sectioned into ultrathin slices (75 nm), with glass knife, using ultramicrotome contrasted with 
uranyl acetate and lead citrate and observed in transmission electron microscope (Bressenot et al., 
2009). 
 
 
 
1.34 Measurement of kidney tissue Malondialdehyde (MDA) level 
 
 
 
Kidney tissue was homogenized in 0.2M sodium phosphate buffer (7.8 pH) and then centrifuged for 
15 mins at 15000g. The supernatant was collected and used for the measurement of lipid peroxidation. 
The procedure was carefully performed according to Chenni et al. (2007) with little modification. 
This methodology uses the complex formed from the reaction between Malondialdehyde (MDA) and 
Thiobarbituric acid (TBA). Into an assay mixture containing 200μL of 8.1% sodium dodecyl sulfate 
(SDS), 750 μL of 20% acetic acid (pH, 3.5), 2mL of 0.25% TBA and 850μL of distilled water, 200μL 
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of sample of MDA standard series (0, 7.5, 15, 22.5, and 30 μm) was added in a Pyrex screw-capped 
test tube. The mixture was heated at 95 0C for 60 min in a sand bath, cooled down to room temperature 
and the absorbance read at 532 nm using spectrophotometer - Synergy HTX multi-mode reader, 
VACUTEC, USA. Thiobarbituric acid reactive substances (TBARS) concentrations in the samples 
were extrapolated from the MDA standard curve. 
 
 
 
1.35 Measurement of kidney tissue Glutathione Concentration (GSH) 
 
 
 
Glutathione concentration was assessed in renal tissue according to methodology modified 
from (Rotimi et al., 2018). The sample was first precipitated with 10% Trichloroacetic 
acid (TCA) and then centrifuged at 2000 rpm for 0 min at 25 0C The reaction mixture 
contained  100  μL of supernatant, 50 μL of 0.5mM 5, 5’‐dithio‐bis‐2‐nitrobenzoic acid 
(DTNB) and 150 μL of 0.2 M sodium phosphate buffer (pH 7.8). After 15 min incubation 
at 25 0C, the absorbance was measured at 412 nm using a spectrophotometer (Synergy HTX 
multi-mode reader, VACUTEC, USA) and GSH concentrations extrapolated from a 
standard GSH curve. 
 
 
 
 
1.36 Renal Function Analyses 
 
 
Serum was used for the estimation of blood urea nitrogen (BUN) and serum creatinine 
CR-S) using a Beckman Coulter Synchron® system(s) BUN and CR-S assay kit. 
Beckman Coulter Synchron® system BUN assay kit and Beckman Coulter Synchron® 
system CR-S assay kit were obtained from Global Viral Laboratory, Durban, South 
Africa. 
 
 
1.37 Statistical analysis 
 
 
Analyses were carried out using one-way analysis of variance, followed by Dunnet’s 
multiple comparison post-hoc tests using Graph pad prism ® statistical software version 
5.02. Values were expressed as mean ± standard deviation and all results tested for 
significance at the 95% confidence level p<0.05). 
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Table 1.3: List of manuscript from project 
 
S/no Reference Manuscript title Journal Status 
1 Kouame et al., 
2018 
Effect of long-term 
administration of  
Cinnamomum cassia silver 
nanoparticles on organs 
(kidneys and liver) of 
Sprague-Dawley rats 
Turkish Journal of 
Biology. 
doi:10.3906/biy-1805-
103 
Published 
2 Kouame et al., 
2018 
Histologic and biochemical 
effects of Cinnamomum 
cassia nanoparticles in 
kidneys of diabetic 
Sprague-Dawley rats 
Bosnian Journal of Basic 
Medical Sciences 
https://www.bjbms.org 
https://blog.bjbms.org 
Published 
3 Kouame et al., 
2018 
Green silver nanoparticles 
synthesis using 
Cinnamomum cassia 
 Under review 
4 Kouame et al., 
2018 
Investigating, the 
ultrastructural changes 
using TEM, on renal tissue 
and mesangial cells of the 
kidneys of STZ- induced 
diabetic rats, treated with 
CcAgNPs. 
 Under preparation 
5 Kouame et al., 
2018 
Quantitative Morphometric 
Study of the renal 
corpuscle of treated with 
Cc and treated with 
CcAgNPs in 
Streptozotozin-Diabetic 
Rats 
 Under preparation 
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BRIDGING  
 
BETWEEN CHAPTER ONE and TWO 
 
Diet and lifestyle choices contribute to the development of type 2 diabetes mellitus. The rise of 
type 2 diabetes mellitus in the world, particularly in Africa has attracted an urgent need to manage 
the Scourge. The previous chapter looked at the etiopathology of diabetes as well as the current 
antidiabetic drugs used in the management of the disease.  The literature review revealed the 
remarkable contribution of Cinnamomum Cassia as a medicinal plant in the management of diabetes 
and the positive health benefit of Cinnamomum Cassia silver nanoparticles on type 2 diabetes 
mellitus. However, the following chapter will be outlining possible adverse effects of CcAgNPs on 
internal organs (Kidney and Liver) of non-diabetic rats. 
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BRIDGING  
BETWEEN CHAPTERS TWO AND THREE 
Silver nanoparticles have opened a new frontier in drug synthesis and delivery needed to target organs 
in the management of various diseases and their complications. But, there is no agreement with 
respect to the safety of AgNPs. The previous chapter revealed possible adverse effects of CcAgNPs 
on internal organs (Kidney and Liver) of non-diabetic Sprague-Dawley rats. However, the following 
chapter will be focusing specifically on the Histopathology effects of Cinnamomum cassia silver 
nanoparticles (CcAgNPs) on the kidneys of type 2 diabetic Sprague-Dawley rats. 
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BRIDGING  
BETWEEN CHAPTERS THREE AND FOUR 
The previous chapter showed the beneficial effects of CcAgNPs on the renal tissue in type 2 diabetic 
rats.  Additionally, the chapter displayed the positive impacts of the green synthesis silver 
nanoparticles on the biochemicals parameters of diabetics rats. The following chapter will be 
describing the safely process to synthesize silver nanoparticles using the green option. 
 
Refer to Appendix 
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BRIDGING  
BETWEEN CHAPTERS FOUR AND FIVE 
In the previous chapter, a rapid, simple approach was applied for the synthesis of silver nanoparticles 
using Cinnamomum cassia aqueous extract. The plant extract acts both as a reducing agent as well as 
capping agent. This chapter was, therefore, describing the safely process to synthesize silver 
nanoparticles using the Cinnamomum cassia as a green option.  
The following chapter will be focussing on the ultrastructural findings in kidneys of STZ induced 
diabetics rats, after 56 days of administration of CcAgNPs.  
Refer to Appendix 
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BRIDGING  
MANUSCRIPT FIVE 
BETWEEN CHAPTERS FIVE AND SIX 
In the previous chapter, the study was elaborating on the ultrastructural findings in kidneys of STZ 
induced diabetics rats, after 56 days of administration of CcAgNPs, using mainly transmission 
electron Microscope (TEM). The following chapter will be focussing on the stereological 
investigation of kidneys in the diabetic group.  
Refer to Appendix 
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CHAPTER SEVEN 
 
SYNTHESIS, CONCLUSION AND RECOMMENDATIONS 
 
7.0 Synthesis 
 
Nanotechnology as a virgin field of study has become a highly demanding branch of science with a 
wide range of interest because of its immense applications to engineering, sciences, pharmaceuticals, 
and medicine. These wide range applications have brought about advancement in all these fields of 
study. More importantly, in the field of Diabetology, it has facilitated the invention of oral insulin 
delivery system and blood sugar measurement device that holds a promising edge in improving the 
lives of patients suffering from diabetes mellitus (Markowitz et al., 2013). However, these great 
inventions have also come with their attendant and unknown consequences. Recently, some studies 
have documented the toxicity and hazards of major elements employed in the chemical synthetic 
method which have been suggested to be responsible for different adverse effects  (Singh et al., 2016). 
This is one of the reason that is stimulating research into the use of plant-based materials as an 
alternative in the green synthesis process for nanomedicine. 
 
 
However, there have been tremendous progress in the chemical synthetic method for nanoparticles 
using plant materials over decades but more significantly only in the last three decades for the 
reduction of metal salts, simply because plant extracts are able to reduce metal ions. The use of these 
plants are based on their important phytochemical components with varieties of biological activities, 
most importantly, anti-oxidant properties, which act to reduce the toxic effects of these elements. 
Consequently, this has made the use of plant extracts to synthesize nanoparticles, a very promising 
aspect of nanotechnology owing to their biological activities (Shanmugam et al., 2017).  
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Diabetes mellitus is a metabolic disease which is characterized by sustained elevated systemic sugar 
concentration caused by defective insulin secretion and/or action. This may be with or without 
attendant microvascular and macrovascular, neurological and frequent serious infectious 
complications secondary to deranged carbohydrate, fat and protein metabolism and impaired renal 
function (Daisy and Saipriya, 2012). Worldwide, type-2 diabetic nephropathy (T2DN) remains a 
member of indelible diseases of the vascular system that manifests in approximately 40% of patients 
suffering from diabetes who may then present with major end-stage kidney disease (ESKD) (Tomino 
et al., 2012). 
 
Recent progress in the field of diabetes research and its interface with nanotechnology has attracted 
the interest of many researchers owing to the dire need to develop treatment strategies that could 
mitigate the complications arising from diabetes mellitus relating specifically to perturbations in the 
kidney. In this study, an experimental rodent model was utilized for investigating the consequences 
of nano-conjugate synthesized plant extract on the morphological and biochemical indices of the 
kidney. Streptozotocin-induced diabetes is an established paradigm for studying experimental 
diabetes in animal models successfully inducing sustained hyperglycemia likely due to perturbations 
in the redox status (Edwards et al., 2008). Streptozotocin is able to induce diabetes by a direct toxic 
action on pancreatic β islet-cells (Edwards et al., 2008).   
 
 
Effect on blood glucose, metabolic and morphologic indices 
 
In this study Streptozotocin-induced diabetic animals showed a statistically significant decrease 
(P<0.05) in blood glucose levels following 56 days of successive administration of both 
Cinnamomum cassia extract and nanoparticles conjugates possibly, as a consequence of the activated 
release of the huge amount of glucose in the peripheral tissue (Daisy and Saipriya, 2012).  
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Daisy and Saipriya (2012) had previously reported a direct relationship between insulin secretion and 
a drop in blood glucose levels in experimentally treated animals and this study shows a 30% drop in 
glucose upon administration of low dose CcAgNPs with a further 50% glucose decline (10 ± 6.4 
mmol/l) following administration of CcAgNPS at twice the concentration (6.1 ± 3 mmol/l). Prabhu 
et al. (2018) reported that glucose absorption by yeast cells increased following the use of plant leaf 
extract and AgNPs in a manner similar to dose-dependent. While the main underlying mechanism 
may be due to the enhanced passage of glucose across the cell membrane and an increase in insulin 
release by the β cells. Moreover, overarching regulation of type-2 diabetes mellitus and its 
complications are still issues of debate nevertheless, literature have linked dietary influences to the 
prevention and control of diabetes and its complications. A study has reported that plant extract of 
Cinnamon could intensify the action of insulin and reduce blood glucose Azimi et al. (2014) but the 
precise component remains to be identified. 
 
 
The sustained elevation in blood glucose in diabetes and the consequent rise in blood urea and 
creatinine negatively affects the nephrons. Therefore, elevation in serum creatinine and blood urea 
nitrogen levels in patients suffering from diabetes mellitus is an indication of protracted high blood 
glucose which results to irretrievable injury to the renal functional unit (Shah et al., 2016). There is 
speculation in literature attributing the destruction of the functional unit of the kidney, to 
hyperglycemia, with subsequent to the kidney homeostatic activities. It is the duty of glomerulus, tuft 
capillaries located within the Bowman’s capsule in the nephron of the kidney to filter the serum 
creatinine, which implies that glomerular filtration is the function of serum creatinine. Therefore, 
elevation in blood urea nitrogen and serum creatinine plasma concentration occurred subsequent to a 
decrease in glomerular filtration rate (GFR). Increase serum creatinine and reduced GFR are reliable 
indicators of kidney dysfunction. But following administration of CcAgNPs, blood glucose of 
diabetic rats was normalized. A recent study reported a significant increase in the levels of uric acid, 
serum creatinine, and serum urea, were observed in diabetic untreated rats when compared with non-
diabetic rats, also a significant decrease in albumin and protein levels was noticed in all diabetic 
treatment groups given AgNPs (Prabhu et al., 2018).   
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A study by BarathManiKanth et al. (2010), shows that the level of creatinine - function, was also 
significantly decreased comparably in diabetic rats administered Ag-nanoparticles which were similar 
in size and type to that used in this study.  In addition, serum creatinine and blood urea nitrogen levels 
in rats treated with plant extracts or with AgNPs were within the healthy values (Prabhu et al., 2018). 
The above results corroborate with our findings, which revealed, a significant decrease in urea (34 ± 
4.6 mg/dl and 27 ± 1.5mg/dl, P < 0.05) and also a significant decrease of creatinine (3.1 ± 0.83mg/dl, 
and 2.0 ± 0.40mg/dl, P<0.05) upon administration of both low and high doses of CcAgNPs. 
 
 
Qualitative histopathological assessment of the kidney tissues showed hypertrophy of the renal 
corpuscles with an increase of the Bowman capsular space in the diabetic control group which were 
mitigated following adjuvant treatment with CcAgNPs. Stereological evaluations also revealed a 
larger diameter of the Bowman capsular space in the diabetic control (20 ± 0.15 µm) against treated 
diabetic rat (11 ± 1.2 µm) and this result was significantly different at P < 0.05.  Bowman capsule of 
the renal corpuscle of treated animals (CcAgNPs) demonstrated that diameter was totally different to 
values in control at a p-value of 0.05 with (104 ± 6596 µm against 132 ± 7807 µm).  
 In addition, electron microscopic evaluations showed thickening of the basement membrane as 
revealed in the H & E as well as special staining (with Masons trichrome) in diabetic rats, but these 
perturbations were ameliorated in the treated (CcAgNPs) groups. The urinary space, also known as  
Bowman’s space is a space enclosing the lobules and loops of the glomerulus within the substance of 
renal corpuscle which serves as exit for glomerular plasma filtrate as it leaves via filtration membrane. 
The membrane is formed by the union of basement membrane of glomerular epithelium and 
endothelial basement membrane located outside the capillary endothelium.  
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The thickening of the filtration membrane which was observed in diabetic rats under various 
qualitative (H & E, PAS, MT) and quantitative tools (stereology and TEM) suggests that DM could 
decrease the rate of filtration by obstructing the free flow of fluid. 
 
 
Electron microscopic evaluations revealed that a decrease in filtration is caused by an increase in 
diameter of glomerular basement membrane as seen in STZ induced diabetic rats, compared to treated 
Cc and (CcAgNPs) groups.  Several morphological studies on the glomerular filtration barrier in 
different disease states have been linked to disorders of the kidney (de Souza et al., 2016).  A recent 
study described the inability of the endothelial layer to perform its fenestration activity has been 
observed in various medical conditions (de Souza et al., 2016). Fewer fenestrae were observed in the 
endothelial cells over the basement membrane and the urinary space on transmission electron 
microscopy comparably to those observed in healthy condition (de Souza et al., 2016). Transmission 
electron microscopy can be employed to easily view the layers of the glomerular basement membrane. 
For the fact that the effectiveness of the filtration barrier totally depends on its diameter, have made 
it generate a wide range of research interest (Chiang and Inagi, 2010).  
 
Furthermore, several disease conditions are responsible for different abnormalities seen in the 
structure of the basement membrane. This condition of membranous nephropathy with thickened 
glomerular basement membrane was corrected positively by the administration of Cc and CcAgNPs, 
after 56 days of the experiment.  
 
 
Ultrafiltration is an important process by which blood is filtered in the Bowman’s capsule. The normal 
filtration rate is in 80 folds of daily blood volume which is amount to 125 ml/min.  A decreased GFR 
may be a sign of renal condition linked to diabetes. 
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 Numerous disorders and diseases can be caused by the malfunctioning glomerulus, as seen in diabetic 
glomerulosclerosis, acute proliferative and glomerulonephritis (D'amico and Bazzi, 2003). There are 
three main changes in the glomeruli histological structure of patients suffering from diabetic 
nephropathy. The first change is the enlargement of the mesangial matrix caused by high blood 
glucose because of increasing accumulation of matrix proteins. The next has to do with the diameter 
of the glomerular basement membrane. The last which have been reported to be caused by 
intraglomerular hypertension is glomerular sclerosis. Researches have suggested that these 
histological changes seen in the glomeruli structure of diabetic nephropathy have homogenous 
prognostic benefits (de Souza et al., 2016). Microalbuminuria also a sign of nephron lesion which is 
an indication of the sudden changes in the kidney structure and beginning of kidney disease 
manifestation and its complications. 
 
 
The main responsibility of the functional unit of the kidney, the nephron is to ensure adequate quantity 
of the circulatory system and blood purification. Within the substance of the nephron is the 
glomerulus which is a tuft of capillaries of approximately 200 µm formed by afferent arterioles. The 
renal internal structures disarrangement or disruption will subsequently impact the nephrons and its 
function that causing the death of this particular group of nephrons. The management of blood glucose 
level is necessary to limit progressive renal dysfunction in diabetes. The interplay between the 
interstitium, the tubule and the glomerulus inside the nephron are possible clue in comprehension of 
multiple disorders as that of diabetic nephropathy.  
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Recently, evidence have supported that tubular damage, has a vital implication in diabetic 
nephropathy development and progression, moreover, the extent of the injury of tubulointerstitial 
have been linked to different consequences on renal outcome in diabetic nephropathy (Hwang et al., 
2017).  
 
The mechanisms behind the tubular damage have been described as multiplex. The epithelium lining 
in the tubules cells is vulnerable to high blood glucose, through tubular reabsorption of sugar in a 
hyperglycemic state (Hwang et al., 2017). Additionally, chronic hypoxia and local renin-angiotensin 
system have been reported to contribute to the progression of tubular damage. A recent study revealed 
that albuminuria may be the cause of fibrosis and tubular inflammation as a result of direct influence 
on renal tubular cells (Hwang et al., 2017). The proximal tubule, especially, is at risk of these 
metabolic and hemodynamic imbalances. Some previous researchers have reported increased in 
diameter of the proximal tubular basement membrane in normoalbuminuria in diabetic conditions 
(Brito et al., 1998).   
 
 
In this study, the kidney of rats in diabetic control was distinguished by obvious fibrosis in the tubular 
interstitium, as well as manifestations of tubular expansion, atrophy in affected cells.  Classically, the 
glomeruli have been described as the key region of damage in diabetic nephropathy and albuminuria 
have been considered a major prognostic tool. Lately, various biologic markers with respect to tubular 
damage and inflammation have been identified as powerful indicators of renal outcome (Stephen et 
al., 2003, N Moresco et al., 2013).  
 
 The histopathology analyses demonstrated various lesions of proximal tubules such as an increase of 
diameters, epithelial and brush borders denudations which were confirmed by the stereological 
assessments (22 ± 6.5 µm), with loss of the brushes, but upon administration of the CcAgNPs, 
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 there was a remarkable mitigation of the tubular lesions which was also confirmed by the 
stereological investigation (13.5 ± 3.5 µm) and significantly different at p-value of 0.05.  
Additionally, distal tubules showed disruptions and dilations with an increase in diameter in the 
diabetic control group. The stereological report showed values at 36 ± 8.8 µm with normalization of 
the tubules upon administration of CcAgNPs to 24 ± 7.5 µm. Urinalysis carried out on STZ-induced 
diabetic rats showed the presence of ketones, albumins, proteins, urea, creatinine, and glucose. But 
upon treatment with CcAgNPs, there was restoration in some of these parameters.  Our study thus 
revealed that albumin excretion is significantly increased in the diabetic when compared with control 
groups (P < 0.05), and treated groups. Proteinuria level after STZ-induced diabetes resulted in 
significant increased, versus controls and treated diabetic groups at P < 0.05. 
 
 
 Previous studies propose that tubular damage is an important factor in the causes of diabetic kidney 
disease in vulnerable patients (Hwang et al., 2017). In the tubules, there are broad changes that 
predispose to tubular damage, reabsorption of protein droplets and atrophy. One and most important 
alteration, which is usually more than the pathogenesis of tubular atrophy is the increase in diameter 
of the basement membranes of atrophic tubules.  The reason why it has been noticed that, at the 
beginning of the diabetic nephropathy, there may be increased in size of the kidney as a result of 
hypertrophy and hyperfiltration, as there will be atrophy with diminution of size and loss of cortico-
medullary differentiation at a later stage.   
 
 
Additionally, other important morphological changes may occur in the diabetic kidney, especially in 
the renal corpuscles called, capsular lesions drop (de Souza et al., 2016).  
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This is associated to an initial increase in the level of glomerular filtration rate which has been 
reported to be crucial to the causes and development of kidney disease in diabetes researches, but 
there is little or no evidence to substantiate that glomerular hyperfiltration is a contributing factor to 
the progression of kidney disease in human. 
 
The renal tubule receives plasma filtrate from the glomerulus and processes it into the urine. Each 
tubule is differentiated into several specialized segments.  Different aspects of filtrate reabsorption 
are localized in different segments.  In the cortex, the proximal tubule reabsorbs most minerals and 
other nutrients from the tubular fluid and transform them into the blood within the peritubular 
capillaries. The loop of Henle dips into the medulla where it greatly assists to establish the hypertonic 
environment of medullary interstitial fluid. The distal convoluted tubule changes direction to move 
toward the juxtaglomerular apparatus of the corpuscle from which the tubule arose. Finally, the 
collecting duct leads back through the medulla to drain into the pelvis. Variation in the structure of 
tubular epithelial cells is mainly associated with the functional differentiation of the different tubular 
segments. Subsequently, it gives the microscopic appearance of the tubules. Therefore, proximal 
tubules disorders will lead to a failure to reabsorb whereas the disorders of the distal will cause a 
failure to secrete and this could explain why the urinalysis outcomes of STZ-induced diabetic rats 
showed the severe presence of ketones, albumins, proteins, urea, creatinine, and glucose. But, upon 
treatment from CcAgNPs, there was the restoration of the tubules ultrastructure.  Previous findings 
suggest that tubular injury plays a key role in the pathogenesis of DKD in high-risk patients (Hwang 
et al., 2017). 
 
Effect on oxidative stress and lipid peroxidation in renal tissues 
 
During the last 25 years, a large body of experimental evidence has accumulated from 
pharmacological intervention studies that suggest an important role for ROS in numerous 
pathophysiological processes. While a variety of chemical mechanisms of reactive oxygen-induced 
damage to lipids, proteins, and DNA is fairly well understood; the molecular pathology of oxidant 
stress-induced tissue injury in vivo remains unclear in many cases (Azu, 2012). 
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 Oxidative stress (OS) results due to an imbalance between the production of ROS and the defense 
systems that functions to scavenge or destroy them (Azu, 2012). Gonadal dysfunction has been long 
documented since the early days of the AIDS pandemic Brown et al. (2013) with many studies 
attributing OS as playing a major role in the pathogenesis of AIDS (Papadopulos-Eleopulos, 1988). 
With the stabilization of global prevalence however, many clinical researchers are pointing to the use 
of antioxidant treatment as a strong means of neutralizing or suppressing the progression of AIDS. 
Nonetheless, drug-induced OS is implicated as a mechanism of toxicity in numerous tissues and organ 
systems with HAART also well characterized to mediate its effects via OS mechanisms (Fojtu et al., 
2017). 
 
 
 
In this study despite exposure to silver nanoparticles (CcAgNPs) at both high (10mg/l) and low 
(5mg/l) concentrations, GSH antioxidant levels were similar in both treated groups and controls.  In 
contrast, Adeyemi and Faniyan (2014) reported significantly decreased levels of GSH upon 
administration of silver nanoparticles.  We may advocate, that GSH levels, showed a variation 
between our study and the previous investigation are mainly linked to the concentration of the silver 
nanoparticles that were administered to the rats. There are several previous reports that claim a 
reduced level of GSH in complicated diabetes (Rahal et al., 2014). A decreased in GSH level may be 
one of the factors in the oxidative DNA damage in type 2 diabetic nephropathy. It is hypothesized 
that maintenance of GSH redox state may be a new option of therapeutic avenue to protect diabetic 
patients against some intracellular bacterial pathogens (Tiwari et al., 2013).   
 
 
The decrease in SOD activity may lead to an increase in the level of superoxide radicals which will 
cause the inactivation of GPx. It was reported that an increase in CAT activity, is to overcome the 
damaging effect of erythrocyte membrane from oxidative attack. There is a compensatory increase in 
CAT activity besides GPx in the cell. CAT disposes off the H2O2 formed in the cell so that fragility 
of red blood cells (RBC) is maintained.  
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The increased CAT activity in diabetes is an indication of the increased production of peroxide 
radicals (Margină et al., 2013). It is known that Glutathione (GSH) is an antioxidant found in plants, 
animals, fungi, and some bacteria and archaea. 
 
 
 Reactive oxygen species such as free radicals, peroxides, lipid peroxides, and heavy metals cause 
damage to major cellular components that may be prevented by Glutathione. It is a tripeptide 
composed by gamma peptide linkage between the carboxyl group of the glutamate side chain and the 
amine group of cysteine, and the carboxyl group of cysteine is attached by a normal peptide linkage 
to a glycine (Valko et al., 2006). Nearly all living cells exposed to oxygen, need superoxide dismutase 
(SOD), as the important antioxidant defense. This is an enzyme that alternately causes the dismutation 
(or partitioning) of the superoxide (O2). Radical into either ordinary molecular oxygen (O2) or 
hydrogen (H2O2). Superoxide is generated by-product of oxygen metabolism and when it is not 
regulated, leads to many types of cell damage.  Hydrogen peroxide is also damaging and the catalase 
(enzyme) causes degradation of the hydrogen peroxide. The Catalase is a common enzyme found in 
nearly all living organisms exposed to oxygen (such as bacteria, plants, and animals). Water and 
oxygen derived from the decomposition of hydrogen peroxide caused by catalase. This is a very 
important enzyme which is protecting the cell from oxidative damage by reactive oxygen species 
(ROS).  
 
 
 
 The decrease in SOD activity may lead to the inactivation of GPx, which is provoked by the increased 
level of superoxide radicals. It was reported that an increase in CAT activity, will assist to overcome 
the damaging effect of erythrocyte membrane from oxidative attack. There is a compensatory increase 
in CAT activity besides GPx in the cell. CAT disposes off the H2O2 formed in the cell so that fragility 
of red blood cells (RBC) is maintained. Increased production of peroxide radicals is associated with 
an increase in CAT activity in diabetes (Margină et al., 2013). The up-regulation in glutathione levels 
in this experiment possibly supports its antioxidant role/properties. Phenolic has been recognized as 
a powerful countermeasure against lipid peroxidation, among many classes of compounds. They 
behave by scavenging free radicals and alleviating the lipid peroxidative side chain, Azu et al. (2010) 
through their hydrogen-donating ability.  
147 
 
 
 
 
 
It was reported that an increased levels of renal malondialdehyde (MDA), and decreased levels of 
glutathione (GSH), as well as SOD activity, were observed in diabetic rats (P<0.001) as compared 
with treated rats (Jain and Saha, 2017).  Chronic hyperglycemia results in oxidative stress; MDA 
level, which is an index of endogenous lipid peroxidation was found to be increased significantly in 
the kidney tissue of diabetic rats reflecting increased oxidative stress (Baynes, 1991). Various 
antioxidants were found to be effective in the treatment and/or the prevention of diabetic 
complications including diabetic nephropathy (Bhat et al., 2017). This is suggesting that the 
generation of free radicals has a key role in the oxidative stress and thus in the pathogenesis of DN. 
In their research, they have noticed a significant increase in the oxidative markers such as MDA, 
while a decrease in the activity of endogenous antioxidants, that is, SOD and GSH in diabetic kidney 
was also observed.  
 
 
 
The current study showed MDA (0.60 ± 0.15) levels in treated rats, significantly different (P < 0.05), 
vis a vis of control groups (1.4 ± 0.22), following both high and low dose concentration of CcAgNPs, 
indicating tissues damage, as it is measuring the lipid peroxidation in the cells and the tissues. It is 
known that an increased oxidative stress is one of the known culprits in the development of 
nephropathy (Mezzetti et al., 2000). Researchers sought to assess the levels of oxidative stress 
markers like Malondialdehyde (MDA) and SOD and they revealed that the oxidative stress was 
increased because of increase of the lipid peroxidation and increases the SOD level (Mezzetti et al., 
2000). The current results are also supported by Prabhu et al. (2018) who revealed that there was 
reparation of the liver tissue in groups treated with piper plant leaf extract and plants-AgNPs when 
compared to control group, subsequent to restoration of the activity of the lipid peroxidation markers. 
 
 
 
148 
 
BarathManiKanth et al. (2010) also demonstrated that Gold nanoparticles possess anti-oxidative 
effects, after treatment of diabetic rats at a dose of 2.5 mg/kg.  However, imbalanced MDA and GSH 
levels were reported in type 2 DM patients with microalbuminuria (Ozdemır et al., 2005). 
 
In this study, we re-confirmed that CcAgNPs treatment could protect against an early stage of diabetic 
nephropathy in the rats with diabetes induced by STZ. Our data revealed, CcAgNPs reduced 
albuminuria and alleviated renal histopathological injury in diabetic rats. The coupled 
oxidant/antioxidant balance was observed as a decrease in MDA and an increase in GSH in kidneys 
of STZ-induced diabetic rats treated with CcAgNPs.  
 
Diabetic nephropathy remains an oxidative-stress related microvascular disease (Roman-Pintos et al., 
2016). Hyperglycemia is known to cause oxidative stress that is due to disturbance of the 
oxidant/antioxidant balance, playing a critical role in kidney injury. The antioxidant treatment plays 
an important role in optimizing renoprotection in diabetes or another kidney disease (Forbes and 
Cooper, 2013). In the present study, CcAgNPs and Cc administration was shown to decrease MDA 
levels and increase GSH levels due to their antioxidant properties suggesting that CcAgNPs and Cc 
could reduce oxidative stress-mediated glucose-induced renal injury. Various studies have postulated 
that lipid peroxidation levels increase in clinical and experimental diabetes (Belka, 1998); 
(Newsholme et al., 2007).  
 
 
 
 
In this study, the MDA concentration was used as an index of lipid peroxidation (and thus oxidative 
stress status) in diabetic rats.  A significant increase of MDA concentration in serum and tissues of 
the diabetic animals compared to controls was noted. Our results are corroborated by reports of 
increased lipid peroxidation in serum and kidney of animals with experimental diabetes (Kinalski et 
al., 2000). This phenomenon is possibly caused by decreased activity of antioxidant enzymes, which 
causes the uncontrolled generation of free radicals, and the subsequent generation of lipid 
hydroperoxides (Kinalski et al., 2000). 
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Liver disease is suspected as a result of biochemical abnormalities of liver function. AST and ALT 
can serve as markers of hepatocellular injury (Limdi and Hyde, 2003). In our study, AST, ALT, ALP, 
and albumin levels were not significantly different from control. The adverse effects of substances 
on animal physiology can vary from minor anatomical changes, such as reduced weight gain, small 
physiological alterations, changes in the levels of hormones in the blood, to severe effects leading to 
organ failure and death (Peter et al., 2018). In this current study, Liver enzymes, AST (9.5 ± 4.4) and 
ALT (87 ± 0.28), was significantly decreased by 8% and 10%, respectively, following administration 
of a low and high dose of CcAgNPs, compared to controls.  Results obtained of the ‘restorative’ effect 
of nanoparticles after assessing the metabolic enzymatic markers are confirming the ability of 
nanoparticles to protect the major organs (kidneys and liver) from damage due to hyperglycemia-
induced oxidative stress (BarathManiKanth et al., 2010). This is an indication that CcAgNPs may 
possess strong positive effects on the markers of the damaged liver when compared to controls. It is 
in agreement with a study performed by previous scientists and may be attributed to the antioxidant 
properties inherent in Cinnamon (Amorati et al., 2013). 
The liver, an organ, is one of the most amazing organs in the human body with its ability to regenerate 
itself. Because the functions of the liver are so wide-reaching, it is easy to see how the dysfunction of 
the kidney affects the function of the liver in many different ways.  The increasing deterioration of 
glomeruli in diabetes causes an increase in liver enzymes production (Glover, 2012). 
 
 
 
Kidneys play also an important role in the detoxification process. Kidneys are master regulators and 
act as a massive filtration system. They are regulating fluid and electrolyte (mineral) balance in the 
body: this is vital for body cells to be able to perform their functions. Subsequently, they are 
controlling blood pressure and regulating the body’s pH or acid-alkaline balance: even small 
variances in pH can result in death. In addition, they are a major detoxification organ.  
 
In fact, the kidneys receive and filter about 1200 ml of blood per minute - about a quarter of our total 
blood flow. Due to this combination of tasks, the kidneys also assist in controlling excessive blood 
glucose and mineral imbalances.  
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Liver dysfunction is a known risk factor in diabetes mellitus and diabetic patients are at further risk 
of developing liver disorders (Adiga et al., 2016). In addition, there is a direct positive correlation 
between elevated liver enzymes and reduced glomerular filtration (Suchy-Dicey et al., 2016).  Our 
report agreed with previous studies cited above, that upon administration of CcAgNPs, there was an 
improvement in renal functions as seen clinically, by the measured parameters of urea and creatinine 
as well as improved liver function clinically expressed via the liver enzymes ALT and AST. These 
results demonstrated, CcAgNPs ability to limit organ dysfunction in diabetic nephropathy and have 
hepatocellular protective effects.   
 
 
The association between liver and renal disease in type II DM have been reported by authors (Adiga 
and Malawadi, 2016) that, it is important to explore therapeutic measures able to delay the progression 
of liver and renal conditions associated with DM. This is in agreement with Kouame et al. (2018), 
who revealed that Cinnamomum cassia silver nanoparticles is capable to alleviate biochemical and 
histological disorders within diabetics’ kidneys and liver, which was published under the title ‘’ 
Histologic and biochemical effects of Cinnamomum cassia nanoparticles in kidneys of diabetic 
Sprague-Dawley rats ‘’. These results concur with the study of (Adiga and Malawadi, 2016) who 
compared the liver profile of diabetic cases with controls and noted a significantly high total bilirubin, 
ALT and AST in diabetics. The statement was also supported by (Al-Jameil et al., 2014) suggesting 
an elevation of liver enzymes in diabetic conditions.  
 
 
 
There is indeed positive association which was observed between liver enzymes and glomerular 
function, supporting the protective role of liver enzymes and subsequently indicating a significant 
correlation between renal and liver disease in DM (Adiga and Malawadi, 2016).  The liver disease 
bears an association with diabetic nephropathy because of the interconnection between renal 
functions and ALT/AST levels as revealed in our study. It is opined that screening and treating liver 
conditions might be useful in prolonging the development and progression of diabetic nephropathy.  
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A retrospective study performed by a team of researchers to know the association between liver 
disease and renal disease in type II DM reported that risk of liver conditions is common in diabetic 
nephropathy attributable to high liver fat content. However, the exact pathophysiology factors 
involved was not known (Adiga and Malawadi, 2016). Continuous liver and kidney conditions may 
lead to cell death. 
 
 
 
Recent studies have revealed that program cell death and necroptosis cell deaths are the important 
mechanisms that lead to renal tubular cell shrinkage and chronic kidney disease progression in 
complicated STZ induced diabetic rat (Zhu et al., 2015; Yang et al., 2001). However, the kinetics of 
cell death during the early and intermediate stages of constantly recurring kidneys disease has 
remained unclear (BarathManiKanth et al., 2010).  
 
 
 
However, the mechanism by which Cc and CcAgNPs exert their anti-diabetic activity was elaborated 
and is probably the result of its effect at different levels of the insulin-signaling pathway. A possible 
underlying mechanism by which the plant material controlled the increase of blood glucose levels in 
diabetic rats is potentiation of pancreatic secretion of insulin from β cells in the islets of Langerhans 
(Hassan et al., 2008). The cellular response to insulin is acting via insulin receptor, which is a 
tetrameric protein consisting of two identical extracellular α-subunits that bind insulin as well as two 
identical transmembrane β-subunits that have intracellular tyrosine kinase activity (Goldfine, 1987). 
When insulin binds to the α-subunit of the receptor, the β-subunit tyrosine kinase will then be 
activated, resulting in autophosphorylation of β-subunit tyrosine residues (Byon et al.,1998). Increase 
of the insulin sensitivity is triggered by increased autophosphorylation and decreased 
dephosphorylation, of the insulin receptor.  
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Cinnamon causes an increase in the expression of Peroxisome proliferator-activated receptor thereby 
increasing insulin sensitivity and decrease blood glucose, subsequently alleviate kidney 
complications in diabetes (Xie et al., 2011).  It can, therefore, be seen that biologically synthesized 
silver nanoparticles are able to affect the renal system of diabetic rats in such a manner as to limit and 
partially restore some of the diabetic complications as seen in blood urea and creatinine levels which 
are indicators of renal function.  The continuous control of blood glucose level is necessary to limit 
progressive renal dysfunction in diabetes. In this investigation, Cc-AgNPs demonstrated its power to 
control blood glucose levels along with blood creatinine and urea which are known to limit and treat 
diabetic nephropathy. The postulated mechanism of its beneficial action is mediated through the free 
radicals scavenging mechanism. 
 
 
Moreover, certain researchers also, proved that nanoparticles have the power to prevent oxidative 
stress-mediated ROS production using various types of mechanisms, because its immense aptitude to 
inhibit inflammatory response created by oxidative stress resulted by toxic elements to the systems, 
because of their antioxidant effects (Onizawa et al., 2009).  Previous studies reported that the foremost 
and dominant event responsible for the triggering of several mechanistic involved in the pathogenesis 
of diabetic complications is possibly a single hyperglycemia-induced process of an excess of 
superoxide from the mitochondrial electron transport coupling (Ceriello, 2003).  Thus, results over 
the ability of nanoparticles in the destruction of ROS induced at long-standing hyperglycemic 
conditions cited by BarathManiKanth et al. (2010), thereby bringing forth the balanced level of the 
anti-oxidant protection system of nanoparticles and confirmed the therapeutic application of 
nanoparticles as a promising antioxidant. 
 
 
These results are underpinned by findings which advocated the non-cytotoxic effect of nanoparticles, 
and the tendency of nanoparticles to reduce the generation and release of reactive oxygen and reactive 
nitrogen species. In addition, they do not prompt secretion of pro-inflammatory cytokines TNF-α and 
IL1-β, making them suitable candidates for nanomedicine (Carnovale et al., 2019). The most 
beneficial intervention materials should ideally restore insulin resistance, reverse renal impairment 
and tissue damage and additionally prevent pancreatic β-cell dysfunction.  
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Therefore, the overall objective of this study was to investigate the extent to which CcAgNPS meets 
this ideal by examining the histomorphological and biochemical effects of the substance. Ideally, 
substitute therapies should generate a commensurate degree of efficacy compared to conventional 
drug therapy, but without the negative side effects that are often linked with them (Vasu et al., 2003).   
 
 
 
Cinnamon activates the phosphorylation of the insulin receptor β-subunit on adipocytes as well as 
other insulin receptors (Abdul et al., 2014). Glucose transporter type 4, major glucose transporter in 
the musculoskeletal system, is also under control of insulin. It is well known that insulin promotes 
the translocation of GLUT-4 from the intracellular compartment to the cell membrane (Sheppard and 
Kahn, 1999). In diabetes mellitus because of the absence or insufficient sensitivity to insulin, GLUT 
4, may be decreased. Researchers, therefore, reported a significant increase in the expression of 
GLUT 4 receptor under the administration of cinnamon and CcAgNPs, which increase significantly 
the use of glucose in skeletal muscle cells and causing hypoglycemia. 
 
 
 
Recently it was also, reported that cinnamon extracts and CcAgNPs ameliorate type 2 diabetes and 
its complications by inducing GLUT4 translocation via the AMPK signaling pathway (Medagama, 
2015). Therefore, the activation of AMPK induces the translocation of GLUT4 to the plasma 
membrane, various studies have demonstrated that AMPK and its signaling pathways are potential 
molecular targets in the development of drugs for the treatment of type 2 diabetes and its 
complications (Shen et al., 2014). CcAgNPs increases the amount of GLUT4 receptors as well as the 
receptors of Insulin and Insulin Receptor substrates, thereby causing the entry of glucose into cells.  
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They demonstrated that extracts of Cinnamomum cassia increased the production and translocation 
to the plasma membrane of the GLUT 4 in adipose tissue and muscle in a dose-dependent manner 
(Shen et al., 2010). Others, demonstrated a similar finding but quantified the effect by demonstrating 
an increase of the membrane translocation of GLUT4 from 42.8 % to 73.1 % in cinnamon and  
Cinnamon silver nanoparticles treated rats when compared to healthy controls,  
subsequently decrease blood glucose in experimental rats, which is in accord with our finding (Anand 
et al., 2010). Glucose transporter-1 (GLUT-1) is a receptor found on mammalian cells that is 
responsible for basal glucose uptake into cells. The specific mechanism of activation of this receptor 
is poorly understood. It was demonstrated a dose-dependent reduction of serum insulin concentrations 
and an increase in glucagon-like peptide 1(GLP-1) under the treatment of cinnamon (Plexopathy, 
2009).  
 
 
 
Investigations into disease pathways and patterns have hugely expanded, with the majority of the 
work performed on animal models (Wall and Shani, 2008). This is because the biochemical 
mechanisms in mammals are largely preserved, enabling researchers to scientifically assume the 
outcome in humans (Wilson, 2011). Animal model scenario thus plays a significant role as the 
foundation for good research in human diseases, such as diabetic nephropathy. Thioredoxin-binding 
protein-2, is the endogenous inhibitor of cellular TRX, inactivating its antioxidative activity by 
binding to the redox-active cysteine residues. Previous studies revealed that overexpression of TXNIP 
was a major contributor to hyperglycemia-induced oxidative stress in kidney cells (Yoshihara et al., 
2010).  
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A recent study showed that TXNIP was upregulated by (Hyperglycaemia) HG in mesangial cells, and 
knockdown of TXNIP reversed the hyperglycemia-induced reduction of TRX function, inhibited HG-
induced apoptosis and ROS generation (Lee et al., 2013). It was also found that Mitochondria-
targeted, significantly inhibited TXNIP system in diabetic complicated and mesangial cells under 
hyperglycemia condition. CcAgNPs will subsequently, act on Thioredoxin through a binding system 
to decrease the blood glucose level in diabetic rats and mitigate renal complications. 
The additional hypothesis that lies on the antioxidant effect of Cinnamomum cassia silver 
nanoparticles is their synergy with the thioredoxin, a highly conserved thiol reductase that reacts over 
an internal inhibitor, thioredoxin-interacting protein (Txnip), and greatly responsible for the 
antioxidative mechanism through cellular redox balance (BarathManiKanth et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
156 
 
7 1 Conclusion 
 
 
Silver nanoparticles are known for their immense applications in the field of therapeutics and 
diagnosis, especially when they are subjected to green synthesis.  In the present investigation we have 
established the anti-oxidative and anti-hyperglycemic activities of Cinnamomum cassia silver 
nanoparticles (CcAgNPs) and of Cinnamomum cassia extracts, in Streptozotocin-induced diabetic 
Sprague-Dawley rats, through the inhibiting ROS over-production under long period hyperglycemic 
conditions, scavenging free radicals; thus causing the rising of the anti-oxidant protection enzymes. 
CcAgNPs nanoparticles have shown for their non-toxic and preventive effects over kidneys, without 
inducing any lethal effects in Sprague-Dawley rats model, thereby, achieving a support control over 
the diabetic complication. These potential applications of green synthesized silver nanoparticles in 
averting oxidative stress and their side effects, induced under hyperglycemic conditions has opened 
up a way for a new resource of cost economic alternative in the treatment and management of diabetic 
and its complications, such as diabetic nephropathy.  
  
 
7.2 Recommendations 
 
In view, of the insufficiency from this study, it is recommended that further exploration of the specific 
molecular pathways and their impacts in hyperglycemic conditions should be engaged. 
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Thus, a detailed, investigation, over the signaling mechanism, such as thioredoxin (Trx) and   GLUT4, 
behind the anti-oxidative effect of Cinnamomum cassia silver nanoparticles to probe their anti-
hyperglycemic role in diabetic conditions, would open door to the strong quest behind the clinical 
implication of green silver nanoparticles in diabetic nephropathy treatments, in particular and may 
render it uniquely medical beneficial as an agent of therapeutic choice for diverse complications, in 
general.treatments, in particular and may render it uniquely medical beneficial as an agent of 
therapeutic choice for diverse complications, in general. 
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Abstract 
 
In this study, we report the green synthesis of silver nanoparticles (NPs) using extracts from selected 
Cinnamomum cassia plants. A detailed spectroscopic characterisation of the biosynthesised silver 
nanoparticles (CcAgNPs) revealed a UV-visible absorption at 450 nm, which was revealing the 
nanoparticles’ surface Plasmon resonance, meanwhile, the Fourier transform infrared (FTIR) 
vibrational frequencies showed that flavonoids, alkaloids and bonded sugars where mostly 
responsible for the reduction and stabilisation of the AgNPs. This was further confirmed by additional 
analysis. The nature, shape and morphology of the biosynthesised CcAgNPs were explored using 
Transmission Electron Microscopy (TEM), Scanning Electron Microscopy and X-ray (D) analysis. 
CcAgNPs were mostly spherical and rounded in shape with particle size in the range from 4.28 nm 
to 30nm. Cinnamomum cassia extracts were efficient in the synthesis of AgNPs with an average yield 
of 150 mg. The synthesised nanoparticles were safely used in the treatment of type 2 induced diabetics 
rats. 
Keywords: Biosynthesis, microscopy, nanoparticles, spectroscopy. 
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 Introduction 
 
Research has moved towards the scientific synthesis and the medical application of nanoscale silver 
particles have gained serious attention in recent years due to their high quality, physicochemical and 
biological properties. The biological interactions of silver nanoparticles (AgNPs) are significantly 
intensified by their wide surface area-to-volume ratio as compared to their bulk counterparts (El-Nour 
et al., 2010). These properties, adding to their chemical, conductive and optical properties make them 
suitable for the applications in modern medicine Pantic (2014), biosensing Doria et al. ( 2012), to 
transport drug Brown et al. (2013), and catalysis (Crooks et al. 2001; Dong et al., 2015). Their large 
spectrum quality to fight fungus and bacteria, properties that have made them popular in the domain 
of consumer products like cosmetics and textiles. Moreover, these properties have also enabled 
nanoparticles to find application in food processing El-Nour et al. (2010) and water purification 
(Zhang, 2013).  
 
 Nano carrier could exhibit good targeting through conjugation with various interesting active bio-
ligands such as biotin. At the same time, core-shell and multilayered nanoparticles could be loaded 
with several drugs and control the drug-release profile. The integration of Nano carriers into DN 
therapeutic may therefore be very promising (Zhou et al., 2012). Nano biotechnology is a fast-paced 
interdisciplinary domain where the nanotechnology is utilised for the exploration and transformation 
of biological systems. The success of green synthesis of biocompatible silver nanoparticles has gained 
greater awareness in the past few years for its application in medical-biosciences (Mieszawska et al., 
2013). Nanoparticles are molecules which are 100 nm in range and possess interesting physical, 
chemical and biological properties. That makes them potent molecules for diagnostics and 
therapeutics in modern medicine. Of the metals silver (Ag) is the metal of choice for applications in 
biology and medicine. Silver nanoparticles (AgNPs) have been increasingly used as anticancer, 
antiangiogenic, and antibacterial agents (Zhang et al., 2015; Lee, 2002; BarathManiKanth et al., 2010, 
and Desai, 2012).   
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AgNPs can also be used to treat diseases that require a sustained presence of the drug at several 
anatomical sites (Panyam and Labhasetwar, 2003).  It has been reported that the small size of AgNPs 
(1–100 nm) intensify their physical, chemical, magnetic, and optical properties (Chen and 
Schluesener, 2008; Awazu et al., 2008).   
 
 
Medicinal plants are known to be rich sources of biologically active compounds (Zulkipli et al., 2015). 
The presence of diverse secondary metabolites in addition to primary metabolic products in these 
plants contribute largely to their efficacy in the green synthesis of AgNPs 
Nanoparticles has large number of advantages for herbal drugs, including enhancement of solubility 
and bioavailability, protection from toxicity, enhancement of pharmacological activity, enhancement 
of stability, improving tissue macrophages distribution, sustained delivery, protection from physical 
and chemical degradation, etc (Ansari and Farha Islam, 2012). 
 
Incorporation of the herbal extracts into novel formulation systems have certain added advantages, 
such as their bulk dosing and less absorption can be overcome, which is the major problem being 
faced, enticing the attention of major pharmaceutical corporations (Ansari and Farha Islam, 2012). 
Natural products such as medicinal plants have therefore been a very good source of green 
nanoparticles.  
 
In this study we will use the powder of the medicinal plant Cinnamomum cassia as the reducing agent 
and aqueous silver nitrate as the precursor for the synthesis of silver nanoparticles (AgNPs). 
Cinnamomum cassia is also called Chinese cassia or Chinese cinnamon, is an evergreen tree 
originating in southern China, and widely cultivated there and elsewhere in southern and eastern Asia 
(India, Indonesia, Laos, Malaysia, Taiwan, Thailand, and Vietnam). Nowadays, the plant is also found 
in the African continent.   
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Medicinal plants have been reported to be useful, worldwide and have been used empirically as 
antidiuretic and antihyperlipidemic remedies.   In this study we are aiming to investigate activity of 
Cinnamomum- cassia silver nanoparticles (AgNPs) on kidneys and blood glucose of type 2 diabetic 
rats.  
 
Materials and Methods 
 Collection of Plant Materials 
Pure Cinnamomum cassia powder was obtained from Warren Chemistry Warren Chem Specialities 
(Pty) Ltd and the silver nitrate was obtained from Capital Laboratory PTY LTD. 
 
Figure 4.0 Cinnamomum cassia adopted from Emilija Manevska/Getty Images 
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Preparation of Aqueous Plants Extracts 
The aqueous extract of Cinnamon cassia was prepared as follows. A fine powder of the plant (10 g) 
was added to 300 mL of double-distilled water and allowed to boil for 10 minutes (Kanagarasu et al., 
2017).  The resulting brownish mixtures were filtered and stored in a refrigerator at 4ºc until analysed.           
                                           
  Synthesis of Green (Cinnamon Cassia) Silver Nanoparticles (AgNPs) 
In the view to reduce Ag+ was achieved by adding 250 mL of aqueous solution of silver nitrate AgNO3 
(1mM) from Capital Laboratory PTY LTD; by drop wise into 100 ml of Cinnamon cassia extracts 
while stirring and heated at 45°C.  While steering the colour of the extracts will be changing, from 
light brown to dark brown, was recorded as a sign of the formation of silver nanoparticles.       
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Figure 4.1: Process of silver nanoparticle formation—Colour changing, from light brown to dark 
brown  
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Quantification of AgNPs 
Each AgNPs   solution was subjected for centrifugation by using the centrifuge of Eppendorf 
(Model:5804/5804 R, USA). The treatment solutions (AgNPs at room temperature and at 80 ºC) were 
then off load into different   Eppendorf tubes. Tubes were weighed beforehand and were sent for 
purification for a duration of 2 h at 5000 rpm and at 4 ºC. The samples were then moved to the oven 
to get dry, as only the powder will be used for the experiment, this process was done at 50 ºC for 24 
h after which the tubes were again re-weighed to assess the yield of the synthesised AgNPs of 150 
mg.  
Morphological Analysis of AgNPs and Characterisation of the Bioreductants 
UV (Ultraviolet) 
The biological reducibility of Ag1 to Ag0 was using a SHIMADZU UV-2600 UV-Vis 
Spectrophotometer (Japan) at a range of 120-900 nm with a resolution of 1 nm. In order to evaluate 
the biological reducing and the functional ability to cap for the AgNPs, infra-red spectra of the crude 
extracts and their corresponding biosynthesised.  
FTIR (Fourier Transform Infrared Spectroscopic) 
AgNPs were obtained on a Perkin Elmer Spectrum 100 Fourier transform infrared (FTIR) 
spectrophotometer (Brito et al., 1998) with universal attenuated total reflectance (Tedong et 
al.,2006) sampling accessory. The size and morphology of the AgNPs were examined using 
transmission and the scanning electron microscopy. 
 TEM (Transmission Electron Microscopy) 
The TEM was also used to obtain selected area electron diffraction (SAED) of the AgNPs in order to 
evaluate their crystallinity. For TEM measurements, solutions of synthesised AgNPs were sonicated 
using a sonication bath (SONICLEAN, England) and the evenly dispersed AgNPs were coated onto 
carbon-coated TEM grids and placed under a lamp for the evaporation of the solvent before viewing. 
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XRD Analysis 
Then a sample was ground/milled to a very fine powder in a gate pestle and mortar. The powder was 
then prepared for XRD analysis using the front loading preparation method. The sample was later 
analysed with a Panalytical Empyrean diffract meter (made in the Netherlands) with an X’ Celerator 
detector and Co-Kα radiation. The generator setting was 40 kV (voltage) and 40 mA (Markowitz et 
al.).  
 Results and Discussions 
Synthesis and Quantification of AgNPS 
Aqueous solution (0.60g) of silver nitrate (AgNO3) was dissolved in 250 mL Erlenmeyer flasks, was 
then added drop wise into 100Ml of Cinnamon extract while stirring and heated at 45°C. Then, the 
solution was kept under constant stirring at room temperature using a magnetic stirrer for 120 minutes 
(Yazid et al., 2016). The colour change of the Cinnamomum cassia extracts from light brown to dark 
brown was recorded as a sign of generating silver nanoparticles. It shows that aqueous silver ions 
could be brought to reduction by aqueous extract of cinnamomum cassia powder to cause extremely 
stable the Silver nanoparticles in water. Therefore, the aqueous solution of biosynthesised AgNPs 
from cinnamomum cassia powder possessed similar shades that give a dark brown colour; strictly 
indicating the formation of AgNPs.  It has been demonstrated that when temperature appears elevated, 
production of molecular energy increases and brings a speeding effect in the absorption of ions within 
the silver and further reducing the particle size.  According to (Phogat et al., 2016), the colour 
difference was due to the reduction of silver ions.  
 UV–Vis Spectral Analysis 
The UV–Vis analysis was performed by running a base line with the solvant (distilled water) at 
different wavelength from 190 to 900 nm, at room temperature and PH: 3.96. An aquoeus component 
of cinnamon cassia was sampled.  The component was scanned over the 190 to 900 nm wavelength 
range. Figure belows, shows the UV–Vis spectra of aqueous component as a function of wave 
variation of with 0.06 g of silver nitrate (AgNO3) into 250 ml of distilled water solution. The sharp 
bands of silver colloids were observed at about 500 nm. The intensity of absorption band increases 
with increasing time period of aqueous component and consequent colour changes were observed 
from light brown to dark brown.  
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 (Phogat et al., 2016) reported that the UV–Vis absorption spectrum with a distinct peak observed at 
445 nm indicated a surface plasmon resonance, which has already been recorded for various metal 
nanoparticles ranging from 2 to 100 nm in size (Zhang et al., 2013).  On contrary, our results display 
a peak at about 500 nm and the TEM revealed nanoparticles are of smaller size. However, the 
absorbance peak observed confirms the formation of AgNPs.  
 
.
 
Figure 4.2: The UV-absorption spectra obtained for Cinnamon Cassia powder. 
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A characteristic peak at 500 nm wavelength is clearly observed, which is indicative of the formation 
of Ag nanoparticles. 
 Fourier Transform Infrared Spectroscopic (FTIR) Analysis  
The functional component present in the Cinnamomum cassia extracts as well as their effects to 
synthesizing (AgNPs) was quantified using the FTIR diagram. A certain amount of the dried powder 
of the (AgNPs) was spared on the pellet of the machine and the analysis was immediately carefully 
performed using Permian Elmer ---Spectrum 100. The absorbance band varies from 3270 to 500 nm. 
The peak of 3270 cm−1   corresponds to the NH, but the carbonic group will be contained in the peak 
of 2921cm−1 and correspond to OH, meanwhile 1604 to 1316 cm−1 should correspond to CO, with a 
stretching to 1075 cm−1 to 1022 cm−1.  
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Figure 4.3: FTIR Spectra of aqueous cinnamon cassia extract and that of AgNPs 
 
 TEM Analysis of Silver Nanoparticles 
Methods: A small amount of powder of the nanoparticles was dispersed in ethanol, and then solicited 
for 10 minutes and dip form, grade into solution. Sample was later dried within 10 minutes.   
Transmission electron microscopy technique was employed to visualize in depth the shape and 
morphology of green Silver nanoparticles produced. Transmission Electron Microscopy (TEM) 
experiments proved the formation of Nano- crystalline silver particles, as shown in Figure 6 and 7.   
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TEM images obtained confirmed that the morphology of nanoparticles is highly variable with a 
variety of shapes- spherical, longitudinal and irregular. The nanoparticles predominately adopt a 
spherical morphology and are not agglomerated into small aggregates. Their size variations are as 
followed: Minimum 12,92 Maximum 42,44 Standard Deviation 7,07 Variance 49,96 Median 25,64 
Mean 25,38 Sum 2055,68.  The nanoparticles behaviour appears to be a function of their size and 
shape, while the difference in shapes and sizes could be due to aggregation and adsorption of 
compounds in Cinnamon cassia extract onto the surface of silver nanoparticles. Although 
nanoparticles size is small but they are very effective when compared with the bulk material.  
TEM of AgNPs synthesized using C. angustifolia reported by (Paton et al., 2014), clearly showed 
that AgNPs are spherical in shape, which is in line with our results.  Further to this, according to  
(Paton et al., 2014) most of the particles in their TEM pictures are not in contact with each other, but 
they are bound to the bio-organic material which is responsible for their stability.  This remark is 
largely confirmed by our result where several particles are spread out 
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  Figure 4.4A2: TEM Images of silver nanoparticles using aqueous cinnamomum cassia 
(magnification 200) 
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Figure 4.4A1: TEM Images of silver nanoparticles using aqueous cinnamomum cassia 
(magnification 200) 
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Figure 4.4B: TEM Images of silver nanoparticles using aqueous cinnamomum cassia (magnification 
500nm) 
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Figure 4.4C: TEM Images of silver nanoparticles using aqueous cinnamomum cassia-Showing 
measurement of particles 
 
 XRD Analysis 
The XRD spectrum showed six distinct diffraction peaks.  The strong peak (Lee et al., 2013) of silver 
heights 1646.63 at 44.693 nm indicating that the biosynthesized nanoparticles are indeed made up of 
only silver.  Followed by two medium peaks 468.56 and 310.62,  
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in addition 2 others medium peaks about 278 and 233.86 were noted. Moreover, one important lower 
peak was also displayed. The XRD results obtained in our experiment show similarities with those of 
(Phogat et al., 2016), which confirm the crystalline nature of the AgNPs with regard to the XRD 
patterns observed in the results.   
 
Figure 4.5: X RD patterns of cinnamon nanoparticles synthesized by treating 100 mL aqueous 
cinnamon with 250 ml aqueous AgNPs. 
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Discussion 
Zeng et al. ( 2014) reported that the UV–Vis absorption spectrum with a distinct peak observed at 
445 nm indicated a surface Plasmon resonance, which has already been recorded for various metal 
nanoparticles  ranging from 2 to 100 nm in size (Sinha et al., 2015; Shankar et al., 2016). On 
contrary, our results display a peak at about 500 nm and the TEM revealed nanoparticles are of 
smaller size. However, the absorbance peak observed confirms the formation of AgNPs. 
TEM of AgNPs synthesized using C. angustifolia reported by Peter et al. (2018) clearly showed that 
AgNPs are spherical in shape, which is in line with our results.  Further to this, according to Peter et 
al. (2018), most of the particles in their TEM pictures are not in contact with each other, but they are 
bound to the bio-organic material which is responsible for their stability.  This remark is largely 
confirmed by our result where several particles are spread out.  
 
Conclusion 
AgNPs were synthesized using cinnamomum cassia extract added to AgNO3 aqueous solution. The 
crystalline nature of the AgNPs was evident from sharp peaks when observed via the XRD spectrum 
with smaller size of CcAgNPs.  FTIR analysis suggests that cinnamomum cassia extract could act as 
the reducing agent responsible for the reduction of Ag+ into Ag. This method is purely 
environmentally friendly, of low cost, and simple and therefore may promote the application of green 
technology for the production of AgNPs.  
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Abstract 
The Streptozotozin (STZ) model of diabetes is being used for studies of diabetic nephropathy 
although the histological morphological lesions of the kidney are mild and do not resemble those 
observed in diabetic patients. The Sprague-Dawley rat model of type II diabetes spontaneously 
develops pronounced abnormalities in renal histology after administration of Streptozotozin (STZ). 
In the present study, we are aiming to investigate the renal ultrastructure in the STZ Sprague-Dawley 
diabetics rats after 56 days’ treatment with Cinnamomum cassia extracts and Cinnamomum silver 
nanoparticles (CcAgNPs). Twenty-four Sprague-Dawley rats (250 ± 20 g) were randomly assigned 
to four groups (A–D) of six animals per group and treated for 8 weeks. Group A was administered 
200 mg/kg of Cinnamon Cassia extract, group B 5 mg/kg of CcAgNPs, group C 10 mg/kg of 
CcAgNPs, and group D normal saline. Body weight was measured weekly and fasting blood glucose 
was measured fortnightly. At the end of the experiment, animals were euthanized and organs (livers 
and kidneys) were fixed in neutral buffered formalin and processed for light microscopy (H&E). The 
renal damage was evaluated by assessing damage indices and by using stereological techniques. In 
addition, electron microscopy was performed. The glomerular and tubulointerstitial changes were 
much more pronounced in the diabetic control group compared to the treated group with CcAgNPs. 
The glomeruli in control groups contained less and larger podocytes as well as smaller mesangial 
cells embedded in more mesangial matrix compared to treated group. exhibits marked structural 
lesions, particularly podocyte damage and mesangial expansion that promise to make it a more 
suitable model for investigation of diabetic glomerulosclerosis. There was change in the Glomeruli 
Basement Membrane in both groups, but more pronounced in the control. CcAgNPs restores 
morphology and function of kidney after a long period of administration.  
Key words: Histology, glomeruli, tubulointerstitial, Streptozotozin. 
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Introduction 
Diabetes mellitus DeFronzo et al. (1991) is characterized by the absence of insulin leading to glucose 
overproduction and its underutilization in the liver. However, the insulin-independent tissues such as 
kidney demonstrate over-utilization of glucose during diabetes due to hyperglycaemia (Witowski and 
Breborowicz, 1999). Various renal pathological changes along with functional disturbances has been 
revealed in experimental diabetes (Yokozawa et al., 2001). It was reported thrombospondin-1 (TSP-
1) was a matricellular, calcium-binding protein that is involved in cellular responses to growth factors, 
cytokines, and lesions. Previous studies have demonstrated that in glomerular mesangium fibrosis 
induced by angiotensin II, many genes expression increased, of which TSP-1 may cause the process 
of diabetic glomerulosclerosis (Hugo, 2003). Our previous study has shown that up-regulation of 
TSP-1 expression in diabetic rodent heart can play a role in diabetic cardiomyopathy. 
Silver nanoparticles (AgNPs) have gained unique attention because of their attractive properties, 
including their high surface to volume proportions, reactant properties, and antimicrobial impact 
(Okafor et al., 2013). This is particularly relevant in the health sciences as it opens new frontiers in 
drug synthesis and delivery needed to target some of the sanctuary sites difficult for normal 
therapeutic doses of drugs to penetrate (Peter et al., 2018). However, most techniques used for the 
synthesis of nanoparticles (NPs) are costly and may negatively influence biological systems. 
The human kidney is responsible for several functions, such as filtration of the plasma, blood pressure 
control, and hormonal production among others. Kidneys are bean-shaped organs located in the 
retroperitoneal space, irrigated by the renal artery, and covered by its fibrous capsule. Renal 
parenchyma can be distinguished into cortex and medullar regions, with different anatomic–
histological characteristics. Inside a human kidney, there are about one million nephrons, which are 
composed of tubules and renal corpuscles. The corpuscles contain several tortuous arterioles covered 
by podocytes. The set of the endothelial layer of these arterioles, its basement membrane, and the 
podocytes correspond to the glomerular filtration barrier. The ultrafiltration of the plasma by 
this barrier and formation of the primary urine requires normal glomerular morphology. It is 
well documented that the podocytes are important to guarantee the selectivity during the filtration 
process, preventing macromolecules that pass through the slit diaphragm formed between its foot 
processes.  
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Many studies suggest that alterations on these cells or on the vessels, as those during hypertension, 
diabetes, or lupus, can reduce the oxygen flux, leading to hypoxia stage, being responsible for 
podocyte alteration and death. The glomerular filtration barrier morphology has been extensively 
studied in several experimental and clinical conditions. For this purpose, electron microscopy (both 
transmission and scanning) suits perfectly for observing the fine structure of this barrier, indicating 
with accuracy morphological alterations when present. Thus, in this chapter, we aimed (a) to describe 
the elements of the glomerular filtration barrier, (b) to present scientific examples of how the 
glomerular filtration barrier elements are related to different clinical and experimental conditions, and 
(c) to show how the elements of the glomerular filtration barrier can be analysed by scanning and 
transmission electron microscopy with qualitative and quantitative methods. 
 
.MATERIALS AND METHODS 
 Materials and Methods 
 Collection of Plant Material 
Pure C. cassia powder was obtained from Warren Chemistry Specialities (Pty), Cape Town 
(Reference 492733) and silver nitrate (AgNO3) was obtained from Capital Laboratory (Pty), 
KwaZulu-Natal.  
 Preparation of Aqueous Plants Extract 
The aqueous extract of C. cassia was prepared by adding a fine powder of the plant (10 g) to 300 mL 
of double-distilled water, which was allowed to boil for 10 min. The resulting mixture was filtered 
and stored in a refrigerator at 4ºC until analysed.                                   
 Synthesis of Cinnamomum Cassia Silver Nanoparticles (CcAgNPs) 
An aqueous solution of AgNO3 was dissolved in 250 mL Erlenmeyer flasks, and was then added, 
dropwise into 100 mL of the plant extract while stirring and heated at 45°C. This solution was stirred 
constantly at room temperature using a magnetic stirrer for 120 minutes. A colour change from light 
brown to dark brown indicated the formation of AgNPs. 
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 Structural Analysis of Cinnamomum Cassia Silver Nanoparticles (CcAgNPs) 
The CcAgNPs solution was centrifuged with an Eppendorf Centrifuge (Model: 5804/5804 R, USA). 
The treated solutions were transferred separately into Eppendorf tubes that were pre-weighed, 
subjected to purification for 2 h at 5000 rpm at 4ºC.  
Animal Handling and Ethics Approval  
Twenty-four (24) pathogen-free, male, Sprague-Dawley rats weighing 250 ± 20 g were selected for 
the experiments; they were kept and maintained under laboratory conditions at a temperature of 21.5 
– 2.2ºC, humidity (60 ± 1%), and 12 h light/dark cycle. They were allowed free access to food 
(standard pellets) and water and fed (ad libitum).  
Animals were allowed seven days to acclimatize in their respective cages before commencement of 
experiments. The institutional Ethics Committee of the University of KwaZulu-Natal (Ethics 
references number AREC/074/016 D) approved experimental protocols and procedures used in this 
study. 
Induction of Type 2 Diabetes  
Hyperglycaemia was induced by injecting nicotinamide (100 mg/kg of body weight) (Sigma Aldrich, 
SA) and Streptozotozin (STZ, 60 mg/kg I.P).   Nicotinamide was administered 15 min before the 
administration of STZ, which was dissolved in phosphate buffer citrate at pH 4.5 immediately before 
use (18). Animals were then kept under observation for confirmation of successful induction. Blood 
glucose was tested and monitored on days zero, seven, fourteen, twenty-eight, forty-two and fifty-
six, respectively. The animals were tested using Accu - chek Active 50 (Roche), blood glucose strips 
(Dischem, South Africa), with blood collected from the tail vein of the rats at 10 am daily.   The 
animals with a fasting blood glucose level > 9 mmol/L were considered diabetic. 
 Experimental Design 
Six experimental Sprague-Dawley STZ induced diabetic rats were assigned randomly to the different 
groups and received different treatment protocols. In Group A (control), rats received normal saline 
(1 mL) orally once per day.  
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Group B rats were administered with CcAgNPs at low dose (5 mg/kg) orally, once per day. Group C 
rats were administered with CcAgNPs at high dose (10 mg/kg) orally, once per day. Group D rats 
were administered with plant extracts at 200 mg/kg.  CcAgNPs and plant extracts were dissolved in 
normal saline and administered orally once daily at 10 am for 56 consecutive days, using a rat gavage 
needle. 
 Fasting blood glucose (FBG) was measured on days 0, 14, 28, 42 and 56.  Body weight was recorded 
every week in the morning between 8:00 and 10:00 am using an electronic balance (Zeiss, West 
Germany (Pty) Ltd; 0.000 g calibration).  At the end of the experiment, all rats were sacrificed with 
excess Halothane anaesthesia. Blood was then collected via transcardiac puncture for biochemistry 
and organs harvested after laparotomy for histology studies. In addition, the weight of the kidneys 
was recorded. 
Histopathological Examination of Kidney Tissues  
Kidneys were washed in saline and fixed in 10% neutral buffered formalin for 24 h. Samples were 
transferred to 70% ethanol (Bailey and Day, 1989). They were then processed using ascending grades 
of alcohol to dehydrate the samples, and xylene was used as the clearing agent. Samples were 
mounted in molten paraffin at 58 - 62ºC.  Slices (5 μm) were cut using a microtome (Microtome HM 
315, Walldorf, Germany) from the prepared blocks and stained with hematoxylin and eosin dyes (H 
& E).  
Additionally, the periodic Acid-Schiff (Inzucchi et al.,2012) staining technique used in routine 
histopathological investigations that detects the presence of polysaccharides (e.g. glycogen) and 
muco-substances (e.g. glycoproteins, glycolipds and mucins) in tissues or slides, was used. The PAS 
technique is most commonly used to demonstrate the thickness of glomerular basement membrane 
when renal disease is being assessed.  Sections were viewed and photographed using an Olympus 
light microscope (Olympus BX51, Tokyo, Japan) with an attached camera (Olympus E-330, Olympus 
Optical Co. Ltd., Tokyo, Japan). 
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Transmission electron microscope (TEM) 
Transmission electron microscope (TEM) was used to further provide a more detailed morphologic 
and compositional information on samples (most especially on Glomeruli and tubules). This was done 
after the tissues were fixed overnight at 4oC in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer 
(pH 7.4) and transferred to 0.1 M phosphate buffer (pH 7.2). The cells were postfixed in 1% osmium 
tetroxide in S-collidine, dehydrated in graded ethanol, transferred to propylene oxide, and embedded 
in Epon 812. Semi-thin sections were stained with 1% methylene blue. The samples were further 
sectioned into ultrathin slices (75 nm), contrasted with uranyl acetate and lead citrate and observed 
on a transmission electron microscope (Bressenot et al., 2009). 
 Statistical Analysis  
All results are presented as the mean ± standard error of mean (SE). Statistical analysis was performed 
using one-way analysis of variance (Oberdörster et al.) followed by Turkey’s post-hoc test with Graph 
Pad Prism 5 version 2007. Comparisons with P < 0.05 were considered to be statistically significant. 
 Results 
 Synthesis of Cinnamomum Cassia Silver Nanoparticles (CcAgNPs) 
The aqueous solution of biosynthesized AgNPs from C. cassia powder gave a dark brown colour 
which was a visual indication of the formation of AgNPs (150 mg). 
Effects of Cinnamomum Cassia Silver Nanoparticles (Ccagnps) on the Histomorphology of 
Kidneys 
Histological sections of kidney tissues (H & E) in the diabetic control group showed a generalised 
distortion in glomerular architecture with atrophic and necrotic changes, pyknotic nuclei as well as 
infiltrations of mesangial spaces and interstitium. Many of the proximal and distal convoluted tubules 
showed hypertrophic cells and vacuolization (Figure)  
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Kidney sections of animals administered with 5 mg/kg of CcAgNPs showed moderate degenerative 
changes in the glomeruli. The mesangium and interstitium were essentially normal with cellular 
components (Figure). In rats treated with high doses of CcAgNPs (10 mg/kg), kidney sections 
 (Figure) showed glomeruli with Bowman’s space and capillary tufts essentially normal, compared 
to controls. The kidney sections of the normal control (Figure) was essentially normal with clearly 
visible glomeruli, basement membrane of capsular wall as well as mesangial tissues. The intirstitium 
was essentially normal with no infiltrations. 
PAS-stained sections of the diabetic control (Group A) showed kidney sections with glomerular 
distortions and ruptured capsular wall (stained purple), thickened basement membranes as well as 
hypocellularity in the interstitial components. Kidney sections in groups B and C (treated with 
CCAgNPs at different doses) shows a better histological PAS-staining intensity for glycogens and 
the capsular walls of the glomeruli in the low-dose group.  
The mesangial tissues were clearly delineated and interstitial tissue did not indicate any abnormalities. 
Group D (normal control) showed kidney sections that are well preserved and PAS-positive 
glomerular capsular basement layers stained purple indicating a normal glomerular tuft/capillary 
meshwork. The proximal and distal convoluted tubular cells are clearly shown with no abnormality 
and the glycogen-stained membranes of tubules are clearly visible (purple). 
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Figure 1: Kidney sections (H & E) from STZ- diabetic Rats-Control group 
 
 
Figure 2. Kidney sections (H & E) from STZ- diabetic rats after treatment with Cinnamomum cassia 
silver nanoparticles (CcAgNPs). -(5 mg/kg). 
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Figure 3. Kidney sections (H & E) from STZ- diabetic rats after treatment with Cinnamomum cassia 
silver nanoparticles (CcAgNPs). (10 mg/kg) 
 
 
Figure 4. Kidney sections (H & E) from STZ- diabetic rats after treatment with Cinnamomum cassia 
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Ultrastructural Findings of Transmission Electron Microscopy  
 
 
Figure 2: bowman space—diabetic group under treatment (CcAgNPs). 
(magnification X10000)—scale 1 µm 
A= Glomeruli –B=Urine Space 
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Figure 1: Diabetic group-control.  
(magnification X10000)—scale 1 µm 
A= Glomeruli –B=Urine Space 
 
 
Figure 3: Glomerular basement membrane and podocytes 
(magnification X10000)—scale 1 µm C=Podocytes  –D=Glomeruli Membrane 
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Figure 4:A control diabetic 
(Magnification X 10000) Scale bar 1 µm, A= Glomeruli –B=Urine Space, D=Glomerular 
Membrane. 
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Figure 4:B control diabetic group.  
(Magnification 10000), Scale Bar 1 µm 
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Abstract 
Cinnamomum cassia was extracted to investigate its ant hyperglycemic and protective effects on renal 
structural changes in STZ-induced diabetes. Eighteen male Sprague Dawley rats were divided into 
three groups randomly; the first group as diabetic control, the second group as diabetic treated with 
low dose (5 mg/kg) of CcAgNPs, the third group treated with high dose of CcAgNPs (10mg/kg), 
through oro-gavage, respectively, for 56 days. Diabetes was induced by administration of 60 mg/kg 
bw of Streptozotozin intraperitoneally.  
Serum glucose level was monitored every day. At the 56 th day, the subjects were sacrificed and the 
kidneys were removed. Tissue sections were stained by periodic acid Schiff and used for stereological 
analysis. The means were compared by one-way ANOVA and Tukey’s post hoc test at the 
significance level of P < 0.05. The results showed that CcAgNPs significantly restored the blood 
glucose level toward normal level. High dose of CcAgNPs could significantly decrease the length 
and space of the bowman space and dimensions of proximal and distal tubules. Both doses 
of CcAgNPs could significantly prevent the glomerular hypertrophy and reduction of the basement 
membrane under the effect of CcAgNPs, compared to control. It can be concluded that CcAgNPs at 
high dose can ameliorate structural nephropathy in diabetic Sprague Dawley rats. 
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INTRODUCTION 
Type 2 diabetes mellitus is about 90% diabetes and had universal widespread evaluate of 2.8% in the 
year 2000 and is expected to be 4.4% in 2030 (Wild, 2004). Both Type 1 and Type 2 diabetes, complex 
pathophysiology, including insulin resistance syndrome and hyperglycaemia, which are associated 
with abnormalities in reactive nitrogen species and fat species (Brownlee, 2001; Green et al., 2004). 
Streptozotocin (STZ) is surely wide vision antibiotic and cytotoxic chemical that is Three days after 
the administration of streptozotocin, the development of diabetes in two experimental groups was 
confirmed by measuring the glucose levels in the blood.  Diabetes mellitus is the very popular lifestyle 
illness distinguished via high blood glucose level and glucose intolerance due to insulin insufficiency, 
reduced performances 5% of the world community human murderer after cancer and cardiovascular 
sickness (Taylor, 1999). Type 1 diabetes mediated autoimmune demolition of pancreatic islet beta 
cells, driving to lack of insulin output. It has ability to take place at all ages. Type 2 diabetes mellitus 
is about 90% - 95% of all diabetes and had universal widespread evaluate of 2.8% in the year 2000 
and is expected to be 4.4% in 2030 (Wild et al., 2004). Both Type 1 and Type 2 diabetes mellitus 
have complex pathophysiology, including insulin resistance syndrome and hyperglycaemia, which 
are associated with abnormalities in reactive nitrogen species and fat species., 2004). It has been 
vastly utilized to stimulate diabetes in animal models particularly rats and mice (Brentjens and Saltz, 
2001; Hayashi et al., 2006). Early diabetes mellitus and acute experimental diabetes have been shown 
to improve renal function and glomerular function (Hostetter, 1981). The number of glomeruli in a 
kidney can change as a result of disease A decrease in the number of glomeruli ca (John et al., 1992).  
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The basement membrane thickening is a broadly acknowledged distinctive of small blood vessel 
diabetic illness (Huang, 1980). In glomeruli and kidneys of diabetic patients, marked basement 
membranes thickening is monitored. Furthermore, it is believed this alteration might result in the 
kidneys premature degeneration (Steffes et al., 1979; Isogia experimental diabetes mellitus in animal, 
STZ and Alloxan are widely utilized medicines. STZ and Alloxan diabetogenic factors damage the B 
cell of the pancreas. In addition, they have various cytotoxic activities. Intracellular construction of 
hydrogen peroxide, hydroxyl radicals and superoxide radicals are generated by reaction the Alloxan. 
Commons Attribution License, which permits toxic to the pancreatic, insulin making beta cells in 
mammals (Szkudelski, 2001; Hayashi et al., 2006; Takeshita et., 2006). It has been vastly utilized to 
stimulate diabetes in animal models particularly rats and mice (Brentjens and Saltz, 2006).Early 
diabetes mellitus and acute experimental diabetes have been shown to improve renal function and 
glomerular function (Mogensen and Andersen, 1984 ). The number of glomeruli in a kidney as a 
result of disease and aging (Heptinstall, 1983). A decrease in the number of glomeruli causes various 
diseases., 1992). The basement membrane thickening is a broadly acknowledged distinctive of small 
blood vessel diabetic illness (Huang, 1980). In glomeruli and capillaries in kidneys of diabetic 
patients, marked basement membranes thickening is monitored. Furthermore, it is believed this 
alteration might result in the kidneys premature degeneration., 1979; Isogia et al., 1998). As to make 
entail diabetes contain trace quantities of reactive iron within secondary lysosomes. The lysosomal 
hydrolases seepage and further cellular degeneration is caused by the ensuing lysosomal membrane 
damage. The weakness excretion of insulin results in production of nitrite, energizing of islet guanylyl 
cyclase and collection of cGMP, and inhibition of islet mitochondrial aconitase activity occurred 
when STZ through the glu transporter (GLUT2) come in to the B cell.  
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The local liberation of nitric oxide from STZ within islets might mediate impact of STZ on β-cells. 
This might results in DNA alkylation and insulin tyrosine kinase receptor activity reduction. After 
that, the damaged DNA makes B cells go through the destruction via necrosis (Szkudelski, 2001).The 
most significant component of the volatile oil from Nigella sativa Thymoquinone (TQ). It has strong 
antioxidant characteristics. The organs are protected by TQ against oxidative impairment enthused 
via a range of free radical producing agents like doxorubicin evoked cardiotoxicity, carbon 
tetrachloride induced hepatotoxicity, nephropathy produced by cisplatin autoimmune and allergic 
encephalomyelitis and stom mucosal damage evoked via ischemia reperfusion (Nagi and Mansour, 
2000; Al-Majed et al., 2006). 
 
.MATERIALS AND METHODS 
 Materials and Methods 
 Collection of Plant Material 
Pure C. cassia powder was obtained from Warren Chemistry Specialities (Pty), Cape Town 
(Reference 492733) and silver nitrate (AgNO3) was obtained from Capital Laboratory (Pty), 
KwaZulu-Natal.  
 Preparation of Aqueous Plants Extract 
The aqueous extract of C. cassia was prepared by adding a fine powder of the plant (10 g) to 300 mL 
of double-distilled water, which was allowed to boil for 10 min. The resulting mixture was filtered 
and stored in a refrigerator at 4ºC until analysed.          
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 Synthesis of Cinnamomum Cassia Silver Nanoparticles (CcAgNPs) 
An aqueous solution of AgNO3 was dissolved in 250 mL Erlenmeyer flasks, and was then added, 
dropwise into 100 mL of the plant extract while stirring and heated at 45°C. This solution was stirred 
constantly at room temperature using a magnetic stirrer for 120 minutes. A colour change from light 
brown to dark brown indicated the formation of AgNPs. 
 
 Structural Analysis of Cinnamomum Cassia Silver Nanoparticles (CcAgNPs) 
The CcAgNPs solution was centrifuged with an Eppendorf Centrifuge (Model: 5804/5804 R, USA). 
The treated solutions were transferred separately into Eppendorf tubes that were pre-weighed, 
subjected to purification for 2 h at 5000 rpm at 4ºC.  
 
Animal Handling and Ethics Approval  
Twenty-four (24) pathogen-free, male, Sprague-Dawley rats weighing 250 ± 20 g were selected for 
the experiments; they were kept and maintained under laboratory conditions at a temperature of 21.5 
– 2.2ºC, humidity (60 ± 1%), and 12 h light/dark cycle. They were allowed free access to food 
(standard pellets) and water and fed (ad libitum).  
Animals were allowed seven days to acclimatize in their respective cages before commencement of 
experiments. The institutional Ethics Committee of the University of KwaZulu-Natal (Ethics 
references number AREC/074/016 D) approved experimental protocols and procedures used in this 
study. 
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Induction of Type 2 Diabetes  
Hyperglycaemia was induced by injecting nicotinamide (100 mg/kg of body weight) (Sigma Aldrich, 
SA) and Streptozotozin (STZ, 60 mg/kg I.P).   Nicotinamide was administered 15 min before the 
administration of STZ, which was dissolved in phosphate buffer citrate at pH 4.5 immediately before 
use (18). Animals were then kept under observation for confirmation of successful induction. Blood 
glucose was tested and monitored on days zero, seven, fourteen, twenty-eight, forty-two and fifty-
six, respectively. The animals were tested using Accu - chek Active 50 (Roche), blood glucose strips 
(Dischem, South Africa), with blood collected from the tail vein of the rats at 10 am daily.   The 
animals with a fasting blood glucose level > 9 mmol/L were considered diabetic. 
 Experimental Design 
Six experimental Sprague-Dawley STZ induced diabetic rats were assigned randomly to the different 
groups and received different treatment protocols. In Group A (control), rats received normal saline 
(1 mL) orally once per day. Group B rats were administered with CcAgNPs at low dose (5 mg/kg) 
orally, once per day (7). Group C rats were administered with CcAgNPs at high dose (10 mg/kg) 
orally, once per day (7). Group D rats were administered with plant extracts at 200 mg/kg.  CcAgNPs 
and plant extracts were dissolved in normal saline and administered orally once daily at 10 am for 56 
consecutive days, using a rat gavage needle (17). 
 
 Fasting blood glucose (FBG) was measured on days 0, 14, 28, 42 and 56.  Body weight was recorded 
every week in the morning between 8:00 and 10:00 am using an electronic balance (Zeiss, West 
Germany (Pty) Ltd; 0.000 g calibration).  At the end of the experiment, all rats were sacrificed with 
excess Halothane anaesthesia. Blood was then collected via transcardiac puncture for biochemistry 
and organs harvested after laparotomy for histology studies. In addition, the weight of the kidneys 
was recorded. 
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Histopathological Examination of Kidney Tissues  
Kidneys were washed in saline and fixed in 10% neutral buffered formalin for 24 h. Samples were 
transferred to 70% ethanol (Bailey and Day, 1989). They were then processed using ascending grades 
of alcohol to dehydrate the samples, and xylene was used as the clearing agent. Samples were 
mounted in molten paraffin at 58 - 62ºC.  Slices (5 μm) were cut using a microtome (Microtome HM 
315, Walldorf, Germany) from the prepared blocks and stained with hematoxylin and eosin dyes (H 
& E).  
 
Additionally, the periodic Acid-Schif staining technique used in routine histopathological 
investigations that detects the presence of polysaccharides (e.g. glycogen) and muco-substances (e.g. 
glycoproteins, glycolipds and mucins) in tissues or slides, was used. The PAS technique is most 
commonly used to demonstrate the thickness of glomerular basement membrane when renal disease 
is being assessed (54). Sections were viewed and photographed using an Olympus light microscope 
(Olympus BX51, Tokyo, Japan) with an attached camera (Olympus E-330, Olympus Optical Co. Ltd., 
Tokyo, Japan). 
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Figure 1: Normal Glomerulus, A 
Figure 2: Damaged Glomerulus,B 
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Figure 3: Damaged and Undamaged 
Glomerula, A and B 
 Figure 4: Undamaged Glomerus,A 
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Figure 5: Indicating the percentage of Undamaged glomeruli, within separate treatment groups 
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